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QUILL ON SCALPEL

Pelvic Ring Fractures
J.P. Waddell, MD, FRCSC
Member, Editorial Board, Canadian Journal o f Surgery. Professor o f Surgery, University o f
Toronto, Division o f Orthopedics, St. Michael's Hospital, Toronto, Ont.

injury to the pelvic ring
Severe
has long been recognized as a

cause of early morbidity and mortal
ity in traumatized patients. Pelvic
fractures are often complicated by
associated visceral and neurologic
injury and serious retroperitoneal
hemorrhage. Patients who survive
the initial injury often have long
term problems associated with the
pelvic injury, such as persistent
visceral dysfunction, pelvic deformi
ty and pain.
The Canadian Journal of Surgery
1867 Alta Vista Dr.
Ottawa, Ont. K1G 3Y6

With experience, orthopedic and
trauma surgeons have learned that
the immediate fixation of long-bone
fractures substantially improves the
prognosis for the multiply injured
patient. This is also becoming evi
dent in the case of pelvic fractures.
The benefit derived from immediate
fixation of pelvic fractures has
greatly enhanced the effectiveness
of the initial resuscitation of trau
matized patients.
In this issue (pages 447 to 450)
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ing care. McLaren, Rorabeck and
Halpenny (pages 492 to 494) dem
onstrate unequivocally that anatom
ic reduction and sound healing of
displaced posterior pelvic ring inju
ries will result in a better long-term
outcome for patients with pelvic
ring disruption. Therefore, there
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are compelling reasons to consider
improved methods of obtaining re
duction and securing fixation of
these fractures.
Long neglected as a fracture for
which no form of active treatment
was possible, pelvic fractures have
been given low priority in the man
agement of the polytraumatized pa
tient. As understanding of the pos
sibility of controlling the acute
symptoms and preventing late com
plications has improved, aggressive
management of pelvic trauma has
become the norm in many trauma
centres. In patients whose pelvic
trauma appears to be associated
with hemorrhage, I recommend a
trial application of the pneumatic
antishock garment (PASG). We use
this in our hospital as an emergen
cy method of managing pelvic trau
ma because it stabilizes the pelvis
and permits patients to be trans
ferred from the emergency room to
the radiology department and to the
operating room rapidly and with a
minimum of difficulty.
At St. Michael’s Hospital we tend
to follow the recommendation of
McLaren’s group: an anterior exter
nal fixator is applied as definitive
management of the pelvic fracture
on the day of injury; open reduction
with internal fixation of the pos
terior injury is carried out later if
necessary. Although we recognize
that some patients with multiple
injuries will not be able to return to
the operating room for days or
weeks because of their other inju
ries, we believe that the immediate
problem with pelvic fractures lies in
a lack of stabilization and not lack
of anatomic reduction. Therefore, in
our opinion, the risk of increased
hemorrhage and the prolonged
anesthetic time that results from
immediate open reduction and inter
nal fixation of such injuries out
weighs the potential benefits of
early anatomic stabilization, despite
O’Brien’s claims to the contrary.
432

The following sequential steps in
management might be deduced
from these two papers.
• Identification of the pelvic
fracture as the most important
cause of ongoing hemorrhage in
traumatized patients.
• Immediate stabilization of the
pelvic fracture with a PASG to
assist in hemodynamic stabilization
and patient transfer. The garment
should not be left inflated for lon
ger than 1 hour. Improved hemody
namic status secondary to pelvic
stabilization with the PASG demon
strates that the pelvic fracture is
the cause of ongoing hemorrhage.
• Stabilization of the fracture by
the application of an anterior frame
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without delay. Definitive open re
duction and internal fixation can be
carried out on the day of injury if it
does not necessitate prolonged an
esthesia or increase the risk of
hemorrhage and is technically pos
sible. If not, the use of an anterior
fixation frame should be instituted
and continued until anatomic reduc
tion and internal fixation of the
posterior injury are feasible.
Active, aggressive management
of pelvic fractures will decrease
both the morbidity and mortality in
polytrauma patients. To be success
ful, treatment depends on a thor
ough understanding of pelvic anato
my, fracture classification and sur
gical technique.*

SESAP VI Question
Item 125

A 40-year-old man is admitted after being pinned under a steel beam. A
severe unstable pelvic fracture is the only injury. He is given 10 units of
blood during the first 4 hours of hospitalization, but his hematocrit
remains 20%. His blood pressure is 90/60 and pulse is 120. The next
step in management should be

(A) continued transfusion only
(B) arterial embolization of internal iliac arteries
(C) celiotomy to oversew bleeding vessel
(D) embolization of pelvic veins
(E) placement of an external pelvic fixation device

For the incomplete statement above select the best of the five
completions.
For the critique of Item 125 see page 498.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa
tion and Self-Assessment Program No. 6. For enrolment in Surgical
Education and Self-Assessment No. 6, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)

QUILL ON SCALPEL

Laparoscopic Cholecystectomy
Fantastic?
N. Schmidt, MD, FRCSC
Member, Editorial Board, Canadian Journal o f Surgery. Clinical professor, Department o f
Surgery, University o f British Columbia, Vancouver, BC

ix months ago I offered the
following words of wisdom:
“ there are not enough facilities,
resources or ‘superlaparoscopists’
available for all centres to offer all
possible treatments to all biliary
tract sufferers” .1 I was trying to
suggest that change in biliary tract
management is moving so fast that
general surgeons will lose out un
less they step firmly into the centre
o f the biliary tract mosaic. General
surgeons must take an increased
interest in all aspects of biliary tract
management, otherwise even the
ordinary cholecystectomy will disap
pear from their slate of operative
procedures.
Laparoscopy as a diagnostic pro
cedure dates back at least to 1937.2
A surgical technique well developed
by gynecologists for use in the
abdomen and female pelvis, it has
been used extensively by only a few
general surgeons who have found it
valuable in abdominal diagnosis and
treatment.3 Apart from peritoneal
visualization, lysis of adhesions, the
occasional removal of an appendix
and biopsy for primary and second
ary tumours, little imagination was
given to other possible uses. Scant
attention was paid to the idea of
removing the gallbladder in this
manner until Reddick and col
leagues published their initial clini
cal experience, a series of five pa
tients.4 Only a few months before
Perissat had described the French

S

experience in a short clinical pre
sentation at the International Surgi
cal Society meeting in Toronto
(September 1988). Following these
descriptions ideas in laparoscopic
surgery swept the world through
publications, videotapes, news re
ports and training programs. Gener
al surgeons are queuing up for
training courses in laparoscopic
cholecystectomy all over North
America. Some centres are reaping
large financial rewards and even
surgical politics and turf issues are
not far behind. General surgeons
dare not remain skeptical if they
wish to continue to manage pa
tients with gallbladder problems.
New advances and procedures in
the field of general surgery come
infrequently. This technique is a
refreshing innovation and is largely
the result of advances in technolo
gy, allowing the procedure to be
done with safe disposable laparo
scopic trochars and disposable, mul
tiple-use endoclipping devices. Best
o f all, clear, high-resolution video
cameras and videoscopes offer a
view of the gallbladder and its duc
tal and arterial anatomy never seen
before. With practice, the initial
uncomfortable eye-hand coordina
tion required to operate by indirect
videoviewing eases. With care, a
satisfying cholecystectomy using
cautery or laser dissection and clip
ping o f structures allows the deliv
ery o f the gallbladder through a

small stab wound in the abdominal
wall. This is all done with or with
out operative cholangiography.
When patients awaken from anes
thesia they often require only mild
oral analgesia and can usually be
discharged from hospital the follow
ing morning, having made a very
easy recovery from a procedure
whose duration averages 90 min
utes. Compared with the standard 5
to 7 days in hospital, a large inci
sion and 4 to 6 weeks’ recupera
tion, it is no wonder that most
patients requiring cholecystectomy
are now inquiring about and re
questing the laparoscopic proce
dure.
Is laparoscopic cholecystectomy
really so simple and are there risks
and contraindications to the proce
dure? The indications for the proce
dure are the same as for standard
cholecystectomy. Relative contrain
dications relate to the operating
team’s experience and will include
acute cholecystitis, jaundice, cirrho
sis, pancreatitis, obesity, pregnancy,
past surgical procedures to the ab
domen, chronicity, fibrous contrac
ture o f the gallbladder and cardiac
and respiratory insufficiency. Oper
ative cholangiography is possible,
but bile-duct exploration is not.
Bile-duct stones, if present, can be
treated by biliary lithotripsy, endo
scopic retrograde cholangiopancreatographic papillotomy or percu
taneous transhepatic approaches to
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the biliary tree. The patient must be
informed of the same possible risks
and complications as open cholecys
tectomy and of the possible need to
“convert” the procedure to an open
operation. Problems of bleeding
have occurred, necessitating open
laparotomy for control. Common
bile ducts have been injured as a
result of anatomical obscurity and
tenting of the duct with gallbladder
retraction (Canadian Laparoscopic
Surgery Interest Group: Unpub
lished data, 1990). The risk of these
problems diminishes with experi
ence, but great care must always be
taken, especially in the early part of
the surgeon’s learning curve. Confi
dence with the technique rises with
the number of procedures per
formed, but 20 to 30 procedures
are considered necessary before the
surgeon extends the indications to
include more complicated gallblad
der disease.
Who should be offering this op
eration and how does one obtain
the training? The Canadian Associa
tion of General Surgeons (CAGS)
has suggested qualifications for
granting privileges to general sur
geons wanting to practise laparo
scopic cholecystectomy. These
guidelines are spelled out in the
editorial “ Laparoscopic cholecystec
tomy: let us control the virus” in
this issue of the journal (pages 435
and 436).
If the CAGS guidelines are fol
lowed experience with diagnostic
pelvic laparoscopy alone is not suf
ficient qualification. Nonsurgeons
experienced with endoscopic proce
dures are not qualified. Laparoscop
ic surgical skills are not the same as
endoscopic skills, although there is
certainly a transfer of coordination
from doing colonic polypectomies

434

to the eye-hand coordination of
laparoscopic cholecystectomy.
To obtain training for this new
procedure, general surgical resi
dents are learning the technique as
the operation becomes increasingly
available and popular. Practising
general surgeons are learning the
technique in the United States and
Europe, until Canadian training
programs become established at
university centres across the coun
try.
The impact of this new approach
on cholecystectomy is obvious.
Hundreds of laparoscopic cholecys
tectomies are being done in the US
as day-care and overnight-stay am
bulatory procedures. It is becoming
the standard procedure for the
treatment of chronic cholecystitis.
About 75% of patients who are
referred have indications for the
procedure and, of these, 95% under
go the procedure, with a conversion
rate of 5% to open cholecystectomy
(Zucker KA: Personal communica
tion, 1990). Surgeons in the US
perform four to five laparoscopic
cholecystectomies per day and have
the instruments, operating-room
time and assistants to do so. The
procedure has reduced the cost of
hospital stay and the turnover rate
to the surgeons’ economic advan
tage. In Canada the evolution of the
procedure will be different. With
the limitations presently evident in
the Canadian health care system of
operating room time, ambulatory
care space, instrument availability
and high cost to the hospital bud
get for the first 48 hours of surgi
cal care, there is no enthusiasm for
doing four to five laparoscopic
cholecystectomies daily. Perfor
mance of this many procedures in 1
week has already caused the admin
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istration in one hospital to limit the
rate and number of procedures. In
smaller community hospitals sur
geons may have to team up to do
their procedures since two or three
operators are required. In single
surgeon communities, this proce
dure may not be feasible at all,
resulting in gallbladder surgery
going to larger centres. Already the
waiting list is growing as people put
off the standard procedure until the
“new operation” is available. With
the decreased morbidity of this pro
cedure additional patients with only
minor gallbladder symptoms, who
had decided against the standard
procedure, may now also be added
to the list.
So it appears that the excitement
and enthusiasm for this new ap
proach to gallbladder treatment
with all its advantages and possibili
ties may open new complexities in
delivering that surgical care. The
problem of not enough “superlaparoscopists” may not be the lim
iting factor after all. The con
straints of a rationed health care
system may confound us in new
ways to thwart what appears to be a
fast, expedient and safe advance in
treating gallbladder disease. This
new approach is fantastic, let’s get
on with it.

References
1. S chmidt N: Biliary colic. Can J Surg
1990; 33: 87-88
2. R uddock JC: Peritoneoscopy. Surg Clin
North Am 1957; 37: 1249-1253
3. Nagy AG, J ames D: Diagnostic laparos
copy. Am J Surg 1989; 157: 490-493
4. Reddick EJ, Olsen DO, Danielli JF et al;
Laparoscopic laser cholecystectomy.
Laser Med Surg News 1989; 7: 38-40

QUILL ON SCALPEL

Laparoscopic Cholecystectomy:
Let Us Control the Virus
Roger G. Keith, MD, FRCSC
Secretary, Canadian Association o f General Surgeons. Member, Editorial Board, Canadian
Journal o f Surgery. Professor and chairman, Department o f Surgery, University o f
Saskatchewan, Saskatoon, Sask.

he virus of laparoscopic chole
cystectomy has become epi
demic in its uncontrolled spread
throughout North America. The
promotion of this new technique as
a panacea for cholecystitis is direct
ly attributable to intense commer
cial profiteering, surgical entrepre
neurship and, not least, patient de
mand as a result of descriptions in
nonscientific publications.
Commercial interest in the non
scientific introduction of this tech
nique to the surgeons of North
America was demonstrated at the
recent annual meeting of the Ameri
can College of Surgeons, attended
by more than 10 000 specialists and
trainees. In an unprecedented man
ner, the overwhelming singular
theme advertised throughout the
30 000 m2 of commercial exhibit
space was the unofficial statement
that the future of general surgery is
laparoscopic cholecystectomy —
purchase equipment, be trained or
fall behind scientifically and finan
cially.
At the same meeting scientific
presentations were delivered by ex
perienced innovators of the tech
nique, and a postgraduate course
was devoted to the subject. Over
subscription and attendance exceed
ing space availability exemplified
the response of surgeons over the
past 15 months.
Training programs for surgical
specialties in Canada are controlled
by university departments of sur
gery, with approval for accredita
tion designated by the Royal Col
lege of Physicians and Surgeons of

T

Canada, which then conducts certi
fying examinations based on nation
ally approved guidelines. National
specialty societies have contributed
to guidelines or modified training
programs through structured rela
tions with the Royal College. In
general surgery, this has been the
case with gastrointestinal endos
copy, general surgical oncology, co
lonic and rectal surgery and critical
care; this valuable working arrange
ment between the Canadian Associ
ation of General Surgeons (CAGS)
and the Royal College will likely
continue.
With this background of repre
sentation of the interests of general
surgeons in Canada, the Board and
Advisory Council of the CAGS ap
proved the following guidelines for
laparoscopic cholecystectomy at its
annual meeting in Toronto, Septem
ber 1990.
• Only general surgeons experi
enced with open cholecystectomy
and management of its potential
complications should perform lapa
roscopic cholecystectomy.
• Laparoscopy should be
learned through appropriate in
struction.
• The individual should have
completed and experienced super
vised performance in a structured
course of a laparoscopic program
that includes laparoscopic cholecys
tectomy. The individual must ob
serve and take part in the perfor
mance of the procedure in humans
with individuals already fully experi
enced.
• The training programs in lapa

roscopic cholecystectomy must be
developed and located in university
centres throughout Canada and
should be coordinated through the
surgical chairmen or the general
surgical division chairmen. The
CAGS endoscopy committee would
be available for resource purposes.
• Training for laparoscopic cho
lecystectomy should be available to
all interested general surgeons.
The CAGS has a unique advan
tage over surgical societies and as
sociations in the United States:
statements of policy may be accept
ed for integration into guidelines of
bodies responsible for training, ac
creditation and licensure in Canada.
This is not the case in the US and
recently has become a problem fac
ing respected specialty societies,
which have developed policy and
guidelines but cannot control the
problem of self-certification by indi
vidual experts or interest groups
not having official sanction from
university departments of surgery
or from national examining boards
whose vested interest is in the train
ing and accreditation of surgical
specialists.
History will confirm that the
basis for sound development of
principles and techniques in the
practice of medicine and surgery
has been the application of the
scientific method. Surgical educa
tion is based on the graduated
acquisition of knowledge and skills
in a structured program at an aca
demic centre. The duration of train
ing has been extended in Canada
and the US because of the complex-
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ities of new therapies constantly
being introduced to various special
ties. Criteria for determining com
petence are examined and reviewed
regularly by bodies responsible for
certification and licensure.
Never before has commercialism
and entrepreneurship undermined
the process of surgical specializa
tion or the acquisition of surgical
skills. Surely, 72 hours of surgical
instruction with a pig model by a
paid surgical tutor without privilege
of accredited certification cannot
constitute training to a level of
competence. Ideally, hospital cre
dentials committees will recognize
that equipment acquisition alone
does not imply competence in lapa
roscopic cholecystectomy.
Is there justification for this ex
pression of concern over the proc
ess of training and credentialing?
The recorded opinion at the Ameri
can College of Surgeons meeting of
the internationally acknowledged
authority Dr. William P. Longmire,
Jr., urged reservation and conserva
tism in the current approach to
laparoscopic cholecystectomy. A re
cent editorial by Cuschieri, Berci
and McSherry1 supported the con
cept of restraint and adequate train
ing with reference to organizations
establishing guidelines and accredi
tation for the procedure.
Current documentation in the US
indicates an increasing incidence of
surgical injuries as the number of
laparoscopic interventionists esca
lates. Deaths resulting from laparo
scopic cholecystectomy in several
states have resulted in legislators
curtailing this procedure in one
southwestern state. It would be
unacceptable if a promising tech
nique became limited in application
through the action of regulatory
bodies and the profession was prov
en indefensible because of a lack of
acceptable training guidelines and a
credentialing process. The CAGS
has provided guidelines upon which
436

university departments of surgery
can develop programs for accredited
training of residents and postcer
tification trainees. The process will
be restricted initially by the develop
ment of academic programs and the
availability of equipment. Neverthe
less, the delays should not consti
tute justification for inadequate
training and the acquisition of per
formance-limiting materials.
The specialty of general surgery
encompasses biliary and gastroin
testinal surgery. Capable manage
ment includes open surgery, endos
copy, interventional techniques in
cluding percutaneous image-guided
diagnostics and therapeutics, and
diagnostic and therapeutic laparos
copy. Newer methods will certainly
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develop in this era of advancing
scientific technology. The special
ist’s responsibility is to maintain
competence, enhance performance,
demonstrate sound judgement and
deliver safe, effective therapy. Spe
cialty societies and the Royal Col
lege in Canada are dedicated to
enabling the individual specialist to
achieve the goals required, through
defined and coordinated regulations
available as resources to members
and fellows.
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1. Cuschieri A, B erci G, McS herry CK:

Laparoscopic cholecystectomy (E). Am J
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Canadian Association of General Surgeons
Resident Research Award
The Canadian Surgical Research Fund will award a prize to the resident in
general surgery submitting the best research paper.

Prize
1) Return Airfare, hotel expenses, and a per-diem allowance to present the work
at the Annual Meeting of the Canadian Association of General Surgeons to be held
in conjunction with the Annual Meeting of the Royal College of Physicians and
Surgeons of Canada, Quebec, Quebec, Sept. 20-23, 1991.
2) $500.

Eligibility
Any resident or fellow in general surgery. The research must have been performed
during surgical training at a Canadian medical school.

Abstract and Brief Description
An abstract must be submitted to the Royal College, but CAGS must be
designated as the first choice for presentation. The abstract must be accompanied
by a brief expanded description of the work performed. This should be a
maximum of two double-spaced pages and include the following headings: Title,
Introduction, Materials and Methods, Results and Discussion. Applicants must also
submit a letter confirming their status as a resident or fellow and indicating
that the work is submitted for the resident research award competition.

Deadline
Feb. 27, 1991.
Inquiries should be addressed to:

Dr. Gerald M. Fried
Chairman, CAGS Research Committee
Montreal General Hospital
1650 Cedar Avenue, # 9863
Montreal, Quebec H3G 1A4
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Perforated Sigmoid
Diverticulum Occurring
After Surgery
To the editors. In a recent issue of
this journal (Can J Surg 1989; 32:
370-372) Voitk and Mustard re
ported on three patients who suf
fered perforation in sigmoid diver
ticula after unrelated surgical pro
cedures. The authors invited other
colleagues to report similar cases in
an attempt to identify any common
factors, to estimate the prevalence
of this complication and to alert
clinicians to its occurrence.
We recently treated a similar
case.

more pronounced, and her leuko
cyte count was 47 X 109/L . Perito
nitis was diagnosed.
At laparotomy, fecal peritonitis
was found. There was a perforated
diverticulum in an area of acutely
inflamed sigmoid colon. Peritoneal
toilet and a Hartmann resection
were done.
The patient’s recovery was de
layed by a wound infection.
B.N. Nathan, FRCS, FRCS(Edin)
Surgical registrar

0. Awar, FRCS(Edin)
Surgical registrar

R.D.C. Southcott. FRCS

Case Report
An obese 66-year-old woman pre
sented with acute pain in the left
iliac fossa. Physical examination re
vealed a pelviabdominal mass. Two
years earlier she had undergone
total abdominal hysterectomy for
uterine bleeding secondary to fi
broids.
Ultrasonography suggested the
presence of a left ovarian cyst. At
laparotomy an 8-cm thin-walled
lymphocele was found; the fluid
was drained and part of the wall
excised. The ovaries appeared nor
mal and were preserved.
For 5 days her recovery was
smooth, but on day 6 she had
abdominal distension and tender
ness and was vomiting. A plain film
of the abdomen showed increased
gas in both the small and large
bowel, suggesting abdominal ileus.
She was treated conservatively. By
day 9, the abdominal distension was

Consultant surgeon
Department o f Surgery.
Mayday University Hospital,
Croydon,
Surrey CR4 7YE
UK

Laparoscopic
Cholecystectomy
To the editors. Laparoscopic chole
cystectomy has become an impor
tant tool in the treatment of choleli
thiasis. Over the last 3 months we
have treated 36 patients using this
technique, with no complications.
Two patients had subacute chole
cystitis, 1 had a hydrops of the
gallbladder and 33 had chronic
cholecystitis. We treated overweight
and thin patients. Many did not
require analgesia postoperatively.
All patients recovered promptly and
were discharged within 3 days of
surgery, most of them on the sec
ond postoperative day.

We prefer this technique to stan
dard open cholecystectomy in most
patients, with the exception of
those who are morbidly obese, have
scars in the upper abdomen from
previous surgery or have severe
acute cholecystitis on echography
and clinical examination. We have
performed the procedure in patients
who had had surgery for appendici
tis or had infraumbilical midline
incisions from a hysterectomy.
We do not perform operative cho
langiography at present because we
cannot remove common-duct stones
by laparoscopy. When preoperative
liver function tests or echography
of the biliary tree suggest a possible
common-duct stone, retrograde
cholangiography is performed be
fore the laparoscopic cholecystecto
my and stones extracted if neces
sary. If symptoms of choledocholithiasis develop after laparoscopic
cholecystectomy, retrograde cho
langiography is performed with
stone extraction. All patients are
informed about the procedure by
the physician and by a special con
sent form that describes the tech
nique, the potential benefits and the
possible complications of laparo
scopic cholecystectomy.
There is a definite learning curve
associated with this new technique.
Our operative time has decreased
from more than 2 hours to little
over 1 hour. Laparoscopy is now a
necessary tool in the surgeon’s armentarium.
Yves-Marie Dion, MD, MSc, FRCSC
Jacques Morin, MD, FRCSC
Hopital St-Frangois d ’Assise,
Universite Laval,
10, rue de I ’Espinay,
Quebec. Que
C1L 315
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6
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8
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Update on Trauma Care in Canada
1. Recent Advances in Thermal Injuries
Edward E. Tredget, MD, MSc, FRCSC
Thermal injury frequently occurs in traumatized patients in North America and
causes serious morbidity and mortality, predominantly to children and young adults.
Over the past decade, considerable technologic advances have improved survival
after burn injury. Ongoing research coupled with current surgical advances in
equipment, technique, early wound closure and alternative forms of wound coverage
offer the potential for greater survival with enhanced quality of life for traumatized
patients with burn injuries. However, sepsis and inhalation injury remain important
ongoing causes of death, for which the understanding and solutions appear to be
unfolding as research into the multisystem effects of the inflammatory process
continues.

Les brulures sont frequentes chez les victimes d’accidents en Amerique du Nord.
Elies sont la cause d’une morbidity et d’une mortalite serieuses, principalement chez
les enfants et chez jeunes adultes. Au cours de la derniere decennie, des progres
technologiques importants ont permis d’ameliorer la survie des brules, et la
recherche actuelle associee aux progres de l’equipement et des techniques chirurgicales, a la fermeture precoce des plaies et aux formes alternatives de pansement des
plaies offre la possibility d’une plus grande survie et d’une meilleure qualite de vie
pour le patient accidente victime de brulures. Toutefois, la sepsie et les lesions par
inhalation demeurent d’importantes causes de mortalite dont la connaissance et les
solutions semblent se devoiler au fur et a mesure de la poursuite des recherches sur
les effets plurisystemiques du processus inflammatoire.

hermal injury remains a major
health problem in North Ameri
ca. Approximately 2 million burn
injuries occur annually in the Unit
ed States where a person has a 1 in
70 lifetime chance of hospitaliza
tion as a result of burn injury.1
From our experience in treating
1705 hospitalized burn victims over
the past 11 years,2 we know that
thermal injury is common among

T

young adults aged 20 to 39 years
(92% males), and children (Fig. 1).
These patients require intensive,
prolonged hospital care (mean hos
pital stay ± standard error 26.2 ±
0.8 days). Of the 25% of burn
patients who suffer major injuries
(more than 20% of the total body
surface area [TBSA]) the death rate
is directly related to age and TBSA
burned (Fig. 2). However, improve
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ments in resuscitative care and pa
tient management combined with
research advances in our under
standing of the physiology of major
trauma have led to declining death
rates, to the extent that the size of
burn injury associated with a 50%
death rate (LA50) in the pediatric
population is greater than 90% in
experienced burn-care centres.3
Thus, the challenge for Canadians
in burn care in the next decade will
be to achieve similar levels of clini
cal excellence and subsequently to
limit the morbidity associated with
major traumatic injuries, thus im
proving the quality of survival.
These goals cannot be met by clini
cal care alone. Research also is
needed in the basic surgical sci
ences as they affect trauma, in
which burn injury represents its
prototypic extreme.4

Clinical Advances in Burn Care
Technologic improvements in in
struments have allowed surgeons to
harvest split-thickness skin from
almost any region of unburned
skin.5 Currently, most burn-care
centres employ electrically driven
dermatomes for uniform and precise
control of depth and dimensions of
harvested skin grafts. This maxi
mizes the available donor sites and
limits morbidity within the unin
jured donor skin, which has been a
common problem with the use of
hand-held skin graft knives.
Early, staged surgical interven
tion is now common in modern
burn care, although excessive or
total excision of a large burn in a
single procedure is associated with
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massive blood loss and no improve
ment in survival.35' 7 In our experi
ence with 272 burned hands, tan
gential excision and split-thickness
skin grafting is associated with
high rates of success, early return
of function and low requirements
for secondary surgery.8 Poor-quality
wound coverage, reduced range of
motion and increased requirements
for secondary surgery are the con
sequences of delayed wound closure
in hand burns, as illustrated in one
or our patients who had suffered an
85% TBSA injury. Spontaneous
healing of the more superficially
injured hand was allowed, and this
resulted in hypertrophic scarring
and reduced function. Similar, early
tangential excision of facial burns
with scalp-skin coverage of esthetic
facial units has been proposed as an
improved method of treatment of
severe facial burns. However, most
surgeons remain reluctant to per
form early excision of facial burns,
preferring elective reconstructive
surgery in the rehabilitative stages.9
Wound Coverage for Major
Burns

rapid development in the area of
wound-coverage techniques for
major burns. Early coverage of the
wound has been attempted to limit
the metabolic, infectious and
wound-healing complications of
major burns.1 Allograft skin cover
age remains the most readily avail
able source of high-quality skin
coverage. However, it is now recog
nized that current cryoprotective
techniques are only partially suc
cessful in preserving viability. Most
burn centres therefore prefer to use
fresh material. Although one case
of transmission of the human im
munodeficiency virus (HIV) has
been documented with allograft
skin,10 this occurred at a time when
tissue was used without serologic
testing of the donor. Current esti
mates of the risk of HIV transmis
sion through allograft skin are less
than 1 in 1 million when proper
screening techniques are used, less
than the risk associated with blood
transfusion.11 Nevertheless, in most
of the burn centres allograft skin is
reserved for life-threatening inju
ries.

Artificial skin, a Silastic-covered
dermal matrix of chrondroitin sul
fate and bovine type I collagen,12 is
currently in the final stages of Unit
ed States Food and Drug Adminis
tration evaluation, and reported tri
als of this material suggest that it
may become an important form of
wound coverage in the period im
mediately after burn injury.13 Also,
reports of the high esthetic quality
of wound coverage suggest that
this material may be a very useful
reconstructive tool.
Cultured epithelial autografting
techniques are being used in two
Canadian centres with good suc
cess. This method of wound cover
age requires 3 to 4 weeks for tissue
culture of biopsy sized autografts to
grow into multiple gauze-backed
sheets of epithelial cells for trans
planting to wounds.14 Methods
combining cultured epithelial auto
grafts with allograft dermis have
also been successful in a limited
number of patients to date15 and are
based on the recognition that the
allodermis is relatively nonimmunogenic compared with the epithelial

The past decade has been one of

FIG. 1. Age distribution of patients
hospitalized for burn injury over
11-year period.
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FIG. 2. Probability of death related to age of patient and body surface area burned.

CJS, VOL. 33, NO. 6, DECEMBER 1990

THERMAL INJURIES IN TRAUMA

elements of skin. Consequently, the
Chinese have developed methods to
use pieces of autograft of postagestamp size (1 to 2 mm2) with large
sheets of allograft to cover major
thermal burns.1617 Improved meth
ods of immunosuppression have
also allowed other burn centres to
prolong the use of allograft skin
indefinitely for selected patients
with major burns who lack suffi
cient donor sites for coverage of
their wounds,18 a technique origi
nally proposed by Burke and col
leagues,19 using antilymphocyte
globulin.
Surgical Metabolism after
Major Injury
Since the early work of Cuthbertson, it has been known that severe
trauma is associated with increases
in the resting energy expenditure
rate and loss of lean body mass in
the form of urinary urea nitrogen.20
The development of indirect calo
rimeters for measuring energy con
sumption has allowed accurate de
livery of appropriate nutrients to
patients with major burns. The use
of stable isotopes and gas chroma
tography with mass spectroscopy
(GCMS) in burn and other trauma
patients has shown the detrimental
effects of providing carbohydrate to
burn patients in excess of 5
mg/kg-min^1 and the importance
of providing protein and amino
acids in balanced proportions to
maximize protein synthesis when
massive catabolism can be only par
tially limited.20 Through similar
techniques, the use of highly en
riched, branched chain amino acids
in burned patients has been found
to be unwarranted.21 Also, the intra
venous use of fat emulsions has
been limited by the growing under
standing of their potential deleteri
ous effects in burn patients who
already have high circulating reticu
loendothelial loads and altered pros

taglandin metabolism.22 Finally, the
importance of supporting metabo
lism of the gastrointestinal tissues
by providing enteral nutrition when
ever possible has limited the use of
total parenteral nutrition (TPN) in
burn patients to those who cannot
tolerate enteral feeding at all.
The Role of Inflammation in
Wound Metabolism and
Healing
With the development of recom
binant molecular biologic tech
niques, it has become apparent that
the burn wound itself is the source
of polypeptide molecules having au
tocrine, paracrine and endocrine
functions. As such, these cytokines
appear to regulate wound healing
and collagen metabolism,23 stimu
late anaerobic metabolism24 and
seem to be of extreme importance
in the development of septic
shock,25 which is the principal
cause of death in burn patients. For
example, interleukin I (IL-I) and
tumour necrosis factor (TNF) both
appear capable of stimulating local
fibrosis, hepatic acute-phase protein
synthesis, muscle protein catabol
ism, increased lactic acid production
and Cori cycle activity,24 and a
septic-shock-like state with changes
of acute respiratory distress syn
drome26 in the pulmonary circula
tion of various animal models.27 The
ability of TNF monoclonal antibod
ies to prevent sepsis and death in
primates infused with live gram
negative bacteria25 is important in
the pathophysiology of burn- and
trauma-related sepsis and offers the
potential for future treatment of
such sepsis.
Research developments in the
pathogenesis of infections due to
Pseudomonas aeruginosa have iden
tified the important role that this
organism plays in the nosocomial
infections unique to burn patients.28
There has been little decrease in

death rates due to P. aeruginosa
infections over the past decade de
spite improvements in antimicrobial
therapy. Sporadic epidemics of this
organism have been reported in
many burn centres including our
own.2829 Although it is the second
most frequent organism found in
wounds or blood cultures of burn
patients, when present it is lethal.
The Pseudomonas organism is
closely associated with aquatic envi
ronments and hospital equipment.
As such, identification of these or
ganisms in hydrotherapy equip
ment, which has traditionally been
used for wound care in our institu
tion, has allowed us to eliminate
septic deaths in our burn centre
over the past 18 months; in the
previous 6 months six patients had
died of sepsis.29
Finally, inhalation injury is be
coming recognized as a second and
increasingly important cause of
morbidity and mortality in burn
care.30 Although research has iden
tified the importance of prostanoids
and cytokines as potentially damag
ing products of pulmonary macro
phages in the pathogenesis of this
injury, the treatment of severe inha
lation injury still remains supportive
only. Further, our own experience
and that of others31 has shown that
early diagnosis of inhalation injury
can be established through diagnos
tic bronchoscopy or xenon lung
scanning in the first 24 hours after
a burn injury. However, this group
of patients has an increased death
rate (1.7% versus 34.7% p < 0.01,
X 2 analysis), prolonged hospitaliza
tion (23.7 ± 0.7 versus 74.4 ± 6.2
days [mean ± SEM], p < 0.01) and
the severity of the injury is neither
quantifiable nor predictable as com
pared with that of burn patients
without respiratory tract involve
ment.2 Thus, inhalation injury rep
resents an important and as yet
poorly understood cause of morbidi
ty and mortality in burn injury.
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Management of Patients With
Major Burn Injuries
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2. Update on Pediatric Trauma
Geoffrey K. Blair, MD, FRCSC, FACS
Selective conservatism is the key to the rational management of pediatric trauma,
realizing that children may harbour severe occult injuries. The modern treatment of
childhood abdominal trauma best exemplifies this approach: nonoperative
management of splenic trauma is now standard for children, and a selective
conservative approach is advised in the handling of childhood liver and pancreatic
injuries. Prevention of childhood injuries should be the goal. The development of a
national database of childhood trauma should provide the basis for action to educate
and legislate for prevention. When prevention fails, however, up-to-date quality
pediatric trauma care is the key.
Un conservatisme selectif constitue la cle du traitement rationnel des traumatismes
pediatriques, quand on realise que les enfants peuvent etre porteurs de lesions
occultes graves. Le traitement moderne des traumatismes abdominaux chez l’enfant
illustre au mieux cet abord: le traitement non operatoire du traumatisme splenique
est maintenant la norme chez Tenfant et une approche conservatrice selective est
recommandee face aux blessures hepatiques et pancreatiques. On doit viser a
prevenir les blessures chez l’enfant. La mise sur pied d’une banque de donnees
nationale sur les traumatismes pediatriques devrait sous-tendre une action en vue
d’eduquer et de legiferer en matiere de prevention. Si la prevention echoue, on doit
s’en remettre a des soins modernes et de qualite des traumatismes pediatriques.

of theory in pedi
T heatricevolution
trauma over the past 15

years has drastically changed the
way we approach the injured child.
Children are not just small adults
— they suffer different types of
injuries that demand a different
treatment approach.
The basic principles of initial
evaluation and resuscitation are the
same for children as for adults; that
is, those set out in the Advanced
Trauma Life Support Course from
the American College of Surgeons.1
However, airway, breathing and cir
culation problems can be more diffi
cult to identify in the injured child.

Occult injury is often overlooked.
The cardinal rules of pediatric
trauma management must be:
• Don’t waste time.
• Suspect occult injury.
• Be aware of key differences
between an injured child and an
injured adult — anatomic, physio
logic and emotional differences and
drug metabolism.
I shall focus on some current
issues in dealing with the child
suffering from abdominal injuries.
Splenic Injury

Surprisingly the proper manage
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ment of the fractured spleen is still
being debated. Splenic injury may
be the result of a low-energy im
pact. The child, because of the
relative lack of truncal musculature
and a very flexible thoracic cage,
may sustain a splenic fracture with
little outward evidence of injury.
The majority of children present
ing with splenic injury are hemodynamically stable, do not require
transfusion and are managed safely
nonoperatively.23 In children the
nonoperative management of sple
nic injuries is now standard. But it
is a selective approach, and sur
geons should realize that a minority
of children will require laparotomy,
splenorrhaphy or splenectomy. The
Hospital for Sick Children in Toron
to led the way years ago when
surgeons first proposed this “radi
cal” conservatism, and four exten
sive reviews of their experience with
this protocol have since been publi
shed.2'5
With most children who suffer
splenic injury not requiring blood
transfusion, the argument that op
erative repair or removal of the
spleen lowers the risk of transfu
sion-related infections — acquired
immune deficiency syndrome or
hepatitis — seems specious.6 Late
bleeding from a rupture spleen and
splenosis are also extremely rare.6
But life-threatening post-splenecto
my sepsis is not. Splenorrhaphy
certainly is possible but may not be
easily executed. Perhaps too many
times a ruptured, but not bleeding,
spleen has been mobilized at lapa
rotomy for intended repair. In the
process, it has bled more, and,
despite a valiant effort at saving the
organ, a splenectomy is performed.
Those spleens can heal themselves.
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Over the past 5 years at British
Columbia Children’s Hospital, 45
children who suffered traumatic
splenic rupture have been cared for
— all nonoperatively. We have not
had to perform either splenectomy
or splenorrhaphy in that period.
Our method of nonoperative man
agement is outlined in Table I.

Other Solid Organ Injuries
It perhaps was only a matter of
time until the nonoperative ap
proach was applied to other child
hood solid organ injuries. In a
cross-Canada study carried out by
the Canadian Association of Pa
ediatric Surgeons in 1988 only 18
of 64 childhood liver injuries re
quired operation. The remainder
were handled nonoperatively in a
manner similar to that for splenic
trauma.7 However, we must remem
ber that serious hemorrhage from
liver injuries is more common than
from splenic injury. Patients with
hepatic or splenic injury must be
very carefully selected for conserva
tive management (Fig. 1).

Gastrointestinal Injury
Fortunately, occult gastrointesti
nal perforation after blunt injury in
childhood is relatively rare. Over a
15-year period at the Hospital for
Sick Children in Toronto, only 16
gastrointestinal perforations sec
ondary to blunt trauma were seen, a

Table I. Nonoperative Protocol for Splenic Trauma
Admit to monitored bed — critical care nursing for 1 - 2 d. Supportive care, transfuse if
hemoglobin < 80 g/L.
Complete bed rest in hospital for 1 wk.
Discharge on restricted non-violent activity for 6 wk.
Follow-up at 6 wk — physical examination
— complete blood count, urinalysis
— abdominal ultrasonography, primarily to look for splenic cyst.
Release to full normal activity if follow-up gives normal results.

Methods o f Diagnosis

How can we best detect these
solid organ injuries? It is well
known that clinical methods often
fail. Diagnostic peritoneal lavage is
not the answer because it is invasive
and nonspecific and, since the pres
ence of blood in the peritoneal
cavity no longer necessitates sur
gery, peritoneal lavage positive for
blood will not necessarily change
the management of the patient.
Computed tomography and, to a
lesser extent, abdominal ul
trasonography can allow quantifica
tion of the abdominal bleeding, re
veal its site and specifically evaluate
the rest of the abdomen and its
organs. Ultrasonography is a rea
sonable screening test, but is less
444

number constituting approximately
1% of the childhood abdominal
traumatic injuries managed during
that period.8
Initially, the clinical picture of
gastrointestinal injury in childhood
can mimic splenic trauma, but the
peritoneal signs tend to persist and
worsen, whereas the tenderness as
sociated with a hemoperitoneum
most often settles during the first
day of injury. A delay in the diagno
sis of traumatic gut rupture in
creases the risk of sepsis. Free air is
most often not seen on the plain
film initially, and if there is a suspi
cion of perforation, a contrast
study, at least, is warranted.
Intestinal injuries are often seen
in children old enough to be out of
infant car seats, relegated to the
back seat of the vehicle with only a
lap-belt restraint. In an accident,
the forceful flexion over the lap belt
without a shoulder strap to restrain
the upper body, may result in the

reliable in detecting splenic frac
tures than computed tomography
or liver-spleen scanning.
However, peritoneal lavage does
have a limited role in assessing the
traumatized child. It may be useful
for rapid assessment of the hypo
tensive child or as a preliminary
screening method before transfer
from an institution that lacks ul
trasonography or computed tomog
raphy facilities. On the other hand
it may be an unreliable means of
discovering gut rupture after blunt
injury.

Llver/splenic trauma
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FIG. 1. Algorithm for management of childhood liver or spleen trauma.
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“lap-belt syndrome” — abdominal
wall disruption, major intra-abdomi
nal injury, including bowel perfora
tion and spinal fracture with possi
ble spinal cord damage. Such inju
ries could easily be prevented by
introducing rear-seat shoulder re
straints.

Other Traumatic Injuries in
Children
The back seat ‘Tap-belt syn
drome” is only one example of
many injuries suffered more fre
quently by children than adults.
Another is the handle-bar injury.9 A
child in falling off a bicycle may
have the butt of the handlebar
cause duodenal injury, a tear or,
more commonly, a hematoma, or
traumatic pancreatitis. The young
ster may appear well initially. Oc
cult injury may become manifest 12
to 24 hours after the accident by
continued or increasing pain, vomit
ing or collapse.
Pancreaticoduodenal Injury

Controversy is currently raging
over the appropriate early manage
ment of childhood pancreatico
duodenal injuries. In our effort to
treat children nonoperatively, are
we perhaps missing the occasional
duodenal disruption most appropri
ately found and treated at early
laparotomy?
Traumatic pancreatitis in children
may best be treated by early explo
ration, appropriate debridement and
attention to ductal injury. Yet,
Burnweit and Filler10 from the Hos
pital for Sick Children in Toronto
reported that the majority of their
children with traumatic pancreatitis
did well with conservative therapy,
and operation was avoided in all but
20%. Their report also cited the
successful use of percutaneous
drainage for persistent pancreatic

pseudocysts in children. Of 14
pseudocysts treated in their series,
8 resolved without operation, 5 re
quired percutaneous drainage and
only 1 was drained internally.

Comments
Thus, the pattern of traumatic
injuries seen in children is no doubt
different from those seen in adults.
We must develop and sustain a
working database of childhood inju
ries in Canada. Only in this way will
we be able to effect proper pro
grams and legislation to prevent
childhood injuries.
Our assumptions or presump
tions about the types of injuries
that are causing childhood death
and disability in Canada may not be
correct.11 For instance, in a recent
study, Brison, Wicklund and Muel
ler12 found that, from 1979 to
1983, 58% of childhood pedestrian
accidents occurred in driveways and
parking lots not on public thor
oughfares. Also 76% of these “non
traffic” fatalities involved light
trucks or vans. Data such as this
are useful, perhaps suggesting new
approaches to at least one aspect of
childhood injury prevention.
The United States figures and
statistics, however, may not accu
rately reflect the situation in Cana
da. For instance, we surely see far
fewer gunshot injuries to young
Canadians. (But with a worsening
drug problem in Canada are gun
shot injuries in youth not going to
increase as well?)
Now, through the efforts of Dr.
Barry Pless of the Montreal Chil
dren’s Hospital, and the Health Pro
tection Branch of Health and Wel
fare Canada, a Children’s Hospital
Injury Reporting and Prevention
Program has been started. Members
of this group will survey and com
pile the childhood injuries and
treatment from children’s hospitals

across Canada. It is hoped that this
database will have a major impact
on injury prevention for children in
Canada’s future.
Prevention of the primary injury
should be our major goal. In Cana
da, education and legislation to
gether could achieve a significant
reduction in the suffering related to
childhood trauma. Children in this
country would materially benefit
from legislation to mandate rearseat shoulder restraints in cars, the
wearing of bicycle helmets, all-ter
rain vehicle (ATV) regulations,
boating regulations necessitating a
minimum age for operation and
stricter gun control than we have at
present. Last, but not least, stricter
laws and penalties for alcohol abuse
would also help. Injury prevention
education programs aimed at par
ents and children would comple
ment such legislation.
Where prevention has failed we
must ensure that injured children
have ready access to quality medical
care. This does not necessarily
mean a level 1 pediatric trauma
facility in every town in Canada.
Rather we need physicians and
nurses who are truly interested in
pediatric trauma and can ensure an
up-to-date approach to the unique
problems of the injured child.
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BOOK REVIEWS

THE SHOULDER. Vol. 1. Edited by
Charles A. Rockwood and Frederick A.
Matsen III. 622 pp, vol. 1; 486 pp, vol.
2. Illust. W.B. Saunders Com
pany/Harcourt Brace Jovanovich, Inc.,
Philadelphia; HBJ-Holt-Saunders Dis
tribution Services, Toronto. 1990.
$227.50 (two-volume set). ISBN 0 7 2 1 6 -2 8 2 9-X , vol. 1; 0 -7 2 1 6 -2 8 3 0 3, vol. 2; 0 -7 2 1 6 -2 8 2 8 -1 , set

This two-volume textbook represents
the natural evolution of subspecializa
tion within orthopedic surgery. This
evolution is evident in the establishment
of societies for the study of diseases of
certain anatomic regions and is support
ed by increasing publication of journals
and textbooks to collate and distribute
the information.
The two volumes, with 46 contribu
tors, provide a comprehensive review of
current knowledge on the pathogenesis
and treatment of disorders of the shoul
der. The text is appropriately divided
into two sections: general topics and
specific diseases and injuries of the
shoulder.
The first section consists of chapters
devoted to developmental anatomy,
gross anatomy, embryology, biome
chanics, and radiologic clinical and ar
throscopic examinations. These chap
ters are comprehensive and follow each
other in a logical sequence, starting
with embryology.
446

In the second section, specific chap
ters are devoted to both injuries and
diseases and cover such troublesome
areas as fractures of the proximal hu
merus, fractures of the adult clavicle,
acromioclavicular joint injuries and dis
eases, and glenohumeral instability. The
shoulder region is divided anatomically
and injuries and diseases peculiar to it
are explored, which makes reference to
this text for a specific clinical problem
extremely simple.
One particularly helpful aspect of
this book is that each contributor is a
recognized expert in the field in which
he or she is writing; where appropriate
the author gives a full explanation of
his or her preferred method of treat
ment at the end of the chapter. Thus, in
addition to a comprehensive review of
recommendations from other works,
there is a definitive suggestion based on
the author’s own experience.
The illustrations are excellent. The
radiographs are clearly reproduced and
the line drawings are uniform in clarity
and orientation. In particular, those
drawings that have been used to illus
trate surgical procedures are most help
ful for the reader not familiar with every
nuance of the described operation.
This volume presents a wealth of
well-referenced clinical material and
would be a valuable addition to any
comprehensive orthopedic library. Its
primary purpose is as a reference book
and therefore it should be included in
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the library of any hospital in which
orthopedic surgery is performed. Its
value to individual practitioners is less
certain unless those individuals have a
specific interest in the treatment of
shoulder problems.
J.P. Waddell, MD, FRCSC
Division of Orthopedics,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.

REVISIONAL SURGERY IN RHEU
MATOID ARTHRITIS. Edited by M.
Hamalainen, F.-W. Hagena, W.
Schwagerl and J. Teigland. Vol. 13 of
Rheumatology. The Interdisciplinary
Concept. Edited by M. Schattenkirchner and F.-W. Hagena. 265 pp.
Illust. Karger, Basel. 1990. $173.50
(US). ISBN 3-8055-4930-X

Based on a European rheumatologic
congress, this book contains four sec
tions: revision total joint surgery in
patients with rheumatoid arthritis, the
cervical spine in rheumatoid arthritis,
assessment in rheumatoid arthritis and
a miscellaneous group of papers. These
are huge topics to attempt to cover in
one small book, and the editors are to
be congratulated on what they have
achieved.
continued on page 469
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3. Pelvic Ring Fractures
Peter J. O’Brien, MD, FRCSC
Correct assessment and treatment of pelvic ring fractures in the multiply injured
patient is important because it can result in fewer deaths and less long-term
disability. There is ample evidence to show that surgical stabilization of unstable
pelvic ring fractures is a life-saving intervention that should be done on the day of
injury. Anterior frame external fixation is the standard form of treatment and is
life-saving. However, it is not ideal biomechanically, and over the next decade open
reduction and internal fixation of pelvic ring fractures will likely become the
treatment of choice.
Chez le polytraumatise, revaluation appropriee et le traitement adequat des
fractures de l’anneau pelvien sont importants car il peut en resulter une diminution
des deces et de Tincapacite a long terme. II existe une vaste preuve demontrant que
la stabilisation chirurgicale d’une fracture instable de Tanneau pelvien est une
intervention salvatrice qui devrait etre effectuee le jour meme de la blessure. Le
traitement standard consiste a poser un appareil de fixation externe en position
anterieure; celui-ci peut sauver la vie. Cependant, ceci n’est pas ideal au plan
biomecanique et, au cours de la prochaine decennie, il est probable que la reduction
ouverte avec fixation interne deviendra le traitement de premier choix des fractures
de l’anneau pelvien.

ring fractures in associa
P elvic
tion with multiple trauma pres

ent a diagnostic and therapeutic
challenge for physicians. Accurate
assessment and correct treatment of
pelvic fractures in the multiply in
jured patient can reduce mortality
and morbidity. Treatment algo
rithms have been published for the
management of the traumatized pa
tient with a pelvic fracture.12 Occa
sionally a pelvic fracture must be
treated early after injury to control
ongoing blood loss from retroperi
toneal hemorrhage in the multiply
injured patient. In the majority of
cases, however, assessment of the
pelvic fracture is left until all other

system injuries have been diagnosed
and life-threatening problems have
been dealt with. Definitive treat
ment of pelvic fractures, however,
should not be delayed and should
be undertaken on the day of injury.
For some patients with unstable
pelvic fractures this will require
open reduction and internal fixation
(Fig. 1).
Importance of Pelvic Ring
Fractures in Multiple Trauma
Survival

Accurate assessment and correct
treatment of unstable pelvic frac
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tures in multiply injured patients
can play a direct role in patient
survival. Death rates for multiply
injured patients with major pelvic
fractures have been reported by a
number of authors.1'3-8 In 1986
Goldstein and colleagues4 reported
a 6% death rate in their small series
of patients, all treated by early open
reduction and internal fixation of
the pelvic fracture. Dalai and col
leagues,3 in 1989, reported a death
rate of 15.5% in a large series of
pelvic fractures. Haasbeek and
Burns5 recently recorded a rate of
24% in multiply injured patients
with pelvic fractures treated nonsurgically. The orthopedic treat
ment of fractures directly affects
patient survival. Immediate surgical
stabilization of long-bone fractures
and pelvic fractures is life-saving
and should not be delayed. It
should be done on the day of injury.
Multiply injured patients are best
prepared for fracture surgery on the
day of their injury, because their
nutritional status is better then
than it will be for many days, their
respiratory status often deteriorates
in the days following injury and
precludes further surgical interven
tion and, finally, colonization with
resistant hospital organisms has not
yet occurred. The advantages of
early stabilization of fractures in
clude the following: early mobiliza
tion; easier nursing care; less pain,
because the fracture fragments are
rigidly immobilized, so that less
analgesia is required; decreased in
cidence of adult respiratory distress
syndrome, thromboembolic disease,
fat embolism and decubitus ulcers.
There are, however, some disad
vantages. Many patients have al
ready undergone thoracotomy, lapa
rotomy, neurosurgical or urologic
procedures. Orthopedic intervention
adds surgical stress and blood loss.

CJS, VOL. 33, NO. 6, D E C E M B E R 1990

447

O’BRIEN

These factors, however, can be ade
quately dealt with by a well-trained
anesthesia staff. The advantages of
early stabilization far outweigh the
disadvantages.
Improved survival with early sur
gical stabilization of fractures has
been documented.6'79-12 Goris and
associates9 presented a prospective
study that documented a death rate
5.5 times higher in patients who
“had their fractures treated in trac
tion’’ than in those who had early
surgical stabilization. Similarly,
Meek, Vivoda and Pirani7 recorded
a 28.5% death rate in multiply
injured patients in whom the ortho
pedic management was nonsurgical
compared with a 4.5% death rate in
multiply injured patients who un
derwent surgical stabilization of the
fractures on the day of injury. De
creased death rates have also been
documented specifically in terms of
pelvic fracture treatment.610 In our
hospital, the death rate for multiply
injured patients treated nonsurgically was 29% compared with 6%
for those who had surgical stabili
zation of their pelvic fractures ini
tially. It is apparent, therefore, that
the advantages afforded by surgical
fixation are life-saving.
Musculoskeletal Outcome

Traumatized patients who survive
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their injuries with major pelvic dis
ruption may be left with a perma
nent disability as a result of the
pelvic fracture. Tile8 and Browner
and colleagues13 have documented
chronic posterior pain in up to 30%
of these patients in long-term fol
low-up. Tile found that the inci
dence was as high as 60% if the
sacroiliac joint was involved in the
fracture. He also documented a
nonunion rate of 4%, a malunion
rate of 4% and a permanent nerveinjury rate of 5.5%. Although the
orthopedic outcome of the pelvic
injury depends to some degree on
the amount of energy involved in
producing the fracture, the stability
of the pelvis and the associated
injuries, treatment also plays a
major role in determining how
these patients will do in the long
term. Accurate reduction and stable
fixation should lead to a decreased
incidence of long-term complica
tions.

Clinical Assessment of Pelvic
Fractures
It is important to emphasize the
priority protocol for the assessment
and resuscitation of the multiply
injured patient. Pelvic fractures are
usually assessed after life-threaten
ing injuries to other systems have
been dealt with. Physical examina
Control Ongoing Blood Loss
■ Application of an anterior frame pelvic
external fixator
• Angiographic embolization

_ Clinical Assessment
• History and physical examination
• Plain radiographs and special views
• CT scan

Within 24 hours.

FIG. 1. Assessm ent and treatment of multiply injured patient with pelvic fracture.
448

CJS, VOL. 33, NO. 6, DECEMBER 1990

tion may reveal swelling and ecchymosis. Direct palpation may elicit
tenderness over the anterior and
posterior pelvic injury site. Patients
multiply injured from blunt trauma,
however, are often obtunded so that
tenderness cannot be elicited. A
defect from symphysis diastasis may
be palpable. The rotatory and verti
cal stability of the pelvis must be
assessed. The examiner can test for
rotatory instability by placing a
hand on each iliac crest and apply
ing force to close and open the
pelvic ring; abnormal motion and
crepitus denote rotational instabili
ty. The examiner can test for verti
cal instability by applying traction
through the lower extremity with
one hand on the pelvis; any vertical
movement of the hemipelvis in ref
erence to the opposite side denotes
instability.
Pelvic fractures may, however, be
difficult to document clinically in
the multiply injured patient. Altered
level of consciousness, obesity,
swelling and multiple injuries can
obscure the physical signs. MacKersie and associates,14 in their review
of 789 cases of blunt trauma, found
that 75% of the pelvic fractures
were clinically occult. Radiologic
evaluation, therefore, is essential in
all multiply injured patients with an
altered level of consciousness. Plain
radiographs should include an
teroposterior, inlet and outlet views.
The anteroposterior film will dem
onstrate most pelvic fracture pat
terns. The inlet view demonstrates
the posterior injury more clearly; it
also shows the shape of the pelvis
and demonstrates whether the in
juring force was of lateral compres
sion, decreasing pelvic volume or
anteroposterior compression, in
creasing the pelvic size. The inlet
view will also demonstrate any pos
terior displacement of the hemipelv
is. The outlet view shows the sa
crum in profile and helps document
sacral fracture patterns. It is also

PELVIC RING FRACTURES

useful for demonstrating any verti
cal displacement of the hemipelvis.
Computed tomography is also
valuable in the assessment of pelvic
ring fractures, particularly in docu
menting the posterior injury. Most
pelvic fractures can be seen fairly
clearly on plain films. However, for
those physicians who do not have
much experience in assessment and
treatment of pelvic fractures, com
puted tomography can more clearly
demonstrate the posterior injury.
This technique can also show undis
placed fractures of the sacrum that
are often invisible on the plain
films. Such fractures, however, do
not usually affect the treatment
plan. Computed tomography, there
fore, is a useful method for defining
posterior injuries but is not essen
tial in all cases of pelvic ring frac
ture. However, it is essential in the
preoperative planning of pelvic frac
tures that involve the acetabulum.

Classification of Pelvic
Fractures
A number of classifications238
have been described for pelvic ring
fractures. We use Tile’s classifica
tion,8 which divides pelvic fractures
into three types. Type A are stable
fractures, type B are rotationally
unstable but vertically stable and
include both open-book and lateral

compression types, and type C frac
tures are rotationally and vertically
unstable (Table I).
When considering the classifica
tion, we must distinguish between
the lateral compression types and
the anteroposterior compression
and vertical shear types. Lateral
compression fractures result in an
infolding of the pelvis and, there
fore, a decrease in pelvic volume.
Retroperitoneal blood loss can usu
ally be controlled by tamponade. As
the pelvic hematoma increases in
size the pelvic volume cannot in
crease beyond normal because the
injuring forces result in an initial
decrease in pelvic volume. Lateral
compression fractures are frequent
ly impacted and are relatively stable.
On the other hand, anteroposterior
compression and vertical shear pel
vic fractures result in an increase in
pelvic volume. As retroperitoneal
bleeding occurs and a hematoma
forms, there is nothing to confine
the blood loss so there is no tam
ponade. The shear forces that pro
duce these types of fractures also
tend to tear vascular structures.
Patients with anteroposterior com
pression and vertical shear fractures
are at a higher risk of being hemodynamically unstable because of
the pelvic fracture injury alone, and
these injuries are more difficult for
the orthopedist to manage.

T a b le 1. Classification of Pelvic Disruption*
Type

D e fin itio n

A
A1
A2

Stable
Fractures of the pelvis not involving the ring
Stable, m inim ally displaced fractures of the ring

B
B1
B2
B3

Rotationally unstable, vertically stable
Open book
Lateral compression: ipsilateral
Lateral compression: contralateral (bucket handle)

C
C1
C2
C3

Rotationally and vertically unstable
Unilateral
Bilateral
Associated with an acetabular fracture

'Reproduced by permission from Tile M: Pelvic ring fractures: should they be fixed? J B on e J o in t
S u r g [ B r ] m % \ 70: 1 -1 2 .

Treatment of Pelvic Ring
Fractures
It is important to emphasize that
patients who have sustained a
major pelvic ring fracture have been
exposed to considerable force and
should be considered multiply in
jured. Initial treatment should be
based on the priority protocol sys
tem for the management of multiply
injured patients. The definitive
treatment of the pelvic fracture fol
lows treatment of other system in
juries.
Stable pelvic fractures usually do
well and are not associated with
long-term disability. Treatment of
the symptoms of stable pelvic frac
tures will usually result in a satis
factory outcome for the patient. In
contrast, unstable fracture patterns
are difficult to treat.
It is occasionally necessary to
stabilize the pelvic fracture during a
resuscitative phase of the manage
ment of a multiply injured patient.
If the patient is hemodynamically
unstable and ongoing blood loss in
the retroperitoneal space, secondary
to a pelvic ring fracture, is thought
to be contributing to the patient’s
ongoing hypovolemia, an anterior
frame external fixator can be ap
plied. This can be done either in the
emergency room or in the operating
room after laparotomy. A simple
anterior frame can be applied percutaneously in about 20 minutes. We
use a Slatis-type trapezoidal frame.
This frame can be turned down in a
caudad direction if necessary to
allow access to the abdomen for
laparotomy.
The external fixator will (a) de
crease pelvic volume and allow for
tamponade, (b) decrease blood loss
from cancellous bone surfaces, (c)
minimize shear forces and therefore
reduce the risk of further vessel and
soft-tissue injury in the pelvis and
(d) allow for early patient mobiliza
tion.
Biomechanical studies81516 have
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shown that no anterior external
fixator is biomechanically strong
enough for the patient to walk
without loss of reduction in unsta
ble pelvic fractures. Therefore, a
simple anterior external fixator is
not definitive treatment for an un
stable pelvic ring fracture.
Some have recommended anteri
or frame external fixation as provi
sional fixation in unstable pelvic
fractures.813 This would allow a few
days for the patient’s condition to
stabilize; definitive open reduction
with internal fixation of the pelvic
fracture could be done later. This
form of management presents two
problems. First a number of compli
cations may develop from the multi
ple trauma over the first few days
and weeks after injury. These may
preclude further surgical interven
tion so that the chance to obtain
ideal surgical stabilization of the
pelvic ring fracture is lost. The
second problem was described by
Browner and colleagues,13 who re
ported a series of patients in which
they used an external fixator for
provisional fixation followed by de
layed internal fixation. In none of
the patients could they obtain an
anatomic reduction, and 25% had
persistent posterior pain. I believe,
therefore, that use of the anterior
frame external fixator should be
limited to the following situations:
(a) in hemodynamically unstable pa
tients who have ongoing retroperi
toneal blood loss, (b) in multiply
injured patients who have unstable
lateral compression fractures, (c) in
multiply injured patients whose sur
geon is not familiar with open re
duction and internal fixation tech
niques, (d) in conjunction with open
reduction and internal fixation and
(e) in patients with open pelvic
fractures.
Angiography and embolization of
pelvic arterial bleeding is indicated
in those who are hemodynamically
unstable, despite having an external
450

fixator applied to the pelvis, and in
whom all other sources of bleeding
have been ruled out. It may play a
larger role in the future. Goldstein
and colleagues4 have suggested
using this technique before open
reduction and internal fixation.
Open reduction and internal fixa
tion of the anterior and posterior
fracture site in a pelvic ring fracture
is biomechanically strong. If it is
done on the day of injury anatomic
reduction can be obtained and rigid
internal fixation can be accom
plished. This, theoretically, should
lead to a better musculoskeletal
outcome as the pelvis will heal in
the reduced position. However, little
experience has been reported con
cerning early open reduction and
internal fixation of pelvic ring frac
tures. External fixation or open
reduction and internal fixation are
life-saving because they provide sta
ble fixation of the pelvic fracture.
Open reduction with internal fixa
tion is biomechanically stronger and
should reduce long-term morbidity.
The procedure appears to be the
treatment of choice for pelvic ring
fractures, but this has yet to be
proved. The potential disadvantages
of open reduction are uncontrolled
blood loss from decompression of
the retroperitoneal hematoma and a
higher infection rate.
More experience with open re
duction and internal fixation of pel
vic ring fractures in multiply in
jured patients is needed before de
finitive recommendations for its use
can be made. At present the proce
dure is indicated only in unstable
pelvic ring fracture, principally in
Tile’s type B1 and C fractures. This
type of surgery should only be
undertaken in a trauma centre that
has sophisticated back-up facilities.
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ROYAL COLLEGE SYMPOSIUM

4. Resuscitation Through the Three
Phases of Hemorrhagic Shock After
T rauma
Charles E. Lucas, MD
There are three phases of acute hemorrhagic shock after trauma. In phase I (from
injury to operation for control of bleeding) the patient suffers from low cardiac
output, tachycardia, reduced organ perfusion, oliguria and decreased capillary
hydrostatic pressure, which in turn reduces extravascular fluid loss. Contraction of
the interstitial space matrix replenishes plasma volume. Optimal therapy includes
blood and crystalloid replacement to restore plasma volume, red cell mass and
interstitial fluid. Three litres of crystalloid are usually required for each litre of
blood lost. After operation, a period of obligatory extravascular fluid sequestration
occurs as the intracellular and interstitial spaces expand (phase II). Optimal
replacement therapy during this phase maintains plasma volume. Replacement is
provided according to the patient’s vital signs, because extravascular fluid
expansion cannot be influenced by therapeutic manipulation. Phase III is a
mobilization and diuretic phase. During this phase systolic hypertension may occur,
and the patient must be treated with restriction of fluid, diuresis and careful
monitoring of the heart and lungs. Attempts to alter these physiologic responses
with supplemental albumin have proved detrimental. The albumin causes salt and
water retention in the nephron, leading to weight gain, higher central filling
pressures and worsening pulmonary function, and a greater need for diuretic and
inotropic therapy. Albumin therapy also induces relocation of non-albumin proteins
into the interstitial space, leading to impaired immunocompetence and coagulation.
Successful resuscitation is facilitated by adaptation to these physiologic responses of
hemorrhagic shock rather than manipulation of them.

Apres un traumatisme, on observe trois phases dans le choc hemorragique. Au cours
de la phase I (de la blessure jusqu’a l’operation pour juguler l’hemorragie), le
patient souffre d’un faible debit cardiaque, de tachycardie, d’une perfusion reduite
des organes, d’oligurie et d'une pression capillaire hydrostatique diminuee qui, en
contrepartie, reduit l’epanchement extravasculaire. La contraction de l’espace
interstitiel retablit le volume plasmatique. La meilleure therapie fait appel aux
transfusions de sang et de cristalloides pour retablir le volume plasmatique, la
masse erythrocytaire et les liquides insterstitiels. Trois litres de solute cristalloide
sont habituellement necessaires pour remplacer chaque litre de sang perdu. Apres
l’operation, une periode de sequestration obligatoire des liquides extravasculaires
survient alors que les espaces intracellulaire et interstitiel s’elargissent (phase II).
Le meilleur traitement de suppleance pendant cette phase consiste a maintenir le
volume plasmatique. Comme l’expansion des liquides extravasculaires ne peut etre
influencee par des manipulations therapeutiques, l’expansion volumique est dictee
par les signes vitaux. La phase III en est une de mobilisation et de diurese. Pendant
cette phase, une hypertension systolique peut survenir. Le patient doit alors etre
traite par restriction liquidienne, diurese et surveillance des fonctions cardiaque et
pulmonaire. Les tentatives pour modifier ces reponses physiologiques a l’aide
d’albumine se sont averees prejudiciables. L’albumine cause une retention de sel et
d’eau dans le nephron, ce qui entraine un gain ponderal, une augmentation des
pressions centrales de remplissage et une deterioration de la fonction pulmonaire, et
un besoin accru de medication diuretique et inotrope. L’administration d’albumine
provoque egalement une relocalisation des autres proteines dans l’espace intersti
tiel, entrainant ainsi des alterations de l’immunocompetence et des mecanismes de
coagulation. Le succes de la reanimation est davantage facilite par une adaptation
aux reponses physiologiques au choc hemorragique, que par des tentatives pour les
modifier.

o resuscitate a patient from
hemorrhagic shock (HS) after
traum a the physician m ust have
knowledge of the normal physiolo
gy and responses to HS. The body
of a patient weighing 70 kg con
tains 60% water — 28 L of intracel
lular fluid (ICF) (red blood cell mass
2 L, muscle-organ mass 26 L) and
14 L of extracellular fluid (ECF)
(plasma 3 L, interstitial fluid 11 L).
The plasma and red blood cell mass
give a blood volume of 5 L which,
with a normal cardiac output, circu
lates through the body each min
ute.
Fluid movement through the cap
illary vessels is controlled by hydro
static, osmotic and oncotic forces.
Salt and water exit from the pre
capillary arterioles into the intersti
tial fluid space due to increased
intravascular hydrostatic pressure.1
Simultaneously, protein, including
albumin and the globulins, exits, by
convective forces, with the water
into the interstitial fluid space (Fig.
1). Salt and water probably re-enter
the plasma at the venular end of the
capillary owing to both oncotic and
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osmotic forces. In contrast, protein
flux is unidirectional from the capil
laries through the interstitial fluid
space into the lymphatics whence
plasma re-enters at a remote site.23
The normal lymph-to-plasma pro
tein ratio varies with size, shape,
charge and other traits of each
molecule.
The interstitial fluid space com
prises a sol portion and a gel por
tion called the matrix. Contrary to
popular conceptions, the interstitial
fluid space with its matrix is dynam
ic and controls much of the re
sponse to HS after trauma.2 Most
interstitial water, salt and protein is
held within this matrix and affects
protein flux through the interstitial
fluid space. The ultrafine proteo
glycans can attract protein by
chemical, ionic and electrical forces.
When the matrix unravels and ex
poses the proteoglycans to the sol
fluid, albumin attaches; in contrast,
when the matrix contracts, proteog
lycans are excluded from the sol
and albumin passes freely into lym
phatics and thence into the plasma.

Hemorrhagic shock may be divid
ed into three distinct sequential
phases:4 phase I, the period of ac
tive hemorrhage extending from the
time of injury until the end of
operation for hemostasis; phase II,
the period of obligatory extravascular fluid sequestration lasting until
the time of maximal weight gain;
phase III, the period of fluid mobili
zation and diuresis. Patients with
HS whose systolic blood pressure
drops below 80 mm Hg for 30 to 40
minutes and who require 10 to 20
blood transfusions in phase I will
have a phase II lasting 30 hours
and a phase III lasting 4 days.

Phase I
A patient who suffers severe HS
with a systolic pressure of 70 mm
Hg will have an acute 40% to 50%
fall in blood volume (Fig. 2). The
homeostatic responses include the
release of catecholamines, antidiu
retic hormone, renin and aldoster
one. Other hormones compliment

NORMAL
IFS 11L

ing this acute response include glu
cagon, growth hormone, parahormone and insulin.5 This causes a
fall in cardiac output and a rise in
peripheral vascular resistance. The
kidneys excrete little urine when
treatment is first initiated.6 Capil
lary water efflux falls because hy
drostatic pressure in the precapil
lary arteriole is reduced. Further
more, plasma volume expansion
from the interstitial fluid space at
the venular end of the capillary
rises due to the relative increases in
the oncotic and osmotic pressures
within the plasma.1-3 Contraction of
the interstitial fluid space drives
albumin into the lymphatic system
and plasma.7
Therapy must restore not only
the red blood cell mass but also the
huge deficit in balanced electrolyte
solution from both the plasma and
the interstitial fluid space. The rec
ommended ratio of balanced electro
lyte infusion to estimated whole
blood loss is 3:1. Thus, a patient
with an acute blood loss of 2 L will
need 6 L of balanced electrolyte
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FIG. 1. Person weighing 70 kg has 42
L of water in both the intracellular
fluid (ICF) (28 L) and extracellular
fluid (ECF) (14 L). Salt and water exits
plasma by hydrostatic forces. Albumin
and globulin flow by connective forces
into interstitial fluid space. P.V. =
plasma volume, IFS = interstitial fluid
space, LF = lymphatic flow, RA =
lymph to plasma albumin ratio, RG =
lymph to plasma globulin ratio.
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FIG. 2. Upon presentation to emergency room with severe hemorrhagic shock (HS),
patient with acute 40% reduction in plasma volume will have vasoconstriction with
contraction of interstitial fluid space matrix causing replenishment of plasma
volume (PV). RBF = renal blood flow, GFR = glomerular filtration rate.
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solution to restore plasma volume
and interstitial fluid deficits. Bal
anced electrolyte solution used for
resuscitation should not contain
glucose, since the release of cate
cholamines, glucagon and growth
hormone causes acute hyperglyce
mia.45 When endogenous hypergly
cemia from HS is augmented by
exogenous glucose in the balanced
electrolyte solution, the hyperglyce
mia may exceed 55.5 mmol/L and
cause inappropriate osmotic diure
sis when homeostasis calls for fluid
conservation. The volume of bal
anced electrolyte solution infused is
guided by the response of blood
pressure, pulse pressure and urine
output.
After blood volume has been re
stored and vital signs have been
stabilized, operation can be per
formed for definitive hemostasis.
Once bleeding is controlled, the
blood pressure quickly returns to
ward normal. When this occurs,
urine output often is low because of
the continued refilling of the deplet
ed interstitial fluid space from the
plasma. Instead of diuretics, which
further deplete the plasma volume,
the patient needs additional bal
anced electrolyte solution to aug
ment refilling of the interstitial fluid
space. In these circumstances a
bolus infusion of 1 to 2 L of
electrolyte solution over 30 minutes
usually induces spontaneous urine
flow. This approach helps postoper
ative management since the volume
of urine flow will reflect circulatory
needs when no diuretics were ad
ministered during operation.

Phase II
After operation, the patient will
enter into an obligatory extravascular fluid sequestration phase (phase
II). This obligatory expansion oc
curs into both the ICF and the
ECF.2’8 Intracellular fluid expansion

is associated with changes in cell
membrane potential because of de
creased efflux of sodium and water
from the cell. This decreased efflux
may be owing to a decrease in
adenosine triphosphate (ATP)
which fuels the sodium-potassium
ATPase pump. Interstitial fluid
space expansion is likely caused by
unravelling of the interstitial space
matrix with exposure of the pro
teoglycans to albumin and other
proteins.2-3 Formerly, ECF expan
sion during phase II was thought to
result from increased capillary per
meability. This concept, however,
discounts normal albumin kinetics.
Contrary to popular opinion, only
45% of ECF albumin is located in
the plasma; the remainder is within
the interstitial fluid space. Further
more, 7% of the 45% in the plasma
exits the plasma hourly as an equal
amount exits the interstitial fluid
space through the lymphatics to
re-enter the plasma at a remote site.
In contrast to the “ colloid leak”
theory, our studies have shown that
the hourly loss of albumin from the
plasma during phase II is decreased
to 6%.2 Since, in phase II, plasma
volume and serum albumin concen
trations are quite low, this 6% es
cape rate represents a very small
amount of albumin flux from the
plasma. Thus, the mechanism by
which serum albumin levels become
low in phase II must be the result of
an even lower amount of albumin
which re-enters the plasma from the
interstitial fluid space (Fig. 3). This
decrease reflects albumin entrap
ment within the expanded matrix of
the interstitial fluid space; the con
ceptual and therapeutic implications
of this are enormous. Fluid shifts
and protein changes with HS result
more from changes in the dynamics
of the interstitial fluid space matrix
and cell membrane responses than
from leaky capillaries. Thus, thera
py should restore red blood cell
mass and plasma volume as judged

by vital signs and not sequential
weights. During phase II, the
weight gain often exceeds 10 kg.
Loop diuresis to prevent or correct
this ECF expansion may be injuri
ous because of reductions in plasma
volume in an already depleted state.
This may lead to renal shutdown
which is almost always fatal after
HS from trauma. Renal function
during phase II is best maintained
by a continuous aggressive regimen
of fluid replacement according to
our guidelines.

Phase III
Once the ICF and interstitial fluid
space reach full expansion, the pa
tient will enter into the fluid mobili
zation and diuretic phase (phase
III). During this phase, the cell
membrane potential returns toward
normal as the sodium-potassium
ATPase pump restores normal ionic
fluxes and the interstitial fluid
space matrix contracts, thereby in
creasing protein flux through the
lymphatics back to the plasma (Fig.
4). During phase III, the plasma
volume and the plasma albumin
level rise, although the serum albu
min level remains well below normal
(Fig. 4). Contrary to popular opin
ion, the amount of albumin “leak
age” through the capillary system
into the interstitial fluid space is
increased (8%). Thus, serum albu
min concentration in this phase is
controlled more by changes in the
interstitial fluid space matrix than
by capillary permeability. Regard
less of physiologic mechanisms, the
hemodynamic responses during
phase III necessitate an abrupt re
duction in fluid infusion. The tran
sition from phase II to phase III
causes a gradual increase in blood
pressure and pulse pressure so that
the need for bolus infusions to
maintain hourly urine output
ceases. When these subtle changes
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first appear, immediate restriction
of fluid intake will reduce the likeli
hood of postresuscitative hyperten
sion syndrome.9 This syndrome is
associated with a sustained rise in
systolic and diastolic blood pressure
and is also associated with an in
crease in the ratio of plasma volume
to interstitial fluid space when com
pared with similarly injured patients
who do not have HS. Therapy in
cludes fluid restriction and gentle
diuresis to prevent congestive heart
decompensation.49
During late phase II and early
phase III, central pressure may rise
precipitously. Rather than assuming
that an elevated wedge pressure
reflects inotropic failure, the physi
cian can give a fluid bolus of 500
ml of balanced electrolyte solution
over 30 minutes and monitor the
ratio of left ventricular stroke work
to pulmonary capillary wedge pres
sure. When the slope created by
that monitoring is steep, it can be
assumed that the elevated central
pressure is due to lung failure and

not heart failure (Fig. 5). Oliguria
and hypotension in this setting are
treated by further fluid replacement
despite the elevated central pres
sure. Once the patient enters the
fluid mobilization phase, fluids are
slowed and continued recovery can
be expected as organ function grad
ually returns to normal.

The Colloid Controversy

Starling, in 1896, stated that the
vascular efflux of water correlates
directly with capillary conductivity
(often misappropriately referred to
as permeability) multiplied by the
capillary surface area, with the cap
illary being influenced by the plas
ma hydrostatic pressure, interstitial
hydrostatic pressure, plasma oncot
ic pressure and interstitial oncotic
pressure. The equation states that
the flux of water out of the plasma
will be inversely related to capillary
oncotic pressure if all of the above
factors remain constant.1 Starling

highlighted the inadequacies of this
equation by emphasizing that it
does not apply to man because
there is a third fluid system, the
lymphatic system, which exits from
the interstitial space. There are dy
namic fluid fluxes between the in
terstitial fluid space and the ICF,
and dynamic changes probably
occur in osmotic and hydrostatic
forces whenever one factor in the
equation is altered. Despite these
disclaimers, modern physicians em
ploy Starling’s equation to justify
albumin supplementation to the re
suscitation regimen for HS. When
our retrospective, nonrandomized
studies suggested that albumin
therapy increased pulmonary dys
function, we stopped using supple
mental albumin.6 This led to severe
criticism by other trauma experts,
thereby, stimulating a prospective
randomized analysis of albumin
supplementation.
During a 2-year interval, 94 pa
tients with HS after trauma were
randomized to receive albumin or
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FIG. 3. During phase II, plasma volume and serum albumin
concentration decrease despite reduced efflux of albumin (6%)
from plasma volume. Thus, increases in interstitial and
intracellular fluid result from changes in interstitial fluid
space matrix and cell membrane changes rather than from
“capillary leak syndrome”.
454

CJS, VOL. 33, NO. 6, DECEMBER 1990

G L O B U L IN

0 .6

<Ra

0 .5

(R g -

-

0 .2

)

0 .1 6 )

FIG. 4. During phase III, plasma volume expands as fluid
moves from cells and interstitial space.

HEMORRHAGIC SHOCK AFTER TRAUMA

no albumin. The average shock
time exceeded 30 minutes and an

average of 15 blood transfusions
were given during phase I. The

FIG. 5. When bolus of fluid leads to rise in left ventricular stroke work (LVSW)
with little change in central pressure (PA„), associated hypotension and oliguria
are best treated by additional fluid replacement, since elevated pressure results
from lung failure and not inotropic failure.

FIG. 6. Effects of albumin supplementation in severely injured patients with HS.
These are statistically significant when compared with similarly injured patients
not receiving albumin supplementation. F i0 2/ p 0 2 = fractional intake of oxygen/oxygen pressure, CVP-Ppw = central venous pressure-pulmonary capillary
wedge pressure, ERPF = effective renal plasma flow, GFR = glomerular filtration
rate, CNa = sodium clearance, Cosm= osmolar clearance.

patients who did not receive albu
min received blood, balanced elec
trolyte solution and some freshfrozen plasma to assist coagulation.
The patients who received albumin
received human serum albumin also
in an amount calculated to restore
serum albumin levels and colloid
oncotic pressure toward normal and
based upon multiple sequential
measurements in similar patients.
The patients who received albumin
had a capillary oncotic pressure
(normal 22 to 24 mm Hg) of 19.7
mm Hg compared with 14.8 mm Hg
in the group not given albumin.24
Consequent to therapy with
human serum albumin, the patients
had a marked rise in serum albumin
concentration, plasma volume and
effective renal plasma flow as mea
sured by para-aminohippurate clear
ance (Fig. 6). Despite the increase
in renal plasma flow, these patients
had a fall in glomerular filtration
rate, sodium clearance, osmolar
clearance and urine ou tp u t.10
Human serum albumin therapy
causes an increase in both the on
cotic and osmotic pressure within
the glomerulus. This leads to salt
and water retention and to an in
crease in the oncotic pressure with
in the peritubular vessels perfusing
the inner medulla of the kidney.
Controversy exists among renal
physiologists regarding the mecha
nism by which human serum albu
min causes sodium retention.11 Our
findings suggested that the sodium
retention after human serum albu
min therapy was due to a sodiumpotassium exchange at the tubular
level. These renal effects disrupt the
original purpose of the human
serum albumin infusion which is to
exert an oncotic effect within the
vascular system in order to extract
extravascular fluid from the pulmo
nary interstices and deliver this
fluid to the kidneys for excretion.
Unfortunately, the renal effects of
human serum albumin therapy lead
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to salt and water retention with an
increased need for diuretic therapy,
a higher incidence of renal failure,
worsening pulmonary function, as
reflected by higher central pres
sures, increased physiologic shunt
ing in the lungs and prolonged need
for ventilatory support.11 The death
rate after human serum albumin
therapy was significantly (p < 0.05,
unpaired Student’s f-test) increased.

Protein Kinetics
The albumin-treated patients had
a substantial reduction in serum
globulin levels; this included most
of the globulin fractions and all
immunoglobulins.7’12 The reduction
in immunoglobulin content was as
sociated with decreased immuno
globulin activity to tetanus toxoid.
The albumin-treated patients re
quired more blood transfusions dur
ing the first 5 postoperative days.
This was associated with decreased
fibrinogen activity and prothrombin
times in albumin patients. Frozen
plasma samples from the two
groups of patients then showed
reduced fibrinogen and prothrombin
content in the albumin patients.13
These findings have been repro
duced in a canine model after albu
min therapy for HS.14
Further canine studies assessed
the mechanism of these changes on
circulating proteins. Animals receiv
ing 5% albumin therapy for HS had
a significant, progressive rise in
serum albumin concentration and a
fall in the serum globulin concen
tration. They also had a fall in
coagulation protein factors and in
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coagulation protein activity. When
1.25% albumin was given, the
serum changes were no longer sta
tistically different for the two
groups, but the albumin-treated ani
mals had a significant increase in
lymphatic proteins including albu
min and globulins.15
We concluded that albumin ther
apy causes a relocation of intravas
cular proteins to the interstitial
fluid space in order to maintain an
ideal oncotic balance of plasma vol
ume to interstitial fluid. These con
clusions have been supported by
subsequent canine studies in which
Hespan and fluorocarbon therapy
were compared with balanced elec
trolyte solution.1617 The driving
force of the intravascular colloid
appears to be dose dependent; as
the intravascular oncotic pressure
increases, the amount of albumin
and globulin leaving the plasma by
way of prenodal skin lymphatics
also increases.
Future generations of traumato
logists will no longer accept the
sequential studies on plasmavolume changes in the scientific
study of various therapeutic modali
ties for HS. Our students and resi
dents in surgery should be stimulat
ed to look within the interstitial
fluid space and the ICF when future
scientific studies on the homeostat
ic effects of HS are planned.
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5. Trauma and Hypothermia
Andrew L. McCallum, MD, FRCPC
Trauma may be accompanied by hypothermia in all climates. Because of the
associated increased death rate due to hypothermia (core body temperature less than
35°C), traumatized patients must be protected from it. The body maintains heat
balance by hypothalamic regulation of endogenous heat generation and heat loss.
Decreased core temperature causes generalized physiologic deceleration and
homeostatic disturbances in all organ systems.
To prevent hypothermia in polytraumatized patients a number of methods may be
used: warming crystalloid, increasing ambient temperature, the use of warming
devices, irrigation of body cavities with warmed fluids, heating of inspired gases
and, in severe cases when there is circulatory instability, the use of extracorporeal
membrane oxygenation.

Sous tous les dimats, les traumatismes peuvent etre accompagnes d’hypothermie.
Comme l’hypothermie (une temperature corporelle profonde inferieure a 35°C)
s’accompagne d’une augmentation du taux de mortalite, les victimes de traumatis
mes doivent en etre protegees. Le corps maintient son homeothermie par regulation
hypothalamique de la generation endogene de chaleur et de la perte thermique.
L’hypothermie cause un ralentissement physiologique generalise et des derange
ments homeostatiques sont observes dans tous les systemes organiques en rapport
avec un abaissement de la temperature profonde.
Plusieurs methodes peuvent etre utilisees pour prevenir Thypothermie chez les
polytraumatises: solutes cristalloides rechauffes, augmentation de la temperature
ambiante, utilisation d’appareils de rechauffement, irrigation des cavites corporelles
a l’aide de solutes chauds, rechauffement des gaz inspires et, dans les cas graves,
quand il y a instability circulatoire, emploi de membranes d’oxygenation extracorporelle.

rauma may be accompanied by
hypothermia (core body tem
perature less than 35 °C) in all
climates. There are two possible
causes for this phenomenon: first,
the victim is injured in an environ
ment which is cold or wet enough
to produce hypothermia; second,

T

the victim must undergo complicat
ed and prolonged resuscitation for
major trauma. The former cause
has been reported only once in the
last 5 years.1 The latter cause is
much more common. Recent publi
cations indicate that hypothermia
accompanies 42% to 66% of major
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trauma (Injury Severity Score [ISS]
greater than 25).23 Most disturbing
is the association between hypo
thermia and increased mortality in
trauma patients noted by Jurkovich
and colleagues.3 They found that
the death rate in seriously injured
patients varied between 69% and
100% if the body core temperature
(Tc) was less than 33°C. Clearly,
polytrauma victims must be protect
ed from hypothermia. In this paper
I shall outline mechanisms by
which core temperature is lowered
in trauma victims and discuss meth
ods by which hypothermia can be
prevented in trauma patients and
treated when it does occur.

Temperature Regulation
Heat is transferred in four ways:
by radiation, conduction, convec
tion and evaporation. Since water
has a specific heat 32 times greater
than that of air, humans who are
immersed in cool-cold water or
who receive cool fluids or blood
intravenously may become hypo
thermic owing to conductive heat
loss.4 Mammals are homeotherms
and have evolved a complex physio
logical system to maintain normothermia. In man, the temperature
control centre is in the anterior
preoptic hypothalamus. This centre
receives afferent nerves from the
spinothalamic tracts, and they relay
information from visceral, great ves
sel and skin temperature receptors.
The hypothalamus maintains Tc at
37.5° to 38.5°C and responds to
deviations from this range in a

CJS, VOL. 33, NO. 6, DECEMBER 1990

457

McCALLUM

predictable fashion. It responds to a
decrease in Tc by causing vasocon
striction of the outer shell arterioles
and venous plexi, causing shivering
(isometric muscular heat produc
tion), and by alerting the conscious
brain to the fact that the body is
cold, leading to protective actions
such as donning extra clothes.
Other mechanisms of heat produc
tion such as non-shivering ther
mogenesis are relatively unimpor
tant in adults.4

Pathophysiology of
Hypothermia
Hypothermia causes generalized
physiological deceleration in all
body systems. Cerebral oxygen con
sumption decreases 3% to 7% for
each degree decrease in Tc, thus
providing a relative protective effect
on the brain. In the 1950s, cerebral
circulation was deliberately stopped
for up to 1 hour, without ill effect,
in the operating room in patients
who underwent cardiac surgery
with induced hypothermia (Tc of
18°C).5 The same phenomenon ren
ders the clinical and electroencephalographic detection of brain death
impossible. Usually hypothermia
does not induce unconsciousness if
the Tc is greater than 30 °C.4-6
The major effects of hypothermia
on the heart are twofold. First there
is a generalized slowing of sinoatri
al node activity accompanied by a
decrease in myocardial contractility.
Second there is an increased poten
tial for dysrhythmias, manifesting
as atrial fibrillation in the early
stage of hypothermia, but seen as
spontaneous ventricular fibrillation
in patients with a Tc less than
29°C. Rough handling, endotrache
al intubation and cannulation of the
central veins and heart have been
found to induce ventricular fibrilla
tion in hypothermic patients, but
fear of these complications should
458

not inhibit treatment.7 Examination
of the electrocardiogram may show
the pathognomonic J or Osborn
wave.4-6'8-9 Cold initially induces
bronchorrhea and later causes pul
monary edema, leading to a de
crease in arterial oxygen pressure.
Hypoxia is exacerbated by the coldinduced leftward shift of the oxyhe
moglobin dissociation curve. Respi
ratory frequency decreases propor
tionately to Tc. Finally, nasal hu
midification and exhalation of
warmed gas may lead to the loss of
40 to 45 J /h .6
Vasoconstriction of the outer
shell blood vessels results in a rela
tive increase in central blood vol
ume and a higher renal blood flow.
Thus, a relative diuresis occurs in
hypothermic patients. The diuresis
is increased by the decrease in oxi
dative metabolism in the nephron,
leading to a diminished reabsorp
tion of water.4-6
Electolyte disturbances may ac
company decreased Tc. Depression
of Na-K ATPase action in the sodi
um-potassium pump may lead to
extracellular fluid hyperkalemia and
hyponatremia that is usually not of
clinical importance.
The alterations in blood pH with
hypothermia are complex and con
fusing. The net effect of decreased
Tc is to decrease pH. Current rec
ommendations are to measure blood
pH and gases without correction as
though they had been drawn at
normal Tc, thereby giving normal
values for the warmed patient.10-11
Hypothermia is associated with de
creased insulin activity when Tc is
less than 30°C. However, blood
glucose levels are variable; about
50% of hypothermic patients are
hypoglycemic. Some authorities
have recommended the routine ad
ministration of intravenous 50%
glucose to all patients who have
hypothermia, in order to correct
hypoglycemia.6
Blood viscosity increases by 2%
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for every degree Celsius, concomi
tant with an increase in hematocrit.
Decreased Tc causes platelets to be
sequestered in the liver and alters
coagulation cascade function so
that disseminated intravascular co
agulation may occur. Coagulopathy
may be aggravated by acidemia and
by dilution of coagulation factors
and platelets when partial blood
products are administered.12

General Treatment
The trauma victim is figuratively
walking a fine line between effective
compensatory mechanisms and in
cipient organ-system failure. It is
much more important to prevent a
decrease in the Tc in these patients
than in a normal population. Also,
very young, very old and debilitated
patients may have blunted homeo
static responses to cold stress.
Thus, trauma victims require care
ful monitoring of Tc.

Prevention of Hypothermia in
Trauma
The potential for hypothermia
must be considered in every trauma
patient. Table I summarizes the
factors that predispose the trauma
patient to hypothermia.
Measures to prevent hypothermia
must be routine in the trauma re
suscitation room. The patient
should be on a warming blanket
and covered with blankets when not
being examined. Wet sheets should
be removed immediately. All pa
tients need Tc monitoring with a
continuous-reading thermocouple.
Ideally, the esophageal temperature
should be monitored at the distal
end, because it correlates best with
myocardial temperature, but moni
toring of the rectal or tympanic
membrane temperature is accept
able as a substitute.13

TRAUMA AND HYPOTHERMIA

Ideally, all intravenous or enteral
solutions should be warmed before
they are administered.13-15 All intra
venous infusion sets should have
warming devices inserted in-line, as
these are a safe and convenient way
to pre-warm intravenous fluid and
blood for transfusion (commonly at
4°C). The device that allows the
greatest rate of infusion with capac
ity to warm fluid to 42°C is a
single-channel counter-current heat
exchanger as measured by thermal
clearance.16 Intravenous solutions
can be warmed effectively in a mi
crowave oven,17-19 but experimenta
tion with different oven models is
necessary before using this method
because of the huge variation in
heating capacity. One author has
raised concern about caramelization
of glucose in intravenous solutions
due to “hotspots” during heating,17
but other studies have failed to
confirm that caramelization is a
legitimate concern.18'19
The temperature of the operating
room should be maintained at 21°
to 24°C,20 because the incidence of
intraoperative hypothermia rises
sharply when the ambient tempera
ture is less than 21°C.

Finally, simple measures such as
increasing patient insulation with
blankets or installing a humidifying
sponge in the ventilating circuit
(the so-called “artificial nose” ) can
decrease the rate of heat loss in the
trauma patient, as can heating in
spired gases.

Management of Hypothermia in
Trauma
Relatively little has been written
about resuscitation of hypothermic
trauma victims. However, many of
the techniques now used to treat
pure hypothermia patients may be
adapted to the trauma victim.7-21-27
Table II summarizes the methods
used to treat hypothermia. Note
that passive methods of rewarming
rely on endogenous metabolic heat
and are thus ineffective in pro
foundly hypothermic patients (Tc
less than 30 °C). Active methods are
subdivided into external and core
rewarming. Many of the methods
listed in Table II, such as immersion
in a water bath, are difficult to use
in the polytrauma victim. Other
methods, such as anticoagulation

T a b le 1. Factors Predisposing the Trauma Patient to Hypothermia
P a tie n t factors

Exo genous fa c to rs

Nakedness
Paralysis (no shivering)
Iatrogenic origin
Cord lesion
Head injury

Cool room
Cool intravenous solutions
and cold blood transfusions
(4°C)
Wound irrigation
Vasodilating anesthetics
Cool, dry gas fo r ventilation

T a b le II. Methods of Treatm ent for Hypothermia
A ctive
P as s iv e

Remove from cold
and wind
Remove wet clothing
Increase insulation

External

Hot tub
Forced warm air
Hot-water bottle
Warming blanket
Radiant heater

C ore

Hot fo od/drin k
Warm intravenously
Gastric lavage
Heated oxygen
Dialysis
Cavity lavage
Extracorporeal mem
brane oxygenation

required for hemodialysis or ex
tracorporeal membrane oxygenation
(ECMO), may exacerbate the pa
tient’s problems. Great care must
therefore be taken during the resus
citation of the traumatized and hy
pothermic patient.
The passive methods of rewarm
ing should be used routinely. The
patient can be placed on a warming
blanket or covered with warmed
blankets. If available, radiant heat
can be a useful adjunct. Rewarming
the extremities should be avoided,
because there is a risk of afterdrop,
which is defined as a drop in Tc
resulting from cold, acidotic blood
returning from the extremities.
Intravenous fluids should be
warmed to 41° to 42°C, as should
inspired gases. Gases also need hu
midification. Gastric, peritoneal and
rectal lavage may be useful; they
can raise the Tc by 5° to 1 0 ° C /h .7
It has been argued that no pa
tient should be actively re-warmed
because of the risk of inducing
intractable ventricular fibrillation.
This phenomenon can occur when
cold, acidotic blood returns from
the peripheral shell to the core as a
result of secondary vasodilation.
Ventricular fibrillation is usually
not reversible at a Tc below 29 °C
but may respond to the administra
tion of bretylium tosylate.23 The
risk of spontaneous ventricular fi
brillation is probably equal to the
risk of rewarming-induced ventricu
lar fibrillation, so a recommendation
for active rewarming can be made.
The risk of induced ventricular fi
brillation can be diminished by
preoxygenation of the patient be
fore all invasive procedures.26
The physician must avoid re
warming shock. This occurs be
cause of rewarming-induced vasodi
lation in a relatively hypovolemic
patient. Pre-loading the patient with
sufficient fluid intravenously can
prevent this problem.
If the patient is pulseless, cardiac
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massage can be started at half-nor
mal rates. However, chest compres
sion can induce ventricular fibrilla
tion in the hypothermic patient, and
vital signs may be difficult to de
tect. Therefore, all vital-sign assess
ment times should be increased and,
ideally, invasive hemodynamic mon
itoring should be instituted. If the
patient is pulseless ECMO may be
helpful but is fraught with difficulty
in the polytrauma patient. This mo
dality should be considered a last
resort2122 and used only in the
pulseless but potentially viable pa
tient.
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6. Update on Trauma Registries and
Trauma Scoring
Judith A. Vestrup, MD, FRCSC
Developments in microcomputer technology and user friendly software have resulted
in rapidly expanding interest in trauma registries and injury scoring. The
trauma registry, particularly when it is population based, is an empowering tool for
epidemiologic research, planning of trauma systems, development of prevention
programs, outcome evaluation and research. Injury coding performed in conjunction
with trauma registry can also provide the basis for institutional quality assurance.
The Major Trauma Outcome Study has played a major role in this, through the
development of normative standards, permitting inter-institutional comparisons.
These issues as well as some of the present Canadian and American initiatives in the
trauma registry field are reviewed in this paper. Advances in injury scaling are
addressed as are some of the limitations in existing coding methodologies.
Les progres de la technologie des microordinateurs et le developpement de logiciels
d’acces facile ont entraine un accroissement rapide de l’interet pour l’enregistrement
des traumatismes et Tevaluation des blessures sur echelles de mesure. L’enregistre
ment des traumatismes, surtout lorsqu’il est rapporte a une population donnee, est
un outil puissant de recherche epidemiologique, de planification des systemes, de
developpement des programmes de prevention et devaluation et de recherche. La
codification des blessures associee a Tenregistrement des traumatismes peut aussi
servir au controle de la qualite des etablissements de sante. L’Etude sur Tissue des
traumatismes graves a joue un role preponderant a cette fin, grace a Tetablissement
de normes permettant des comparisons entre les etablissements. La presente
communication traite de ces questions de meme que des initiatives canadiennnes et
americaines en matiere d’enregistrement des traumatismes. On y traite aussi des
progres dans le domaine de echelles devaluation des blessures ainsi que des limites
des methodes actuelles de codification.

he ready availability of micro
computers and of user-friendly
software has resulted in increased
interest in medical databases. No
where has this been more evident
than in the rapidly expanding area
of trauma registries. The trauma
registry is rightly recognized as a
powerful tool for epidemiology
studies, planning and evaluation of
prevention programs, quality assur
ance, trauma systems design, and

T

research. I will highlight some of
the recent developments in trauma
registry and injury scoring and in
the implementation of coding and
registry programs.

Deficiencies in Trauma
Registries
The first comprehensive effort at
a population-based trauma registry

began in 1970 when a computer
ized state-wide trauma registry was
established in Illinois. The aim was
to collect over 700 data fields per
trauma patient, for a 5-year period;
a loss of federal funding brought an
end to this registry. Subsequently
an evaluation review identified a
number of problems with the ap
proach taken.1 Underreporting was
one of many difficulties encoun
tered, with only 37% of cases admit
ted to hospital appearing in one
study sample. The critics concluded
that registry goals need to be very
clearly defined and that funding,
staffing and a mechanism for evalu
ating the completeness and accura
cy of case reporting must be in
place. They also concluded that
minimizing the number of data ele
ments to be captured would help in
achieving compliance with case re
porting.
Another issue that has been
raised is the deficiency in hospitalbased rather than population-based
registries.23 In particular, Payne
and Wallers’ study3 of woodwork
ing and logging injuries showed
major differences between hospital
ized and ambulatory patients and
between primary care and interinstitutional transfer patients. To
achieve a more comprehensive data
base they recommended that sam
pling techniques be applied to am
bulatory care patients and to pre
hospital deaths.
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Development of Trauma
Registries
The recent impetus for registry
development has stemmed from in
creased awareness that “ injury is
no accident” and that standard epiCJS, VOL. 33, NO. 6, DECEMBER 1990
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demiologic tools can be applied to
the study of injury4 and from the
need for hospitals to demonstrate to
funding agencies that their trauma
programs are both cost effective
and provide an exemplary standard
of care (outcome evaluation).
Leadership in the field has been
shown both by the American Col
lege of Surgeons and by the United
States Centers for Disease Control
(CDC). In the American College of
Surgeons Major Trauma Outcome
Study (MTOS) a minimal data set
was used to accumulate information
on more than 60 000 injured pa
tients reported by 118 acute care
institutions in the US and Canada5
and normative standards were pro
duced against which each trauma
centre can measure its own perfor
mance. In addition, the MTOS illus
trated the limitations of using the
injury severity score (ISS)6 as the
only measure of trauma severity.
Thus, the MTOS has made a major
contribution to the North American
understanding of the power of the
trauma registry and its value to
quality assurance programs.
Another breakthrough occurred
in 1985 when the CDC received a
congressional mandate to develop a
new injury research program. This
resulted in the establishment of the
Division of Injury Epidemiology and
Control,7 which subsequently led to
the organization of a trauma regis
try workshop at the CDC in Janu
ary 1988. This meeting was co
sponsored by the American College
of Surgeons, the American College
of Emergency Physicians and other
groups having a special interest in
developing trauma registries.8 They
demonstrated that an interdisciplin
ary consensus on a minimal data set
can be achieved. Subsequently, the
CDC has produced a trauma regis
try software package which has
been acquired by over 40 hospitals
and is available to institutions in
Canada and the United States free
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of charge (Pollock DA, Biometrics
Branch, Division of Injury, Epidemi
ology and Control, Centers for Dis
ease Control, Atlanta, Ga.: Personal
communication, 1989).
Although the CDC project had as
its initial aim the development of a
standardized hospital-based regis
try, Australia, with its National In
jury Surveillance and Prevention
Project started in 1986, has taken a
different approach, by attempting to
develop a broader based system,
recording all injuries resulting in
visits to emergency departments not
just those resulting in hospital ad
mission. This registry has two com
ponents, a self-administered ques
tionnaire on the injury circum
stances, filled out by the patient or
a relative, and a clinical component
completed by a physician. Using
this format over 100 000 injuries
have been reported over an
18-month period. A review of this
study highlights well the challenges
in achieving high capture rates and
evolving a population-based regis
try.9
In Canada the Trauma Associa
tion of Canada and the Ontario
Ministry of Health jointly sponsored
a national consensus conference in
June 1989 aimed at developing con
sensus amongst governmental, clin
ical, injury prevention and other
interested agencies on a minimal
data set that could ultimately be
used to achieve a national trauma
registry. This conference was well
attended, with representation from
the federal Ministry of Health and
Welfare, five provincial health min
istries, the Canadian Medical Asso
ciation, the Canadian Association of
Emergency Physicians, the Canadi
an Association of General Surgeons
and the Canadian Orthopaedic As
sociation. At the provincial level,
both Ontario and British Columbia
have allocated funding to the devel
opment of a province-based regis
try, with similar efforts also under
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way in other provinces. It is hoped
that these projects can be melded
into a minimal data set that will
permit interprovincial sharing of
data and ultimately a national data
base. A number of trauma hospitals
in Canada maintain hospital-based
trauma registries, some having de
veloped their own software pack
ages, others making use of com
mercially available ones. For those
interested in hospital-based regis
tries the issues and potential pitfalls
are well detailed in Payne and Wal
ler’s study.3
Projects are also under way to
develop a pediatric trauma registry.
Tepas and associates10 recently re
ported on a US national pediatric
trauma registry, which has collect
ed data on 10 177 children from 32
centres and has already resulted in
a number of presentations and pub
lications. Like other registries it
suffers from high initial error rates
in data reporting, and because it is
hospital based it lacks an accurate
population denominator. Despite
this, the study has helped to estab
lish patterns of injury disability and
has tracked changes in clinical
practice within the reporting insti
tutions. A Canadian initiative spear
headed by the Childhood Diseases
Injury Section of the Labora
tory Centre for Disease Control in
Ottawa is about to undertake a
prospective data collection from the
10 Canadian pediatric teaching hos
pitals (Sherman GD, Childhood Dis
eases and Injury Section, Laborato
ry Centre for Disease Control, Otta
wa, Ont.: Personal communication,
1989). This study will use the same
database as the National Injury and
Surveillance and Prevention Project
of Australia.
There is also growing interest in
injury-specific trauma registries.
Currently, the American Burn Asso
ciation is attempting to develop a
minimal data set, for use by all its
associated institutions, with the ob-

TRAUMA REGISTRY AND SCORING

jective of providing a more repre
sentative view of burn injury issues
in the US (Heimbach DM, Harborview Medical Center, Seattle,
Wash.: Personal communication,
1989). Dr. Charles Tator collects
data on sports injuries through the
Canadian Sports Spine and Head
Injury Research Centre in Toronto.
In addition British Columbia has
established a prospective spinal
cord injury registry. A Canadian
spinal cord injury registry has also
been proposed.

Injury Scoring Systems
An important spin off of all these
developments has been the growing
awareness of the importance of in
jury scoring in permitting interinstitutional comparisons of trauma
populations and outcomes. Indeed,
it is unlikely today that peerreviewed journals or granting agen
cies will accept trauma papers or
research proposals without evidence
that the patient population is char
acterized by some form of injury
coding.
Trauma scoring systems are gen
erally divided into physiological sys
tems, which are used for pre-hospi
tal triage and for assessing the
efficacy of pre-hospital care inter
ventions, and anatomical scoring
systems, which provide information
on injury severity, thereby permit
ting the development of normative
standards for evaluating outcome.
Although there are many physiolog
ical scoring systems,11 the most
commonly used has been the trau
ma score. Recently, Sacco and col
leagues5 have proposed a revised
trauma score that requires field per
sonnel to record only Glasgow coma
scale, systolic blood pressure and
respiratory rate. In addition to sim
plifying their task, this revision has

resulted in improved predictive val
ue. The abbreviated injury scale
(AIS-85), which is the most widely
accepted anatomic scale for injuries,
has undergone revision and the new
version will be available early in
1990 (Petrucelli E, Executive Direc
tor, Association for the Advance
ment Of Automotive Medicine, Des
Plaines, 111.: Personal communica
tion, 1989). This revision will pro
vide increased descriptive material
for defining injuries and will en
deavour to incorporate terminology
currently used in ICD-9 descriptors.
Although the ISS, which uses the
AIS of the three most seriously
injured body regions squared and
summed to create a severity score,
has become the standard for report
ing injury severity, certain methodologic problems have been
identified.5-12 Those already familiar
with the use of the AIS/ISS recog
nize that the ISS may not always
accurately reflect the seriousness of
injury. For example, the ISS makes
no provision for the additive effect
of multiple injuries in one body
region. Bilaterality of musculoskele
tal injuries, which affects morbidity
and length of hospital stay is also
not reflected in the ISS. Some of
these issues have been addressed by
Sacco and colleagues5 by the intro
duction of severity profiles which, if
validated, hold promise for improv
ing the predictive value of anatomic
injury data.
The other important development
on the horizon is the introduction
of a variety of coding aids to short
en the learning curve for injury
coders and to improve coding con
sistency. These aids run the gamut
from software packages designed to
assist in deriving ICD-9 E codes7 to
Tri-Code (Tri-Analytics, Inc., Bel
Air, Md.), which will translate a
narrative injury description into
both AIS and ICD-9 codes.

All these developments reflect
great interest and research activity
in the areas of injury coding, which
is leading to refinements both in
methodology and in applications of
these scaling systems. The enhance
ment of scoring systems can only
add to the power of trauma registry
in shaping the focus of injury pre
vention campaigns, setting quality
assurance standards and planning
trauma care systems.
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A ortic Dissection: Current Expectations
and Treatment. Experience With 258
Patients Over 20 Years
G. Fradet, MD, MSc, FICS, FRCSC; W.R.E. Jamieson. MD. FACS, FRCSC;
M.T. Janusz, MD, FRCSC; H. Ling, MD, FRCSC; R.T. Miyagishima, MD, FACS, FRCSC;
A.I. Munro, MD, FRCS, FRCSC
Aortic dissection, the most common acute disease of the thoracic aorta, is associated
with high mortality and morbidity. The authors reviewed their experience over the
last 20 years with 258 patients who had aortic dissection (259 dissections). The
diagnosis was made at autopsy in 69 (27%) patients (59 type A, 10 type B). Of the
remainder, 97 patients had type A dissection (78 acute, 19 chronic) and 93 had type
B dissection (56 acute, 37 chronic).
The sudden onset of severe, unremitting chest pain associated with hyper- or
hypotension or a history of hypertension are suggestive of acute aortic dissection.
The diagnosis should be followed by prompt investigation and treatment. The
30-day survival rate for patients with type A dissection who underwent surgical
treatment was 62%; survival rates for patients with type B dissection, acute and
chronic, were 70% and 86% respectively with pharmacotherapy and 66% and 91%
with surgery.
The authors stress the importance of early, accurate diagnosis and immediate
surgical treatment for all patients who have type A dissection and complicated or
unresponsive (carefully monitored pharmacologic control of blood pressure) type B
dissection.

La dissection aortique est la pathologie la plus frequente de Taorte thoracique, se
manifestant par un tableau de presentation clinique soudaine et souvent severe.
Cette entite est associee a un taux eleve de morbidity et de mortalite. Les auteurs
ont revu leur experience des 20 dernieres annees representant 258 patients avec
259 dissections. Chez 69 patients (27 pourcent), le diagnostique ne fut etabli qu’a
l’autopsie (59 de type A, 10 de type B). Quant au reste de la population, 97 patients
ont de type A (78 de presentation clinique aigue, 19 chronique) et 93 de type B (56
de presentation clinique aigue, 37 chronique).
Le diagnostic de dissection aigue de l’aorte devrait etre soupconne lors de
Tapparition soudaine de douleurs thoraciques severes, souvent persistentes, associees ou non a de l’hypo- ou de Thypertension, ainsi que la presence d’une histoire
medicale anterieure d’hypertension. Lorsque le diagnostic est soupfonne, une
investigation prompte ainsi que Tinitiation rapide du traitement approprie est
necessaire. Le taux de survie obtenu chez les patients de type A qui ont subi un
traitement chirurgical est de 62 pourcent. Le taux de survie chez les patients de
type B est de 70 pourcent et 86 pourcent respectivement pour ceux de presentation
clinique aigue et chronique ayant ete traites par pharmacotherapie alors que ceux
ayant subi un traitement chirurgical ont un taux de survie de 65 pourcent et 91
pourcent respectivement.
Les auteurs demontrent Timportance d’un diagnostic precis et rapide suivi d’un
traitement chirurgical immediat pour toutes les dissections de type A ainsi que
celles de type B avec presentation clinique severe ou ne repondant pas de fa?on
satisfaisante au traitement medical ayant pour but le controle pharmacologique de la
pression sanguine.

he frequency o f aortic dissec
tion annually is 5 to 10 per 1
million population.1-2 It is a condi
tion usually associated with cystic
medial necrosis and atherosclerosis.
An intimal tear as the initial event is
followed by antegrade or retrograde
propagation, or both, o f a dissect
ing hematoma in the outer half of
the aortic media. Three scenarios
can then develop alone or in con
junction. The dissecting hematoma
can come to a halt, it can re-enter
the true arterial channel or it can
rupture externally. The rapidity
with which the dissection pro
gresses and its extent are directly
related to the mean arterial blood
pressure and the maximal rate o f
rise
of
the
blood
pressure
(dP /dT m ax).3-5 Without early rec
ognition and treatment, 50% o f the
patients who have acute aortic dis-
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section (less than 14 days since the
onset of symptoms) will die within
48 hours of the onset of symptoms,
and 90% of them will die within 3
months.6-10 Early, accurate diagno
sis is therefore essential for success
ful management. However, this is
difficult because of the multiple
forms of clinical presentation and
the often-complicated course of
acute aortic dissection.
The current therapeutic approach
has evolved over the last 30 years;
DeBakey, Cooley and Creech11 re
ported their early, successful, surgi
cal experience in 1955. The cur
rently accepted standard of treat
ment consists of early aggressive
surgical therapy for all cases of
dissection involving the ascending
aorta (type A). Surgical intervention
is directed at resection or repair of
the involved ascending aorta, pre
serving, if possible, the aortic valve
(with or without leaflet resuspen
sion), unless it is found to have a
primary abnormality.6'7'9’12-17 Con
troversy still exists about the treat
ment of type B dissection, which
involves the descending thoracic
aorta but not the ascending aorta.
Many still follow the initial recom

mendation of Wheat, Palmer and
Bartley3 to base drug therapy on
the pharmacologic control of blood
pressure and pulse pressure for type
B dissections.1'2'6'7'9'12'14'15'18-20 How
ever, Miller and colleagues,17 re
porting the Stanford experience in
1979, showed improved surgical re
sults in patients with type B dissec
tion, likely resulting from improved
surgical and cardiopulmonary by
pass techniques and from increased
expertise. Miller and colleagues rec
ommended immediate operation for
all type B dissections as the treat
ment of choice.
In this paper we review our last
20 years’ experience with 258 pa
tients who suffered aortic dissec
tion, and present and comment on
the current expectations and treat
ment of this most common acute
disease of the aorta.

Results
Patients and Methods
Between January 1966 and De
cember 1986, 259 aortic dissections
were documented in 258 patients
(177 men, 81 women) by angiogra
phy, computed tomography, opera

Table 1. Classification of 259 Aortic Dissections According to Method of Diagnosis and Treatment
in 258 Patients*
Type A
Diagnosis/treatment
Autopsy
Clinical diagnosis
Medical therapy
Surgical therapy
Totals

tion or autopsy. The patients
ranged in age from 19 to 97 years
(mean 61 years). The type of dissec
tion was classified according to the
definition proposed by Daily and
associates21 from Stanford in 1970:
type A dissection involves the as
cending aorta, irrespective of the
site of the primary intimal tear; all
other thoracic dissections not in
volving the ascending aorta are
classified type B; the process is
considered acute if there is less
than 14 days from the onset of
symptoms to the initiation of treat
ment. The type of dissection in our
258 patients is set forth in Table I.
One patient sustained type A and
type B dissections 5 years apart. In
69 instances, the diagnosis was
established only at autopsy.

Acute

Type B

Chronic

Acute

Chronic

Total no. of
dissections

58

1

9

1

69

17
61

3
16

27
29

14
23

61
129

136

20

65

38

259

*0ne patient sustained both type A and type B dissections 5 years apart.

The most common symptom at
the time of presentation, both type
A and B dissections, was pain (Ta
ble II), which was usually sudden
and unremitting. A substantial pro
portion of our patients presented
with major complications at the
time of diagnosis (Table III). These
included hemopericardium, hemo
thorax, major vessel involvement,
cerebrovascular accident, aortic in
sufficiency or paraplegia (anterior
spinal artery syndrome).
The 30-day survival rates after
admission and diagnosis are shown
in Table IV for the different groups
of dissection. Of the patients who
died within 30 days of surgery, 9
could not be weaned off cardiopul-

Table II. Symptoms and Signs by Type of Dissection
Symptom/sign

Type A, no. (%)
(n = 156)

Type B, no. (%)
(n = 103)

79 (51)
29(18)
11 (7)
24(15)
28(18)
12 (8)
3 (2)

44 (43)
43 (42)
15(14)
2 (2)
3 (3)
9 (9)

Anterior chest pain
Back pain
Abdominal pain
Neck and/or jaw pain
Collapse
Vascular occlusion
Visual disturbance
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Table III. Complications at Time of Initial
Presentation
Complication

No. (%)

Hemopericardium
Hemothorax
Multiple vessel involvement
Cerebrovascular accident
Aortic insufficiency
Paraplegia

58 (22)
22 (8)
38 (15)
15 (6)
29(11)
8 (3)

AORTIC DISSECTION

monary bypass, 3 suffered massive
cerebral infarction and 22 died of
uncontrollable hemorrhage (Table
V). Among the medically treated
patients who died (Table VI), two
(one acute type A and one acute
type B) had myocardial infarction;
one was given only supportive med
ical treatment because of extensive
mesenteric infarction and eventually
died of sepsis and shock. Thirteen
patients (11 acute type A, 2 acute
type B) died of tamponade, 7 pa
tients (2 acute type A, 4 acute type
B and 1 chronic type B) died of
exsanguination into a pleural cavi
ty, and 1 patient with chronic type
B dissection died as a result of
rupture of the hematoma into the
abdominal cavity.
The influence of preoperative
medical therapy was assessed, con
sidering the outcome of all 51 sur
gically treated patients with acute
type B dissection. Nineteen (76%) of
25 patients patients who underwent
initial surgical therapy without a
trial of medical treatment survived
more than 30 days. Of the remain
ing 26 patients, who initially under
went a trial of medical therapy and
later required surgery because of
complications or failure of the medi
cal therapy, 17 (65%) survived. All
patients who underwent initial sur
gical treatment presented with un
remitting or recurrent pain, with or
without complications.

tions of aortic dissection and the
difficulty of establishing an early
diagnosis. This re-emphasizes the
need for constant awareness of this
entity, so that the diagnosis can be
established as early as possible once
clinical symptoms have appeared,
particularly in view of the poor
prognosis of the “ undiagnosed”
aortic dissection and, thus, the un
treated patient. The acute onset of
severe chest, back or upper abdomi
nal pain associated with hyper- or
hypotension or with a medical his
tory of hypertension should prompt
the physician to consider the diag
nosis of acute aortic dissection. The
association of hypertension, at the
time of initial evaluation, with type

B dissection and the frequent asso
ciation of hypotension with type A
dissection was shown in our previ
ously reported analysis of our last 6
years’ experience.2 A substantial
proportion of these patients present
with major complications, empha
sizing the need for prompt stabiliza
tion, investigation and treatment to
minimize morbidity and mortality.
Our approach to the patient sus
pected of having an acute aortic
dissection encompasses medical
therapy for pain and pharmacologic
control of the pulse pressure
(dP/dT) to limit the extent of the
dissection, together with aggressive
investigation consisting of aortogra
phy or computed tomography, or

Table V. Cause of In-hospital Deaths After Surgical Treatment by Type of Dissection
(Number of Dissections)
Type A
Cause

Acute

Cardiac
Cerebral
Hemorrhagic
Other

4
3
12
4

Totals

23

Type B
Chronic

Acute

Chronic

Totals

_

_

2

_
_

3
—

5
3

2
—

9
3
22
7

6

10

2

41

3

Table VI. Cause of In-hospital Deaths After Medical Treatment by Type of Dissection
(Number of Dissections)
Type B

Type A
Cause
Tamponade
Rupture
Pleural cavity
Abdominal cavity
Infarction
Myocardial
Mesenteric
Cerebrovascular
accident
Aortic
insufficiency
Other

Discussion
Of the 259 dissections 69 (27%)
were diagnosed at autopsy, because
of the variety of clinical presenta

Acute

Chronic

Acute

Chronic

Totals

11

—

2

____

13

4

1
1

7
1

2

—

--

--

—

1
1

—
—

—

____

1

—
1

16

—

2
1

—

1

—

1

____

_

Totals

1

—

—

—

—

1
1

8

2

27

1

Table IV. Survival at 30 Days According to Type of Dissection and Treatment
Type A

Type B

No.

Medical
Surgical

17
61

Survived
1
38

%

No.

6
62

3
16

Survived
2
10

Chronic

Acute

Chronic

Acute
Treatment

%

No.

66
62

27
29

Survived
19
19

%

No.

70
66

14
23

Survived
12
21
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91
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both, to establish the diagnosis. All
patients with acute type A dissec
tion undergo emergency surgery
with the therapeutic goals already
described; we achieved a 62% sur
vival rate in these patients. The
outcome was much worse when
surgery was not undertaken for
reasons stated previously. Patients
with type B dissection underwent
an initial trial of medical therapy
unless they presented with unremit
ting and recurrent pain with or
without associated complications. If
hypertension or pain could not be
controlled or if complications devel
oped while pharmacologic control
(a /J blocker and sodium nitroprusside infusion) of the patient’s blood
pressure was adequate, immediate
surgery was undertaken. With this
protocol, we achieved a 30-day sur
vival rate after surgery in 65% of
patients with acute type B and 91%
of those with chronic type B dissec
tions; of dissections that responded
to medical therapy we achieved a
30-day survival rate of 70% for
patients acute type B and 86% for
those with chronic type B dissec
tions.
In the 1979 report of Miller and
colleagues17 from Stanford Universi
ty, all 125 patients underwent sur
gery, regardless of whether they
had type A or type B dissection.
Indeed, nobody in their series was
denied operative treatment because
of age or complications at presenta
tion except patients who were brain
dead or moribund. They reported
survival rates of 77% for acute type
A dissection, 86% for chronic type
A, 55% for acute type B dissection
and 78% for chronic type B. Their
survival rates were better than ours
for type A dissections, possibly be
cause of variations in surgical tech
nique and myocardial protection or,
more simply, the different popula
tions studied as reflected by the
high incidence of complications at
presentation in our series. This may
468

be because our referral area includ
ed the whole province of British
Columbia where large distances,
isolation and difficult transportation
can lead to long transfer times and
delay in initiating surgical or appro
priate medical treatment. However,
our experience with type B dissec
tion compares favourably with that
of Stanford University, even with
our surgical cohort, which repre
sented a selective group of patients
having failed a trial of medical ther
apy or first seen with severe clinical
presentation. Indeed, our surgical
results in type B dissections, both
acute and chronic, are comparable
to the experience obtained with the
more favourable medical type B
cohort who underwent pharmaco
logic treatment only. It seems that
selective surgical treatment of these
patients is appropriate at the time
of initial presentation.

Conclusions
Acute aortic dissection remains a
challenge for the physician; it re
quires an early diagnosis followed
by aggressive pharmacologic sup
port and appropriate investigation
to establish a correct anatomic diag
nosis. Clearly, suspicion is the key
in these initial hours. The impor
tance of pharmacologic control of
any hypertension and constant
monitoring as the investigation pro
ceeds cannot be overemphasized.
All patients with type A dissection
should undergo prompt surgical re
pair. Our experience favours a more
selective surgical approach to type
B dissections; however, other fac
tors than early survival must be
considered in the establishment of
final recommendations as to the
treatment of type B dissections.
Indeed, the outcome of medically
versus surgically treated patients
over a longer follow-up period is
needed, with particular interest paid
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to late morbidity and mortality. If
there is evidence of an increased
incidence of sudden death from aor
tic rupture in medically treated pa
tients, a case could be made for
initial surgery. Certainly, all these
patients should now be followed up
closely, with particular attention
paid to the fate of the false lumen
and possible extension of the origi
nal dissection, and to the develop
ment of new aneurysms, demanding
medical attention.
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BOOK REVIEWS
continued from page 446

The superb section on rheumatoid
arthritis of the neck, comprising five
papers, should be read by all those who
look after patients with rheumatoid
arthritis. The authors point out that the
introduction of computed tomography
and nuclear magnetic resonance imag
ing is changing our concept of the
cause of the myelopathy occasioned by
vertical, supra-axial and horizontal subaxial dislocation. Neural compression
can occur, not only from the obvious
bone displacements, but also from the
build-up of pannus. One paper describes
the transoral approach for removal of
both pannus and the odontoid peg in
severe myelopathies caused by vertical
dislocation.
The chapters on assessment will be
of some interest to orthopedic sur
geons. There is one particularly good
paper on functional aids for patients
with rheumatoid arthritis that shows
how simple changes, such as altering
the angle of the hand grip on elbow
crutches, can help considerably. It also
demonstrates the clean simple look that

has become the hallmark of Scandina
vian design.
A paper by Yeoman on the follow-up
of patients who have ankylosing spon
dylitis dispels the notion that the joint
will restiffen after total hip replacement.
The enduring Scandinavian debate on
the value of surgical synovectomy con
tinues. While recognizing its value in
the odd case, most orthopedic surgeons
on this side of the world limit its use to
the rare cases of failure of synovectomy
with radioactive chemicals.
The section on revision surgery is
interesting. There are papers on the
treatment of failed Meuli and Swanson
wrist prostheses and failed total replace
ments of elbows, shoulders and ankles.
The results of one study of the Thomp
son total ankle replacement were sur
prisingly good, with only 3 failures out
of 66 replacements, all done above a
triple arthrodesis. In another paper on
the same ankle prosthesis the results
were poor; however, the numbers were
small, and the results may simply reflect
a low position on the learning curve.

The papers on hip and knee revision
were good but, of necessity, limited.
Revision of these joints is now such a
huge field that a separate book could be
written on the revision of either joint.
The papers show the European surgical
trend towards noncemented implants,
especially for revision, and the contin
ued use of the threaded cup. The
Mecron ring singlehandedly destroyed
the threaded cup market in North
America. I was surprised to see one
author advocate the use of the Mecron
ring with structural allografts. Since
this is one of the absolute contraindica
tions to the use of a smooth threaded
cup, I would expect the author’s results
to change fairly dramatically in the next
few years.
All in all, this is a worthwhile book.
It provides an excellent window into
northern European thinking in the
treatment of rheumatoid arthritis.
Hugh U. Cameron, MB, ChB, FRCSC

Ste. 318,
43 Wellesley St. E,
Toronto, Ont.

CJS, VOL. 33, NO. 6, DECEMBER 1990

469

CANADIAN SOCIETY OF CARDIOVASCULAR AND THORACIC SURGEONS

Determination of Operability in
Candidates Who Undergo Lung Resection
for Bronchogenic Carcinoma
Terrence P. Murphy, MD; M. Thomas Casey, MD, FRCSC
In this prospective study the authors attempted to determine the effect of lung
resection for bronchogenic carcinoma on final pulmonary function in patients who
had severe limitation of lung air flow preoperatively and were therefore likely to
have severe, progressive pulmonary failure and in those who had acceptable
pulmonary function preoperatively.
Preoperative and postoperative pulmonary function tests were performed on 20
patients chosen to undergo various types of resection for bronchogenic carcinoma.
Those who underwent pneumonectomy had changes in lung volume that were
expected for a resection of that magnitude. Patients who underwent lesser resections
had more variable postoperative lung volumes and flows. The patients whose
preoperative pulmonary function was poorest had the least change postoperatively
and even, in some cases, showed some improvement in function, yet they were the
ones most likely to be denied surgery, because of their poor preoperative pulmonary
function.

Dans ce projet d’etude, les auteurs tentent de cerner l’effet de la resection
pulmonaire pour epithelioma bronchique sur le fonctionnement pulmonaire ultime
chez les patients qui presentaient une capacite pulmonaire tres limitee avant
l’operation et par consequent sujets a une defaillance pulmonaire progressive grave
et chez ceux qui jouissaient d’une fonction pulmonaire preoperatoire acceptable.
Des tests fonctionnels pulmonaires pre et postoperatoires ont ete effectues chez
20 patients designes pour subir divers types de resection pour epithelioma
bronchique. Ceux qui ont subi une pneumonectomie presentaient des changements
de volume pulmonaire previsibles pour une resection de cette ampleur. Les patients
qui ont subi des resections moins importantes presentaient des volumes pulmonaires
et des debits plus variables. Les patients qui presentaient la fonction pulmonaire
preoperatoire la plus mauvaise presentaient le moins de modifications post
operatoires et meme, en certains cas, benificiaient d’une certaine amelioration
fonctionnelle; ils etaient pourtant ceux a qui Ton refusait le plus souvent la
chirurgie, a cause de leur mauvaise fonction pulmonaire preoperatoire.
nce the resectability of a pul
monary malignant tumour has
been determined for a given patient,

O

operability must be assessed. Usual
ly pulmonary function tests (PFTs)
in combination with split-lung ra
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dionuclide scanning is carried out
to estimate the postoperative pul
monary function of the candidate
for pneumonectomy. Values calcu
lated in this manner are taken into
consideration, along with the over
all medical status of the patient, in
determining the ability of the pa
tient to tolerate the planned sur
gery. Adherence to strict guidelines,
with respect to operability may,
however, deny a number of patients
a potentially curable procedure.
Assessment of this higher risk
group of patients has involved more
invasive and technologically de
manding techniques. The equip
ment and special skills required to
perform the tests are not readily
accessible to most practising tho
racic surgeons so they resort to
established, more fundamental eval
uation techniques, such as physical
examination, bronchoscopy, pulmo
nary function tests, split-lung scan
ning and clinical judgement. Re
cently, we randomly selected for
lung resection 20 candidates on
whom we performed preoperative
and postoperative pulmonary func
tion testing. We wished to compare
the postoperative pulmonary func
tion of higher risk candidates, that
is, those with severe limitations of
lung flow, who are more likely to
suffer severe, progressive pulmo
nary failure, with the postoperative
values of those who had acceptable
preoperative pulmonary function.

Patients and Methods
The study group consisted of 20

OPERABILITY IN BRONCHOGENIC CARCINOMA

randomly selected patients (17 men,
3 women) who were being seen
during postoperative follow-up of
lung resection. The preoperative
work-up of these patients had con
sisted of history and physical exam
ination, a complete blood count,
liver profile, determination of urea,
creatinine and electrolyte levels, and
urinalysis. Electrocardiography was
performed. Pulmonary function
tests included measurement of lung
volumes and flows. Perfusion mac

.

Table 1 Operative Procedures Performed
on 20 Patients Who Underwent
Pneumonectomy or Lobectomy
No. of patients

Procedure
Right pneumonectomy
Left pneumonectomy
Left upper lobectomy
Right upper lobectomy
Right middle/lower
lobectomy
Right lower lobectomy
Left lower lobectomy

4
2
9
2
1
1
1

Table II. Pathological Findings of Lung
Resection Specimens
No. of patients

Tumour type
Squamous cell
Adenocarcinoma
Bronchoalveolar
carcinoma
Carcinoma
Small-cell carcinoma

11
4
3
1
1

roaggregate scanning was per
formed in selected patients. Once
resectability was established, opera
bility was evaluated.
The patients ranged in age from
54 to 85 years (mean 65.2 years).
They had an average pack-year
smoking history of 38.1 years. The
operative procedures (Table I) were
performed between September 1981
and June 1985. Pulmonary function
testing was performed on average
15.5 months postoperatively (range
from 3 to 45 months); 14 of the 20
patients had their PFTs performed
within 12 months of surgery. The
pathological diagnoses are listed in
Table II; there were 16 stage I and
4 stage II lesions.
Pulmonary function testing was
performed on a P.K. Morgan Dry
Rolling Spirometer. Functional re
sidual capacity (FRC) was deter
mined by helium dilution (multiplebreath technique) and diffusion ca
pacity of carbon monoxide (DCo)
was determined by the single-breath
breath-holding technique. Three
sets of maneuvers with values with
in 5% of each other were necessary
for successful tests of forced vital
capacity (FVC) and forced expirato
ry volume in 1 second (FEVi).

Other measurements routinely
made were residual volume (RV),
total lung capacity (TLC) and vital
capacity (VC). We selected FEVx,
FVC and TLC as indicators of pre
operative and postoperative pulmo
nary function. The differences were
analysed by Student’s t-test.

Results
The selected parameters and the
differences (preoperative versus
postoperative) in the six patients
who underwent pneumonectomy
are presented in Table III. The
average decreases in the postopera
tive value over the preoperative
value for left and right pneumonec
tomy respectively were 42.5% and
37% for FEV!, 44% and 37% for
FVC, and 41.5% and 33% for TLC.
Because of the small number of
patients these differences are not
statistically significant.
The selected parameters and their
differences (preoperative versus
postoperative) in patients who un
derwent lobectomy are presented in
Table IV. For all lobectomy pa
tients, the average percentage de
creases of postoperative over preop
erative values for FEVi, FVC and

Table III. Preoperative and Postoperative Values and Their Differences for Forced Expiratory Volume in 1 Second (FEV,), Forced Vital Capacity (FVC)
and Total Lung Capacity (TLC) in Patients Who Underwent Pneumonectomy_________________________________
FEV,
Patient/age, yr

Litres

Procedure

1, 59

Left pneumonectomy

2,58

Left pneumonectomy

3, 61

Right pneumonectomy

4, 62

Right pneumonectomy

5, 62

Right pneumonectomy

6, 60

Right pneumonectomy

Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff

3.40
2.12
-1 .2 8
1.82
0.96
-0 .8 6
2.75
1.94
-0 .8 3
2.92
1.97
- 0 .9 5
1.99
1.28
-0 .7 1
2.80
1.44
- 1 .3 6

FVC__________
%Pr
98
61
58
32
83
60
94
63
62
42
76
40

Litres
4.70
3.11
- 1 .5 9
2.74
1.26
-1 .4 8
3.74
2.78
- 0 .9 6
4.68
2.60
- 2 .0 8
2.79
1.98
-0 .8 1
4.21
2.13
- 2 .0 8

%Pr
107
70
69
33
88
68
116
64
68
51
90
46

__________TIC
Litres
7.19
4.64
- 2 .5 5
5.34
2.80
- 2 .5 4
5.27
3.68
— 1.59
6.67
4.23
-2 .4 4
5.17
3.53
- 1 .6 4
6.37
4.29
- 2 .0 8

%Pr
108
69
89
48
81
58
103
64
82
59
89
61

%Pr = percentage of the predicted value for that patient. Diff = difference between preoperative and postoperative values.
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TLC were 11.4, 5.0, and 11.4 re
spectively (p < 0.01 for all three
parameters).
All patients were ambulatory and
doing well at the time of postopera
tive pulmonary function testing.

Discussion
In determining the operability of
the lung resection candidate, the
surgeon must complete a total as
sessment of the physical status of
the patient and weigh the risks of
the operative procedure against the

risk of death from an untreated or
partially treated malignant lesion.
Included in this evaluation is a
prediction of the postoperative pul
monary function of that patient,
that is, the ability to ventilate and
oxygenate blood without unaccept
able pulmonary hypertension.
Many studies have been under
taken to establish objective guide
lines for acceptable predicted post
operative pulmonary function. Kristersson, Lindell and Svanberg1 sug
gested a predicted postoperative
FEV] of 1.0 L as the lower level of

operability. Boushy and associates2
showed that tests for forced expir
atory flow of 200 to 1200 ml
(FEF20o-i2oo), FEF25_ FRC, RV
and maximal ventilatory volume
(MW) are useful in predicting
death in lung resection candidates,
in addition to FEVj. They empha
sized the importance of age in de
termining risk when patients were
older than 60 years and had a
preoperative FEV] of less than 2 L;
these patients do especially poorly.
Miller, Grossman and Hatcher3 list
ed specific criteria for the various

Table IV. Preoperative and Postoperative Values and Their Differences for FEV„ FVC and TLC in Patients Who Underwent Lobectomy
FEV,
Patient/age, yr
7, 75

Left lower lobectomy

8, 68

Right middle/lower
lobectomy

9, 70

Right lower lobectomy

10, 64

Right upper lobectomy

11, 67

Right upper lobectomy

12, 73

Left upper lobectomy

13, 62

Left upper lobectomy

14, 54

Left upper lobectomy

15, 85

Left upper lobectomy

16, 62

Left upper lobectomy

17, 66

Left upper lobectomy

18, 60

Left upper lobectomy

19, 58

Left upper lobectomy

20, 67

Left upper lobectomy

/oPr
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Procedure

Litres
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff
Preop
Postop
Diff

1.45
1.44
-0 .0 1
1.80
1.32
- 0 .4 8
2.79
2.14
-0 .6 5
2.10
1.64
- 0 .4 6
2.34
1.86
-0 .4 8
1.28
1.33
+0.05
2.14
1.95
-0 .1 9
1.39
1.35
-0 .0 4
2.03
1.90
- 0 .1 3
2.45
2.23
-0 .2 2
2.93
2.34
- 0 .5 9
2.97
2.53
-0 .4 4
2.73
2.77
-0 .0 4
2.19
2.01
- 0 .1 8

FVC
%Pr
58
58
93
69
90
72
91
71
78
65
68
71
66
60
48
46
70
66
71
64
87
70
86
72
83
89
78
76

Litres
2.33
2.45
+0.12
2.34
1.97
-0 .3 7
4.83
4.11
-0 .7 2
2.59
2.33
-0 .2 6
3.58
2.92
- 0 .6 6
2.22
1.64
-0 .5 8
3.49
3.58
+0.09
2.69
3.16
+0.50
3.07
2.90
-0 .1 7
4.05
4.58
+0.53
4.00
3.02
-0 .9 8
4.21
3.86
-0 .3 5
3.77
3.79
+0.02
3.17
3.50
+0.33

TLC
%Pr
71
77
96
82
120
107
89
80
93
79
93
68
83
86
73
84
80
76
93
102
93
85
96
86
91
89
87
102

percentage of predicted value for that patient. Diff = difference between preoperative and postoperative values.
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Litres
4.75
5.47
+0.72
4.54
2.38
-2 .1 6
7.70
7.55
- 0 .1 5
4.98
4.39
- 0 .5 9
6.39
5.81
-0 .5 8
4.24
3.94
-0 .3 0
6.10
4.96
- 1 .1 4
7.73
5.45
- 2 .2 8
6.40
5.99
-0 .4 1
7.46
7.85
+0.39
6.70
6.19
-0 .5 1
7.77
5.89
- 1 .8 8
6.85
6.06
- 0 .7 9
5.12
5.19
+0.07

%Pr
87
103
114
61
120
122
102
90
105
98
98
97
95
77
140
97
98
91
111
114
99
90
117
87
108
95
90
94
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types of pulmonary resection, in
cluding pneumonectomy, lobectomy
and wedge resection; however, their
criteria for establishing these limits
were quite vague.
The effectiveness of various
methods of predicting postoperative
pulmonary function in patients who
undergo pneumonectomy is well es
tablished. DeMeester and col
leagues4 and Olsen, Block and
Tobias5 have shown the reliability
of ventilation-perfusion radionu
clide studies, used in conjunction
with standard PFTs, to predict the
postoperative pulmonary function
of pneumonectomy candidates. Sev
eral studies6’7 have supported the
use of the simple lateral position
test (LPT), described by Bergan8 in
1960, which does not require any
elaborate equipment. DeMeester
and colleagues4 found the LPT less
reliable, and Schoonover and asso
ciates9 found notable variability of
the LPT in patients who had
marked obstruction. Olsen and col
leagues10 used temporary unilateral
pulmonary artery occlusion in com
bination with macroaggregate lung
scanning to determine operability in
a high-risk group of patients who
might otherwise have been denied a
lung resection. This technique,
however, requires technology and
expertise unavailable to the majori
ty of thoracic surgeons.
Although methods for predicting
postoperative pulmonary function
and, thus, morbidity and mortality
in patients who undergo pneumo
nectomy are well established, simi
lar criteria for predicting the out
come of patients who undergo less
er lung resections are not well
identified. Both Wernly and associ
ates11 and Ali and colleagues12 have
developed formulas for predicting
postoperative pulmonary function
in patients who are candidates for
lung resection, based on the num
ber of segments removed. These
methods, however, are inaccurate in

the resection of small numbers of
segments and require more sophisti
cated radionuclide scanning analy
sis than is readily available in most
centres.
In our study, we looked at two
groups of patients: those who had
pneumonectomy and those who had
lobectomy. The patients who had
pneumonectomy demonstrated aver
age expected drops in lung flows
and volumes postoperatively. The
results in the lobectomy patients,
however, were much more variable.
Many of these patients showed a
minimal decrease in flows and vol
umes over preoperative values and
some even showed improvement.
The patients with the worst preop
erative values showed the least
change. They were patients who,
based on their preoperative evalua
tion, were most likely to be denied
surgery. Boushy and associates2
pointed out that many patients with
severe obstructive disease experi
ence no worsening of their dyspnea
after lung resection and that those
with more normal PFT results preoperatively are more likely to suffer
a decrease in exercise tolerance
postoperatively.
Parameters determined by preop
erative PFTs and their relation to
previously established criteria for
prognosis must be interpreted in
the light of the physical-medical
status of each patient. Bronchoscopic findings, such as an ob
structed bronchus, leading to the
lobe to be resected, are indicators of
minimal change in postoperative
PFT results and even of improve
ment. A small, thin patient is un
likely to require the suggested
FEV! of 1.0 L /s to ventilate and
oxygenate the blood adequately.
A close look at the patients in
our study showed that those with
borderline function on preoperative
pulmonary function testing may be
the patients who will have the least
change postoperatively. Therefore,

surgeons must be careful not to
deny seemingly high-risk patients
curative resections on the basis of
previously established criteria of
safety.
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Improvement in Thoracic Aortic Pressure
After Proximal Aortic Cross-Clamping
by Balloon Occlusion of the Distal Aorta
Paul A. Spence, MD, FRCSC;* Robert M. Lust, PhD;*t You Su Sun, MD;* Hiroshi Iida, MD;* Samuel B.
Pollock, MD;* J. Mark Williams, MD, FACS;* Erie H. Austin, MD, FACS*
Spinal cord hypoperfusion injury is a devastating complication of cross-clamping the
proximal thoracic aorta. The collateral circulation around the cross-clamp is
generally poorly developed, and the run-off is immense, resulting in extremely low
thoracic aortic and spinal cord perfusion pressures. The authors postulated that
balloon occlusion of the abdominal aorta might confine this reduced collateral flow
around the cross-clamp to the thoracic aorta. In 8 of 16 dogs subjected to aortic
cross-clamping of the aorta just beyond the arch vessels, the abdominal aorta was
also occluded by a balloon. Thoracic aortic pressure and spinal cord perfusion
pressure were significantly higher in the animals with aortic balloon occlusion than
in those without balloon occlusion (77 ± 8 mm Hg versus 26 ± 1 mm Hg, p < 0.01,
and 67 ± 8 mm Hg versus 18 ± 2 mm Hg, p < 0.01, at 10 minutes after
cross-clamping). Abdominal aortic balloon occlusion increases thoracic aortic
pressure after the aorta is cross-clamped proximally. Further studies are necessary
in primates to assess the effect of this procedure in spinal cord perfusion and the
rate of paraplegia.

Les dommages causes par hypoperfusion de la moelle epinere demeurent une
complication catastrophique du clampage total de l’aorte thoracique proximale. La
circulation collaterale autour de clampage est habituellement peu developpee, et
l’ecoulement est immense, resultant en des pressions de perfusion de l’aorte
thoracique et de la moelle extremement basses. Les auteurs ont considere que
l’occlusion de l’aorte abdominale au moyen d’un ballonet pourait contenir cette
chute du debit de la circulation collaterale autour de clampage de l’aorte thoracique.
Chez 8 de 16 chiens soumis au clampage total l’aorte thoracique tout just au dela
des vaisseaux de l’arc, l’aorte abdominale a aussi ete obstruee par un ballonet. La
pression de perfusion de I’aorte thoracique et de la moelle fut sensiblement plus
elevee chez les animaux avec occlusion par ballonet aortique abdominal que chez
ceux qui n’avaient pas d’ocdusion par ballonet aortique (77 ± 8 mm Hg versus 26 ±
1 mm Hg, p < 0,01, et 67 ± 8 mm Hg versus 18 ± 2 mm Hg, p < 0,01, 10 minutes
apres clampage total). L’occlusion par ballonnet aortique augmente la pression
aortique thoracique apres clampage proximal de l’aorte. II importe d’effectuer
d’autres etudes chez des primates pour verifier l’effet de cette manoeuvre sur la
perfusion de la moelle et le taux de paraplegie.
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pinal cord injury is a dreaded
complication of aortic sur
gery . 1-2 Many clinical and experi
mental investigations have been car
ried out to discover its cause and to
prevent it. Factors thought to be
important in its pathogenesis in
clude a large decrease in the thorac
ic aortic pressure after cross-clam
ping , 1" 3 an increase in cerebrospinal
fluid pressure , 1-4 5 division of vessels
perfusing the spinal cord 1-6 and pe
rioperative hypotension . 1"5 Various
techniques have been used to avert
spinal cord injury. Shunts from the
ascending aorta to the descending
aorta have been used ,7-8 and femoral
vein to femoral artery bypass has
been studied.9 Recently, Svensson
and colleagues10 described the in
trathecal use of papaverine to im
prove blood flow through the ante
rior spinal artery.
When the aorta is cross-clamped
proximally the distal thoracic pres
sure drops markedly, because col
laterals around the cross-clamp are
normally poorly developed and the
run off is immense (to the abdomi
nal viscera, the kidneys and the
lower limbs). We postulated that it
may be possible to occlude the
entire abdominal aorta below the
level of the spinal cord arteries,
thereby confining this limited collat
eral flow to the thoracic aorta,
increasing thoracic aortic pressure
distal to the proximal cross-clamp
and, presumably, increasing the spi
nal cord perfusion pressure.

S

Materials and Methods
Sixteen mongrel dogs, weighing

BALLOON OCCLUSION DURING AORTIC CROSS-CLAMPING

18 to 24 kg, were anesthetized with
sodium pentobarbital (30 mg/kg,
supplemented as needed), intubated
and ventilated. Ventilation was ad
justed to maintain an arterial oxy
gen pressure above 100 mm Hg and
carbon dioxide pressure at approxi
mately 40 mm Hg. Bicarbonate was
added to maintain the pH between
7.35 and 7.45.
A midline incision was made in
the neck, and the carotid artery and
jugular vein were exposed and en
circled. The carotid artery was cannulated with a Millar Mikro-Tip
pressure transducer (Millar Instru
ments, Houston, Tex.), which was
advanced into the aortic arch. The
jugular vein was cannulated with a
fluid-filled catheter advanced into
the right atrium. A 21-gauge can
nula was positioned in the lumbar
cerebospinal fluid (CSF) and con
nected to a fluid-filled transducer to
monitor CSF pressure.
Thoracotomy was performed
through the left fifth intercostal
space and the aorta encircled just
beyond the arch in preparation for
cross-clamping. Distal to the site
designated for aortic clamping, a
pursestring suture was placed in
the aorta, and an identical Millar
pressure transducer was positioned
in the descending thoracic aorta.
The pericardium was opened and
the main pulmonary artery dissect
ed and encircled with a calibrated
flow probe (Zepeda Instruments, Se
attle, Wash.) for continuous mea
surement of right ventricular out
put. A second pursestring suture
was then placed in the distal thorac
ic aorta. Through this suture, an
intra-aortic balloon catheter (Datascope Corp., Paramus, NJ) was ins
erted and advanced into the lumbar
aorta so that its proximal end lay at
the LI level and its distal end at the
aortic bifurcation (Fig. 1). The bal
loon was of sufficient calibre that it
completely occluded the aorta when
it was inflated.

Baseline hemodynamic measure
ments including heart rate, proxi
mal aortic pressure, distal aortic
pressure, right atrial pressure, car
diac output and CSF pressure were
then obtained. The aorta was crossclamped just beyond the arch ves
sels. In 8 of the 16 animals, the
balloon, which had been positioned
but left deflated, was inflated with
air to occlude the lumbar aorta
completely. In the remaining eight
animals, the balloon was not inflat
ed; these dogs served as controls.
Every 10 minutes after cross-clamp
ing all hemodynamic parameters
were measured. After 30 minutes
of aortic cross-clamping, the proxi
mal aortic clamp was released and
the balloon deflated completely in
the experimental animals. All he
modynamic parameters were again
measured. The animals were killed
by a lethal overdose of anesthetic.
All recorded data were analysed
using SAS software (SAS Institute,
Cary, NC). The results are reported
as the mean ± the standard devia
tion. The spinal cord perfusion gra
dient was calculated as the differ
ence between mean thoracic aortic
pressure and the higher of CSF or
central venous pressure. All statisti
cal comparisons were made using
analysis of variance and significant
differences were specified by a mod
ified t-test (Duncan’s). Significant
differences were specified at p <
0.01. All animals received humane
care in compliance with the Princi
ples o f Laboratory Animal Care for
mulated by the National Society for
Medical Research and the Guide for
the Care and Use o f Laboratory
Animals (NIH publication no.
80-23, revised 1978).

groups after cross-clamping (Fig.
2), but the increases were similar.
Thoracic aortic pressures (Fig. 3)
and spinal cord perfusion gradients
(Fig. 4) were significantly higher in
the animals with distal aortic occlu
sion at all times after proximal
cross-clamping. Cerebrospinal fluid
pressures increased slightly in all
animals after cross-clamping (Fig.
5), but the changes were insignifi
cant. Right atrial pressures (Fig. 6)
and pulmonary artery flows (Fig. 7)
were not significantly different, al
though both tended to be higher in
the control group.

Discussion
When the aorta is cross-clamped
just beyond the subclavian vessels,
the distal thoracic pressure falls
precipitously.1' 4 Collaterals around
the clamps are normally poorly de
veloped and the run-off for this
limited collateral flow is immense.
Wadouh and colleagues11 noted
that proximal cross-clamping of the
descending aorta resulted in a mean
thoracic aortic pressure of 18 mm
Hg, but when a second clamp was
applied at the T13 level, the thorac
ic pressure increased to 48 mm Hg

Results
There were no differences in the
baseline measurements between the
two groups. Ascending aortic pres
sure increased significantly in both

FIG. 1. Occlusive balloon in abdominal
aorta.
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FIG. 2. Significant increase in mean ascending aortic pressure
is noted in both groups (dark bars = experimental group,
light bars = control group) after aortic occlusion. ■ = p <
0.01 versus baseline, ▲ = p < 0.001 versus baseline.
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FIG. 3. Pressure in thoracic aorta was significantly higher in
animals that underwent balloon occlusion (dark bars) of aorta
after cross-clamping. Light bars = control animals, * = p <
0.01 versus no balloon, ▲ = p < 0.001 versus baseline, ■ = p
< 0.01 versus baseline.
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FIG. 4. Gradient to spinal cord perfusion was significantly
higher at all times after cross-clamping in animals with
abdominal aortic balloon occlusion (dark bars). Light bars =
control animals, * = p < 0.01 versus no balloon, ▲ = p <
0.001 versus baseline, ■ = p < 0.01 versus baseline, O = p <
0.05 versus baseline.
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FIG. 5. Cerebrospinal fluid levels were higher (but not
significantly) in animals with balloon occlusion (dark bars).
Light bars = control animals.
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FIG. 6. Right atrial pressures were not significantly different.
Dark bars = experimental animals, light bars = control
animals.
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FIG. 7. Pulmonary artery flow tended to be higher (NS) in
animals without balloon occlusion (light bars). Dark bars =
experimental animals.
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above and 14 mm Hg below the
second clamp. This indicated that
distal aortic clamping could im
prove thoracic aortic pressure. It
also indicated that the second clamp
did not prevent collateral flow from
entering the abdominal aorta, since
the pressure measured distal to the
second clamp (14 mm Hg) would
almost certainly be higher than the
simultaneous central venous pres
sure in a healthy dog. These indica
tions suggested to us that balloon
occlusion of the distal aorta could
further confine collateral flow
around the proximal clamp to the
thoracic aorta and thus improve
spinal cord flow.
The results of this experiment
confirmed previous observations
that thoracic aortic pressure after
proximal aortic cross-clamping is
extremely low (mean 26 mm Hg). In
animals that underwent abdominal
aortic balloon occlusion the mean
thoracic aortic pressure was ap
proximately 77 mm Hg. The calcu
lated spinal cord perfusion gradient
(67 mm Hg) obtained with balloon
occlusion is also well above perfu
sion pressures suggested by previ
ous investigators as necessary for
adequate spinal cord protection.12
In evaluating angiographic tech
niques to visualize the spinal cord
arteries, Chiro, Fried and Doppman13 found that a combination of
increased intra-arterial pressure and
abdominal compression produced
the greatest visualization of the
spinal cord arteries. Balloon occlu
sion of the distal aorta appears to
provide a higher pressure and a
lower run-off in much the same
way.
The rise in CSF pressure after
aortic cross-clamping observed by
other investigators4514 was not
found in our experiments; little
change in CSF pressure was noted
in either group of animals. Eleva
tion of CSF pressure may be impor
tant since it limits spinal cord perfu

sion by decreasing the hemodynam
ic gradient to flow and has been
postulated as a mechanism for spi
nal cord injury during aortic sur
gery. However, neither cross-clamp
ing nor balloon occlusion appeared
to have a marked effect on CSF
pressure in these experiments.
There are also disadvantages. If
the balloon is inadvertently inflated
so that the spinal cord arteries are
occluded, paraplegia might be in
duced rather than prevented. It is
also possible that profound renal,
intestinal and limb ischemia could
result in multiorgan failure, if all
distal perfusion was eliminated by
the occluding balloon. Balloon oc
clusion could not be used when the
thoracic aorta is opened. The great
est potential use for balloon occlu
sion is probably during repair of
traumatic aortic tears, especially in
situations where shunts and bypass
equipment are not easily available.

Conclusions
The use of abdominal balloon
occlusion appears to increase tho
racic aortic pressure and spinal cord
perfusion gradients. The dog model
did not allow the assessment of
abdominal aortic occlusion on spi
nal cord perfusion or paraplegia
rates. Further studies in primate
models are necessary to investigate
this method.
We gratefully acknowledge the techni
cal assistance of Roshi Moghadam and
Kathy Dennis in the conduct of these
experiments. The assistance of Mike
Dulude in preparing the illustrations
and of Kay Stallings and Laurie Rouse
in preparing the manuscript is recog
nized.
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Kndoscopic Nd:YAG Laser Therapy of
Malignant Esophageal Obstruction
on an Outpatient Basis
Pasquale Ferraro, MD; Gilles Beauchamp, MD, FRCSC; Guy Aumais, MD, FRCPC
Between May 1985 and December 1988, 41 patients were treated palliatively with
endoscopic neodymium:yttrium-aluminum-garnet laser therapy for obstruction of
the esophagus by malignant disease. All were considered incurable, because they
presented with distant metastases, severe systemic disease, extensive local disease or
recurrent disease. Thirty-nine percent were managed as outpatients; the remainder
required admission to hospital. Sixty-three percent of the outpatients had
adenocarcinoma, and 31% had squamous cell carcinoma; over 90% of the tumours
were less than 8 cm long, and 63% were in the distal one-third of the esophagus or
the cardia. Forty-four percent of the inpatients had adenocarcinoma, and 44% had
squamous cell carcinoma; in this group, over 90% of the tumours were less than 8
cm long, and 56% were in the distal one-third of the esophagus or the cardia. The
mean number of sessions and laser energy administered were 2.6 and 4949 J for
outpatients and 2.7 and 4974 J for inpatients. Palliation of dysphagia was good to
excellent in all outpatients but was not as good for the inpatient group, in which
one major complication occurred. The mean length of survival for outpatients and
inpatients was 6.3 months (range from 1 to 16 months) and 3.9 months (range from
1 to 18 months) respectively.
De mai 1985 a decembre 1988, 41 patients ont ete traites de maniere palliative au
moyen de laser endoscopique neodymium:yttrium-aluminium-grenat pour occlusion
de l’oesophage par neoplasme. Tous etaient reputes incurables, car ils presentaient
des metastases a distance, une maladie generalise grave, un envahissement local
important ou une recidive de la maladie. Trente-neuf pour cent des patients furent
traites en extern; les autres ont du etre hospitalise. Soixante-trois pour cent des
patients externes presentaient un adenocarcinome, et 31 pour cent presentaient un
epithelioma spino-cellulaire; plus de 90 pour cent des tumeurs mesuraient moins de
8 cm de longueur, et 63 pour cent occupaient le tiers distal de l’oesophage ou le
cardia. Quarante-quatre pour cent des patients hospitalises presentaient des
adenocarcinomes et 44 pour cent des epithelioma spino-cellulaires; de ce groupe,
plus de 90 pour cent des tumeurs mesuraient moins de 8 cm de longueur, et 56 pour
cent se trouvaient au tiers distal de l’oesophage ou au cardia. La frequence moyenne
des sessions et l’energie laser administree fut de 2,6 et 4949 J pour les patients
externes et 2,7 et 4974 J pour les hospitalises. La palliation de la dysphagie fut
bonne a excellente chez tous les patients externes mais ne fut pas aussi bonne chez
le groupe des hospitalises, chez lequel une complication majeure s’est produite. La
survie moyenne pour les externes et les hospitalises fut respectivement de 6,3 mois
(de 1 a 16 mois) et 3,9 mois (de 1 a 18 mois).
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Accepted for publication Sept. 19, 1989
Reprint requests to: Dr. Gilles Beauchamp, Hopital Maisonneuve-Rosemont, 5415, blvd. de
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astroesophageal carcinoma re
mains a highly lethal and mor
bid disease, which, in most cases, is
incurable at the time it is diag
nosed. During its course all patients
will suffer serious complications.
Obstruction of the esophagus with
dysphagia or aspiration with pneu
monitis are the complications most
often encountered.
Palliative therapy is generally all
that can be offered to patients with
advanced disease. The use o f endoluminal prostheses to maintain a
patent esophageal lumen has dimin
ished, and an increasing number of
studies have shown that therapy
with the neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is an
effective form o f palliation.1^3 Few
studies, however, have reported its
use on an outpatient basis.
In this report, we present our
results o f Nd:YAG laser therapy in
41 patients suffering from esopha
geal obstruction due to malignant
disease and describe our experience
with laser therapy on an outpatient
basis.

G

Patients and Methods
The study group comprised 41
consecutive patients with biopsy
proven gastroesophageal carcinoma
treated
at the
MaisonneuveRosemont Hospital between May
1985 and December 1988. Most
patients had previously undergone
treatment for their disease (Table I).
Nevertheless their disease was con 
sidered incurable because they pre
sented with distant metastases
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(46%), severe systemic disease
(20%), extensive local disease (20%)
or recurrent disease (12%). One
patient (2%) refused surgery.
Patients were assessed to deter
mine what form of palliation would
be most appropriate. Those for
whom we elected to use laser thera
py received their first treatment in
hospital. Thereafter all patients
whose general condition permitted
were offered laser therapy on an
outpatient basis. Sixteen patients
(39%) accepted and were treated as
outpatients. This group comprised
14 men and 2 women; the group
treated in hospital comprised 17
men and 8 women. The mean ages
were 72.3 years (range from 43 to
91 years) for the outpatient group
and 66.4 years (range from 47 to
88) for the inpatient group.
Each patient’s dysphagia was
graded as follows: (1) able to eat all
foods, (2) difficulty swallowing sol
ids but able to swallow liquids, (3)
unable to swallow solids and diffi
culty swallowing liquids and (4)
unable to swallow solids or liquids.
Inpatients were treated every 3 to
5 days during their hospitalization.
Outpatients were admitted the
morning of their procedure and
discharged 2 to 4 hours after the
treatment. They were treated on
average every 2 to 4 weeks. Surveil
lance during the laser sessions was
provided by an anesthesiologist. Pa
tients were sedated with diazepam
and meperidine, given intravenous
ly.
After laser therapy, palliation of
the dysphagia was considered excel
lent if patients had achieved grade
1, good if patients improved from
grade 4 to 3 or from grade 3 to 2
and poor if the patient’s grade was
unchanged.

GIF-D2 endoscope (Olympus Corp.,
Lake Success, NY) after appropriate
topical pharyngeal anesthesia.
Laser therapy was administered
through the flexible endoscope with
a MEDILAS 2 (model K621101;
MBB-At Angewandte Technologie,
Munich) laser system. The power
source was set between 80 and 100
W and the laser pulse duration at
1.0 to 2.5 s. Most patients were
treated by a retrograde technique.
As described by Pietrafitta and
Dwyer,4 an initial dilatation with an
Eder-Puestow wire-guide system is
carried out. The tumour is then
vaporized and coagulated under di
rect vision, beginning at the distal
margin and moving retrogradely to
ward the proximal end. The ante
grade technique as described by

Laser Technique

Upper gastrointestinal endoscopy
was performed using an Olympus
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Fleischer and Sivak5 was also used.
Beginning at the tumour’s proximal
margin laser pulses are applied cir
cumferentially. At the start of the
second treatment, the proximal
margin is debrided to evacuate tu
mour debris and laser therapy is
resumed.

Results
The majority (63%) of cancers in
the outpatient group were adeno
carcinomas; in the inpatient group
equal numbers (44%) were adeno
carcinomas and squamous cell car
cinomas (Table II). Over 90% of the
tumours in both groups were less
than 8 cm long.
All the patients complained of
dysphagia, and two had a history of

Table 1. Clinical Data on 41 Patients Who Received Nd:YAG Laser Therapy for Esophageal
Obstruction by Malignant Disease
Data

No. of patients

%

5
2
1
3
4
9
17

12
5
2
7
10
22
42

19
8
8
5
1

46
20
20
12
2

Previous or associated treatment
Radiotherapy
Surgery
Chemotherapy
Combination of above
Endoluminal prosthesis
Dilatation
None
Contraindication to curative therapy
Metastatic disease
Severe systemic disease
Extensive local disease
Recurrent disease
Refused surgery

Table II. Histologic Type, Location and Length of Gastroesophageal Tumours in the 16
Outpatients and 25 Inpatients
Outpatients
Tumour
Histologic type
Adenocarcinoma
Squamous cell carcinoma
Other
Location*
Cervical
Mid
Distal/cardial
Length, cm
< 5
5 -8
> 8

Inpatients

No.

°/o

No.

%

10
5
1

63
31
6

11
11
3

44
44
12

3
3
10

19
19
63

1
10
14

4
40
56

7
8
1

44
50
6

12
12
1

48
48
4

'Cervical = < 20 cm, mid = 20 - 30 cm, distal = > 30 cm from pharynx.
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hematemesis (Table III). The dys
phagia was light to moderate (grade
2 or 3) in 94% of the outpatients
and 92% of the inpatients. Eightysix percent of the outpatients had
good to excellent results of laser
therapy compared with only 37% of
the inpatients; in 63% of the inpa
tients there was no change after
laser therapy (Table IV).
The patients in the two groups
received a similar number of treat
ments (2.6 versus 2.7) with an
equivalent average dose of laser
energy (4949 J versus 4974 J). The
total dose per patient was sightly
greater in the outpatient group.
The average length of survival from
the time of diagnosis was 6.3
months in the outpatient group and
3.9 months in the inpatient group.
No major complications were de
tected in the outpatient group; one
patient in the inpatient group suf

fered a perforation.
The average length of hospital
ization was 38 days for the inpa
tients.

Discussion
The palliation of esophageal tu
mours holds great interest for the
clinician who manages patients with
gastroesophageal cancer. The op
tions available for the patient with
incurable disease include surgery,
radiotherapy, insertion of endoluminal prostheses and laser therapy.
The popularity of laser therapy has
increased as preliminary studies,1'4
followed by more extensive series,
demonstrated the safety and effec
tiveness of esophageal laser thera
py-

In our series of patients the re
sults were functionally satisfactory

T a b le III. S y m p to m s and R e s u lts o f L a s e r T h e ra p y
In p a tie n ts

O utpatients
S ym p to m s /re s u lts
P re se n tin g s y m p to m s
D ysphagia
D y s p h a g ia /w e ig h t lo s s
D y s p h a g ia /d y s p h o n ia
H e m a te m e s is
G rade o f d y s p h a g ia
1
2
3
4
R e su lts *
E xce lle n t
G ood
P oo r

No.

%

No.

%

8
7
0
1

50
44
0
6

3
17
4
1

12
68
16
4

1
10
5
0

6
63
31
0

1
16
7
1

4
64
28
4

5
8
2

33
53
13

2
7
15

8
29
63

*F o r 15 o u tp a tie n ts and 2 4 in p a tie n ts .

T a b le IV . D e ta ils o f L a se r T h e ra p y and S u rviva l
D e tails
T o ta l no. o f tre a tm e n ts
M ean tre a tm e n ts /p a tie n t, no.
M ean do se o f la s e r e n e rg y p e r tre a tm e n t, J
M ean to ta l d o s e per p a tie n t, J
M ean le n g th o f h o s p ita liz a tio n , d
M a jo r c o m p lic a tio n s , n o .*
M ean s u rv iv a l fro m d ia g n o s is , m o
Range o f s u rv iv a l, m o

O u tp a tie n ts

In p a tie n ts

43
2 .6
4949
16 731

69
2 .7
4974
11 3 3 3
38
1
3 .9
1-18

—

0
6 .3
1-16

'D e a th , p e rfo ra tio n , fis tu la , h e m o rrh a g e .

e d ,

in the majority of outpatients, with
an 86% initial success rate. The
results are comparable to those ob
tained by Fleischer and Sivak5
(80%), Brunetaud and colleagues6
(83%) and Naveau and colleagues7
(82%). In a group of patients ma
naged on an outpatient basis, Lightdale, Zimbalist and Winawer8 re
ported a 70% success rate.
The effectiveness of treatment
should not be considered solely on
the basis of patency of the esopha
geal lumen, as shown by Fleischer
and Sivak,5 Mellow and Pinkas2 and
Naveau and colleagues.7 Factors
such as anorexia, poor general
health and tumour load often deter
mine to what extent adequate oral
intake will be re-established. Re
gardless of the type of palliative
treatment the nutritional status of
the patient generally remains poor.
A patent lumen, however, reduces
the risk of aspiration. The ameliora
tion of symptoms was less marked
in the inpatient group, in which
there was only a 37% initial success
rate. Since the tumours in the two
groups were similar in most re
spects and since nearly equivalent
treatments were given, we believe
that the patient’s overall condition
was responsible for the difference in
response to therapy. This is also
reflected in the length of survival of
the inpatients compared with the
outpatients. The outpatients lived
substantially longer (6.3 versus 3.9
months) because they were in better
general health at the start of treat
ment and responded better. To con
firm this impression, a greater num
ber of patients and a more objective
evaluation of the patients’ perfor
mance status, such as the Karnofsky score, would be needed.
The parameters affecting initial
response to therapy were first es
tablished by Fleischer and Sivak5 as
location of tumour in the upper
one-third of the esophagus, length
of tumour and endoscopic appear
VOL. 33, NO. 6, DECEMBER 1990
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ance. Studies by Brunetaud and
colleagues6 and Naveau and col
leagues7 added the following param
eters: recurrence after non-laser
therapy and age-related type of sur
gical contraindication. More con
trolled trials, taking into account
these parameters, are necessary to
establish the effectiveness of laser
therapy.
In an interesting report Nava and
associates9 compared the use of
endoscopic monopolar electrofulguration with laser therapy. They
achieved similar results with the
two techniques, and the complica
tion rates were low. Further studies
comparing the two techniques are
certainly warranted when one con
siders the differences in cost and
the paucity of lasers outside major
centres.
Safety is an important component
of any palliative therapy. We en
countered one major complication
(a perforation) in 112 treatments
administered to 41 patients. Many
workers1' 8 have reported major
complication in 8% to 10% of pa
tients. Murray and associates10 re
ported a complication rate of 26%
and questioned the safety of laser
therapy in older patients. However,
we must also consider the rate of
major complications and the com
plications directly attributable to
the laser procedure. The natural
evolution of obstructive esophageal
lesions and the risks that accompa
ny the use of prostheses or radio
therapy are in themselves formida
ble, and the laser remains a safe
alternative.
How does Nd:YAG laser therapy
compare to endoluminal prostheses?
The effectiveness of endoluminal
prostheses has been demonstrated
in cases of esophagotracheal Fistula.
Buess and colleagues11 recently re
ported a 90% success rate and a
9.5% death rate in patients with
fistulas. When there is malignant
obstruction of the esophagus, how
482

ever, complication rates as well as
the effectiveness of prostheses to
relieve dysphagia vary from series
to series. Tytgat12 reported an
11.2% complication rate, Hegarty,
Angorn and Bryer13 a 16% rate and
Ogilvie and colleagues14 a 27.1%
rate. Toure, Beauchamp and Bastien,15 from our centre, reported a
37% global morbidity and 11% mor
tality, and Chavy and colleagues16
had a 20% rate of complications in
their study. Lasers have proven less
effective in fibrous strictures and
long stenotic lesions, as shown by
Buset and colleagues17 and othe r s _57.8,i8 These lesions remain po
tential indications for intubation.
There is no doubt that the use of
the Nd:YAG laser as palliative ther
apy for esophageal tumours holds
much promise. In our series of
patients it was possible to adminis
ter safe and effective treatment on
both an inpatient and an outpatient
basis. The laser meets most criteria
for ideal palliation: it is effective
and rapid, well tolerated and safe.
The cost can be greatly reduced if
patients are managed through the
outpatient department. The patients
in turn benefit emotionally and
physically from their home environ
ment. However, we must not ne
glect the use of prostheses and the
possibility of other treatment meth
ods in association with laser thera
py-
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Laparoscopic Cholecystectomy:
a Report of 60 Cases
Yves-Marie Dion, MD, FRCSC, FACS; Jacques Morin, MD, FRCSC
From April to August 1990, 60 patients underwent laparoscopic cholecystectomy.
Patients with biliary colic were included, but those who had florid acute
cholecystitis, morbid obesity or scars in the upper portion of the abdomen were
excluded. Three patients had acute cholecystitis, 56 had chronic cholecystitis and 1
had hydrops of the gallbladder. Nineteen patients had had previous lower abdominal
surgery. Five patients did not require analgesia, but the remainder needed
parenteral analgesia on an average of 1.7 occasions and enteral analgesia on an
average of 1.8 occasions. There were no intraoperative complications, and no patient
had the procedure completed by standard surgery. Postoperative hospital stay
averaged 2.5 days. The mean follow-up was 39 days. Few postoperative
complications were noted: two patients suffered from ileus; two patients had biliary
colic postoperatively (one required endoscopic sphincterotomy with stone extraction,
and in the other no common-duct stones were seen on retrograde cholangiography);
one patient had an intra-abdominal abscess, which was drained percutaneously; and
one patient complained of upper abdominal pain that was incisional in origin.
Laparoscopic cholecystectomy should be considered the procedure of choice for
elective treatment of uncomplicated symptomatic gallstone disease.
Entre avril et aout 1990, 60 patients ont ete soumis a une cholecystectomie par
laparoscopie. Les patients souffrant de coliques hepatiques etaient candidate. Les
patients presentant une cholecystite aigue severe, une obesite morbide ou des
cicatrices dans la partie superieure de l’abdomen furent exclus. Aucune complication
operatoire ne fut notee, et aucun patient n’a du subir une cholecystectomie standard
suite a l’echec de la cholecystectomie par laparoscopie. Trois patients souffraient de
cholecystite aigue, 56 de cholecystite chronique et 1 d’une mucocele. Dix-neuf
patients avaient subi anterieurement une chirurgie a l’etage inferieur de l’abdomen.
Cinq patients n’ont re?u aucune analgesie postoperatoire. Les autres patients a
reclame en moyenne de l’analgesie parenterale a 1.7 reprises et de l’analgesie
enterale a 1.8 reprises. Le sejour hospitalier postoperatoire fut en moyenne de 2.5
jours. Apres un suivi moyen de 39 jours, peu de complications ont ete notees: deux
patients ont presente un ileus; deux patients ont presente des douleurs ressemblant
a des coliques hepatiques (un fut traite par sphincterotomie endoscopique, et aucun
calcul ne fut demontre chez l’autre a la cholangiographie retrograde); un abces
intra-abdominal fut draine de fa?on percutanee; et la douleur abdominale presentee
par un patient etait d’origine incisionnelle. La cholecystectomie par laparoscopie
devient la procedure chirurgicale de choix pour le traitement non urgent de la
cholelithiase symptomatique.
From the Department o f Surgery, Hopital St-Frangois d ’Assise, Quebec, PQ
Accepted for publication Oct. 30, 1990
Address reprint requests to: D r Yves-Marie Dion, Hopital St-Frangois d ’Assise, 10, rue de
I ’Espinay, Quebec, Que G IL 3L5

developments in endo
R ecent
scopic equipment have allowed

physicians to treat by laparoscopy
conditions that previously could be
managed only by conventional sur
gery. Laparoscopy is now used rou
tinely to treat some gynecologic
diseases.12 Endoscopic appendecto
my is performed frequently3 (Mouret P: Personal communication,
1988). Laparoscopic surgery has
also been considered safe for lysis
of adhesions.1-3 Laparoscopic chole
cystectomy has been suggested as a
safe and advantageous alternative
to the standard procedure.45 We
report our experience with 60 lapa
roscopic cholecystectomies.

Patients, Materials and
Methods
From Apr. 18 to Aug. 27, 1990,
60 patients (51 women, 9 men),
ranging in age from 21 to 73 years
(mean 43 years), were offered lapa
roscopic cholecystectomy. An oper
ative consent form, stating the pur
pose of this intervention as well as
the potential complications, was
signed by the patient before the
procedure. Patients with biliary
colic were candidates, but those
with florid acute cholecystitis, mor
bid obesity or scars in the upper
portion of the abdomen were ex
cluded.
The follow-up extended from 4 to
135 days (mean 39 days). Seventeen
patients were followed up for 4 to
15 days, 19 patients for 16 to 30
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days and 24 patients for 31 to 135
days.
The laparoscopic instruments,
the Aqua-Purator for irrigation, the
insufflator, the video camera and
the monitor were all supplied by
Raymond Laborie & Associates
Inc., Brossard, PQ. The clip applica
tors for the cystic duct and artery
were supplied by Ethicon Ltd.,
Montreal.
Under general anesthesia, the pa
tient is placed in the modified lithot
omy position (Fig. 1). A Veress
needle (Laborie) is inserted in the
upper portion of the umbilicus for
insufflation of carbon dioxide (3.5
to 5 L) (Fig. 2). The intra-abdomi
nal pressure is constantly moni
tored and is not allowed to exceed
20 mm Hg.
A 1-cm skin incision is then made
in the upper portion of the umbili
cus for insertion of an 11-mm tro
car through which a 10-mm laparo
scope is inserted (Fig. 3). A 5-mm
incision is made in the epigastric
region, slightly to the right of the
midline to avoid the falciform liga

ment. A 5-mm trocar is inserted and
an atraumatic grasping forceps in
troduced; this is used to retract the
fundus of the gallbladder and the
liver. Another 5-mm incision is
made in the right subcostal region
laterally. Through a second 5-mm
trocar, another atraumatic grasping
forceps is introduced to hold Hart
mann’s pouch. These two forceps
can be manipulated together to re
move omental adhesions on the
gallbladder. A fourth incision, 1 cm
wide, is made midway between the
umbilicus and the xyphoid process
but on the left paramedian line, to
insert an 11-mm trocar through
which the working instruments
(scissors, electrocoagulating hook,
clip applicators and Aqua-Purator)
are introduced.
The patient is then placed in
Fowler’s position with the right side
elevated. This gives better visualiza
tion of the gallbladder and related
structures by allowing the omen
tum, transverse colon, duodenum
and stomach to be displaced caudally and toward the midline. Clips are

FIG. 1. Performance of laparoscopic cholecystectomy in operating room. Surgeon
stands at end of table. Assistant and scrubbed nurse is on left of patient. Shown
above surgeon’s left hand are video monitor, camera system and Aqua-Purator for
irrigation. Left hand of unscrubbed nurse points to insufflator.
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applied to the cystic duct and the
cystic artery before division of these
structures, and the gallbladder is
dissected from its bed starting at
the cystic duct. Care is taken to
visualize the common duct and es
pecially the common hepatic duct,
which could easily be injured.
The gallbladder is extracted
through the umbilical wound under
the guidance of an endoscope ins
erted through the left paramedian
trocar. When the stones are too
large to be removed through this
1-cm incision, their extraction with
a stone forceps or by widening the
fascial opening with a hemostat will
permit the passage of the gallblad
der through the abdominal wall (the
fascia is closed only when a hemo
stat is used). The subphrenic and
subhepatic spaces are irrigated
with the Aqua-Purator and the
cystic duct and artery stumps are
inspected.

Results
Three patients had acute chole
cystitis, 56 had chronic cholecysti
tis and 1 had a hydrops of the
gallbladder. Nineteen patients had
undergone previous lower abdomi
nal surgery. Two patients had two
scars each from previous surgical
procedures. Nine patients had previ
ously undergone appendectomy,
eight had undergone gynecologic
procedures that included hysterec-

FIG. 2. Site of insertion of Veress
needle at umbilicus. After creation of
pneumoperitoneum one trocar will be
inserted at site of each black circle.

LAPAROSCOPIC CHOLECYSTECTOMY

tomy, cesarean section and salpingo-oophorectomy, two had under
gone inguinal herniorrhaphy and
two had undergone lipectomy.
No intraoperative complications
were noted and no patient had the
procedure completed by standard
surgery.

Pain medication was notably less
than with standard cholecystecto
my. During their postoperative hos
pital stay, which varied from 2 to 6
days (mean 2.5 days) (Fig. 4), five
patients took no pain medication.
No patient took more than four
parenteral injections of narcotics

FIG. 3. Photograph taken from cephalad position. Surgeon holds electrocoagulating hook in right hand and atraumatic grasping forceps in left. Assistant holds
video camera in left hand and atraumatic grasping forceps in right.

FIG. 4. Postoperative hospital stay.

for pain (mean 1.7 injections). The
average number of times oral medi
cation was given was 1.8 (range
from 0 to 6 times).
Postoperative Complications
The complication rate was low.
Two patients had a postoperative
ileus, but they were discharged
home by postoperative day 6. One
patient complained of upper abdom
inal pain 1 week postoperatively.
The pain was diagnosed as incision
al (over the left paramedian inci
sion), and it resolved spontaneously
over 3 days. No herniation was
demonstrated. Investigation of this
patient (vital signs, complete blood
count, liver function tests, echogra
phy of the abdomen) revealed no
abnormality.
Ten days postoperatively one pa
tient was readmitted because of an
episode of abdominal pain due to
choledocholithiasis. She underwent
endoscopic sphincterotomy and re
moval of her common-duct stones.
A second patient was readmitted 17
days after surgery with symptoms
compatible with choledocholithiasis.
Endoscopic retrograde cholangiog
raphy revealed no residual stone
and she was asymptomatic when
discharged. Preoperatively these pa
tients had normal liver function test
results and no common-duct abnor
mality on ultrasonography.
One patient was readmitted 8
days postoperatively with fever and
upper abdominal pain. Ultrasonog
raphy and computed tomography
revealed an infrahepatic fluid collec
tion. It was drained percutaneously
by the interventional radiologist,
and Escherichia coli was cultured
from the drainage. Leakage from
the stump of the cystic duct was
documented by injecting radiopaque
material through the percutaneous
drain. The patient made a smooth
recovery.
There were no deaths.
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Discussion
Laparoscopic cholecystectomy
was first reported 3 years ago,45
but it was not until recently that
the potential benefits of this proce
dure were recognized: rapid disap
pearance of pain, no danger of
wound dehiscence, improved cos
metic appearance and a shorter hos
pital stay and recovery period. All
these advantages were noted in our
series. Pain or discomfort was often
located in the supraumbilical re
gion, corresponding to the site of
insertion of the laparoscope, which
is also the site of removal of the
gallbladder. Pain was most often
noted when the fascial opening had
been widened with a hemostat to
allow large stones to be extracted.
Some of our patients returned to
work 3 days after the procedure,
but we routinely allow them a
2-week recovery period. Our esti
mated operative time has been re
duced from just over 120 minutes
to 45 to 75 minutes depending on
the size of the patient and the
operative findings.
The only contraindications to la
paroscopic cholecystectomy are
morbid obesity, severe cholecystitis
and scars from previous surgery in
the upper half of the abdomen.
Previous lower abdominal surgery,
provided it was not for generalized
peritonitis, is not a contraindica
tion. Some of our patients had
infraumbilical midline incisions or
McBurney incisions, which did not
present any technical difficulty.
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At present we do not perform
operative cholangiography because
we cannot complete adequate com
mon-duct exploration by laparos
copy. Dubois and colleagues5 rely
on preoperative intravenous cholan
giography. When choledocholithiasis is noted, they do a preoperative
endoscopic sphincterotomy with
stone extraction. However, intrave
nous cholangiography is positive in
less than 30% of the cases. Reddick
and Olsen4 do peroperative cholan
giography and perform postopera
tive endoscopic sphincterotomy if
common-duct stones are noted. We
adopted the following attitude: if
choledocholithiasis is suspected
preoperatively, either by ul
trasonography or from the results
of liver function tests, endoscopic
retrograde cholangiography is car
ried out; if stones are demonstrated,
sphincterotomy and stone extrac
tion are done. If choledocholithiasis
is suspected after laparoscopic cho
lecystectomy has been performed,
endoscopic retrograde cholangiog
raphy and, if necessary, sphinc
terotomy and stone extraction are
done.
Two of our 60 patients present
ed, at follow-up, with symptoms of
choledocholithiasis. One underwent
successful stone removal with endo
scopic sphincterotomy. Retrograde
cholangiography did not demon
strate common-duct stones in the
second patient.
Indications for surgical commonduct exploration are likely to de
crease with the combined availabili
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ty of laparoscopic cholecystectomy
and endoscopic sphincterotomy
with stone extraction.
Although results from our series
were good, the number of patients
was insufficient to provide reliable
data about the true complication
rate when this procedure is applied
to a large number of patients.
In view of our low morbidity and
mortality rates, we recommend la
paroscopic cholecystectomy as the
procedure of choice for most pa
tients with gallbladder disease.
However, proper training in the
procedure is highly recommended
because of the disastrous complica
tions that could follow inappropri
ate entry into the abdomen and the
injuries that could be inflicted on
the common bile duct during chole
cystectomy with electrocoagulating
instruments. There is a definite
learning curve associated with the
acquisition of this technique.
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R enal Cell Carcinoma:
Incidental Detection
H.P. Lanctin, MD; N.G. Futter, MB, BS, FRCSC
The mode of presentation of renal cell carcinoma is changing; in 40% of cases the
condition is now found incidentally during the investigation of complaints other
than those usually associated with this tumour. Chemotherapy and radiotherapy
have not improved the survival of patients with renal cell carcinomas, but, with the
introduction of ultrasonography, renal cell carcinomas, including those found
incidentally, are being diagnosed earlier than they were a decade ago, resulting in
improved survival rates.

Le mode de detection des cancers des cellules renales se modifie; dans 40% des cas
cette maladie est maintenant decouverte accidentellement, au cours d'examens relies
a des symptomes autres que ceux qui sont habituellement associes a cette tumeur.
La chimiotherapie et la radiotherapie n’ont pas ameliore la survie des victimes du
cancer des cellules renales. Neanmoins, avec la venue de l’echographie, les cancers
des cellules renales decouverts de fa?on accidentelle ou autrement, sont diagnostiques plus precocement qu’ils ne l’etaient il y a une decennie, ce qui ameliore le taux
de survie.

he presenting symptoms, signs
and laboratory findings of renal
cell carcinoma are diverse and often
obscure. Only 10% of patients with
this tumour present with the classic
triad of pain, a mass and hematuria.
Renal cell carcinoma is associated
with a wide spectrum of paraneo
plastic syndromes, including hyper
calcem ia, hypertension, erythrocytosis and abnormal results of
liver function tests, as well as the
nonspecific features of malignant
disease — weight loss, anemia and
fatigue. Metastases may be solitary
and in unusual sites. This diversity
has resulted in the renal cell carci
noma being called “the internist’s
tumour” .

T

With the increased availability of
noninvasive imaging techniques,
particularly ultrasonography, unex
pected and incidental findings are
inevitable. Increasingly more renal
cell carcinomas are being diagnosed
this way. In this paper the impact of
serendipitous detection of renal cell
carcinoma on tumour staging is
discussed.

Patients and Methods
Between 1979 and 1986, 202
patients (120 men, 82 women) with
proven renal cell carcinoma were
managed at the Ottawa General
Hospital and the Ottawa Civic Hos
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pital. The age, sex, mode of presen
tation, pathological staging and
subsequent follow-up were reviewed
and recorded.
Patients were divided into four
groups according to their mode of
presentation. Group 1 comprised
those presenting with the classic
urologic symptoms and signs of
renal cell carcinoma; that is, pain,
gross and microscopic hematuria or
a mass, alone or in combination. In
group 2 were those presenting with
metastatic disease. Group 3 con
tained patients presenting with pa
raneoplastic syndromes of fatigue,
weight loss, hypercalcemia, erythrocytosis and hypertension. In
group 4 were patients whose tu
mour was found incidentally.
Ultrasonography was done in 33
patients and intravenous pyelogra
phy in 26. Seven underwent com
puted tomography, one nuclear
scanning and one laparotomy.
All tumours were staged from the
pathological findings, according to
Robson’s criteria:1 stage I — tu
mour confined to the parenchyma
within the renal capsule; stage II —
invasion of the perinephric fat with
Gerota’s fascia intact; stage III —
involvement of renal vein, inferior
vena cava or regional nodes; stage
IV — distant metastases or involve
ment of contiguous structures.
The follow-up and the patient’s
condition (free of disease, alive with
metastases or dead) was recorded.
Computed tomography became
available at both hospitals late in
1981, and ultrasonography was
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available in most clinics in the city
at that time. To assess the impact
of these imaging techniques pa
tients were divided into subgroups
of those presenting before and after
1981.

Findings
Grouping

The average age of the 202 pa
tients was 60 years. Their grouping
by mode of presentation is shown in
Table I.

Of the patients who presented
before 1982, 49% had the classic
urologic symptoms of renal cell
carcinoma, and 21% were found
incidentally. From 1982 onward
42% of patients presented with
pain, mass and hematuria; 40% of
tumours were found incidentally.
There was a corresponding decrease
in the numbers presenting because
of metastases (from 21% to 7%).
Investigation

Table II shows the manner in
which the incidentally found tu

T a b le 1. M o d e o f P re s e n ta tio n

Group
1
2
3
4

-

pain, m a s s, h e m a tu ria
m e ta s ta s e s
p a ra n e o p la s tic s y n d ro m e s
in c id e n ta l fin d in g

1981 or before,
no. (% )
(n = 68)

A fte r 1981,
no. (% )
(n = 134)

3 3 (4 9 )
1 4 (2 1 )

5 6 (42)
1 0 (7 )
1 4 (1 0 )
5 4 (40)

7 (1 0 )
1 4 (2 1 )

Tumour Stage

Figure 1 shows the pathologic
stage at the time of diagnosis for
the tumours found in patients pre
senting with urologic symptoms
and those found incidentally; the
tumours were confined to the renal
capsule (stage I) in 44% and 53%
respectively. On subsequent investi
gation 15% of patients presenting
with classic symptoms and 14% of
those whose tumour was found in
cidentally had stage I disease.

T a b le II. D ia g n o stic Im a g in g M e th o d s
M ethod
U ltra s o n o g ra p h y
In tra ve n o u s p y e lo g ra p h y
O ther

1981 or before

A fte r 1981

4
8
2

29
18
7

mours were diagnosed. Increasingly
ultrasonography was the principal
source of serendipitously found tu
mours. After 1981, 55% of tumours
were detected by ultrasonography
(Table II).
The investigations were carried
out for the following reasons: gas
trointestinal symptoms such as dys
pepsia or biliary colic (33 patients);
urologic problems including bladder
outlet obstruction, follow-up of
proven renal cysts and urolithiases
(16 patients); and staging and fol
low-up of other malignant tumours
(7 patients). When symptoms were
lateralized to one side of the body
there was an equal distribution of
tumours to either side.

Discussion

FIG. 1. Pathological stage of renal cell tumour at time of diagnosis in patients with
classic symptoms and signs (cross-hatched bars) and those with carcinoma found
incidentally (hatched bars).

Our data show that the presenta
tion of renal cell carcinoma has
changed substantially since the in
troduction of ultrasonography. In
this series computed tomography
scanning had little impact on the
number of tumours found inciden
tally, probably because it is rarely
performed without previous ultra
sonography at the University of
Western Ontario teaching hospitals.
Riches, Griffiths and Thackery2 in
1951 reported on 1746 renal cell
carcinomas; 4% were found inciden
tally. Skinner and colleagues3 in
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1971 reported that 6% of 309 tu
mours were incidental findings, and
Haertig and Kuss4 in 1982 reported
8%. Konnack and Grossman5 com
pared the presentation of 56 pa
tients between 1961 and 1973 with
46 presenting between 1980 and
1984. The incidence of incidentally
found tumours in the two groups
was 13% and 48%. Veda and Mihara5 who reviewed 53 cases in similar
time frames reported that 13% and
35% of tumours were found inci
dentally. In our series 40% of renal
cell carcinomas in patients present
ing after 1981 were found inciden
tally; and 55% were diagnosed by
ultrasonography.
In our patients tumour stage at
the time of diagnosis was similar for
those with incidentally found tu
mours and those presenting with
classic features. That renal cell car
cinomas presenting with classic
urologic symptoms and signs are
being recognized at an earlier stage
now than 10 years ago can be
attributed to physician awareness of
the tumour and need for investiga
tion of hematuria, and particularly
to the availability of ultrasonogra
phy, which allows the detection of
smaller lesions than those found on
intravenous urography. The con
cept that any renal parenchymal
mass less than 3 cm in diameter be
considered a benign adenoma must
now be seriously questioned. Other
series13 have shown a lower tumour
stage of incidentally detected tu
mours, but the comparison can be
questioned because the patients
were gathered over 10 to 20 years,
and the authors did not compare
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tumours found in the same limited
time span. The number of cases of
renal cell carcinoma diagnosed an
nually has shown an increase in
recent years. Data from the Ontario
Cancer Treatment and Research
Foundation7 showed the incidence
to be 5.6/100 00 for males in 1976
and 2.7/100 000 for females. In
1985 the figures were 7.4 and 4.4,
respectively.8
All primary tumours are clinically
silent initially; some maintain this
silence even after the development
of metastases. The fortuitous diag
nosis of renal cell carcinomas
should result in tumour recognition
at an earlier pathologic stage and
fewer tumours presenting with me
tastases. From our data no differ
ence was noted in the pathologic
staging, but the percentage of pa
tients presenting with metastatic
disease after the introduction of
ultrasonography was reduced from
21% to 7%.
A full assessment of the behavi
our of these tumours will have to
await 5- and 10-year follow-up ex
aminations. At present the disease
free interval of tumours found inci
dentally and tumours in patients
presenting with classic symptoms is
determined by the stage at the time
of recognition. Thompson and
Peek9 reported that 90% of patients
with incidentally diagnosed stage I
tumours were alive and disease-free
after 5 years. Since Robson1
showed improved 5-year survival
with radical nephrectomy in 1963,
there have been no important ad
vances in the treatment of this
disease. Chemotherapy and radio
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therapy have had no notable impact
on patient survival at any stage of
the disease. Improving the overall
survival figures for patients with
renal cell carcinoma at this time
depends upon an early diagnosis.
Population screening with ul
trasonography cannot be justified;
however, consideration should be
given to renal cell carcinoma in all
patients having ultrasonography of
the upper abdomen — a “quick
peek’’ adds little to the examina
tion; any solid lesion in the kidney
demands further investigation.
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Long-term Pain and Disability in Relation
to Residual Deformity After Displaced
Pelvic Ring Fractures
A C. McLaren, MD, FRCSC; C.H. Rorabeck, MD, FRCSC; J. Halpenny, MD, FRCSC
In a retrospective review and follow-up study of 43 patients who had had
high-energy pelvic fractures 5 or more years earlier, the occurrence of late pain and
the functional outcome were adversely related to residual deformity of the pelvic
ring. Among patients who had no residual deformity (displacement less than I cm),
88% had no serious pain and 82% had normal function. Of patients who had residual
deformity (displacement more than 1 cm posteriorly), only 30% had no serious pain
(p < 0.01) and only 30% had normal function (p < 0.01). Definitive reduction and
stabilization is therefore recommended early after the injury whenever possible.
Dans une etude retrospective et une etude de post-cure portant sur 43 patients qui
avaient subi, au moins 5 ans plus tot, des fractures pelviennes a haute vitesse
d’impact, l’apparition de douleurs tardives et les resultats fonctionnels etaient
negativement relies a la difformite residuelle de l’anneau pelvien. Parmi les patients
qui n’avaient aucune difformite residuelle (un deplacement inferieur a 1 cm), 88%
n’avaient aucune douleur importante et 82% etaient fonctionnellement normaux.
Chez les patients qui presentaient une difformite residuelle (un deplacement
posterieur superieur a 1 cm), seulement 30% ne souffraient pas de douleurs intenses
(p < 0.01) et seulement 30% avaient une fonction normale (p < 0.01). II est done
recommande de pratiquer une reduction et une stabilisation definitives tot apres la
blessure, chaque fois que cela est possible.
he current management of pel
vic fractures is aimed at imme
diate stabilization to control hem
orrhage and subsequent definitive
fixation to prevent malunion.1"4 Be
fore aggressive orthopedic treat
ment was recommended in trauma
protocols, patients with pelvic frac
tures were generally managed con
servatively. This often resulted in
marked residual displacement,56
which appears to have been accept
ed in many patients.

T

If residual deformity were an im
portant determinant of late morbidi
ty, one would expect patients with
such deformity to present a contin
uing management problem. Howev
er, few patients were seen at follow
up with long-term functional dis
ability or late pain following pelvic
fracture.
At the University of Western On
tario aggressive management of un
stable pelvic fractures has become
the norm. However, the principle of
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accurate reduction and fixation to
prevent residual deformity can only
be justified if this leads to an im
proved outcome. It was our pur
pose, therefore, to review the out
come in patients who had been
treated for high-energy pelvic frac
tures at the University of Western
Ontario teaching hospitals.

*

I
A

Patients and Methods
We searched all medical records
in the University of Western Ontar
io teaching hospitals from 1978 to
1982 for patients in whom a diag
nosis of pelvic fracture had been
made. The mechanism of injury was
reviewed, and only those patients
who had sustained a high-energy
pelvic fracture were included.
Each patient’s chart and available
x-ray films were reviewed. The pa
tients were all examined again, and
new x-ray films were obtained, in
cluding anteroposterior, inlet and
outlet views of the pelvis. Radiolog
ic assessment included determina
tion of the fracture pattern6 and the
amount of residual displacement.
We identified fractures of the
sacrum, dislocations and fracturedislocations of the sacroiliac joint,
and fractures of the iliac wing en
tering the sciatic notch as involving
the posterior aspect of the pelvic
ring. Displacement of the posterior
elements greater than 1 cm in any

S'
-A

■A
'‘m.

DISPLACED PELVIC RING FRACTURES

direction was considered a signifi
cant residual deformity. Clinical
evaluation included questioning the
patient to assess the current levels
of pain, neurologic, gastointestinal
or genitourinary symptoms and
measurement of leg length and de
gree of function.

Chronic urinary symptoms were not
noted in any of the five patients
whose pelvic fracture had healed
with less than 1 cm of displace
ment, but were present in three of

the eight patients with more than 1
cm of displacement (Table III).
Paresthesia was present in 2 of
the 17 patients without residual
deformity. More patients with resid-

Table 1. Characteristics of 43 Patients Treated From 5 to 9 Years Earlier for High-Energy Pelvic
Ring Fractures
Displacement of posterior ring

Findings
There were 43 patients (32 men,
11 women) in our review, 41 with
closed fractures and 2 with open
fractures. The patients ranged in
age from 18 to 50 years (median 29
years) (Table I). The follow-up
ranged from 5 to 9 years (median
6.5 years).
Thirty-five patients had received
injuries to other systems, and 15
had local pelvic visceral injuries
(Table II).
Twenty-six patients had had ei
ther incomplete reduction or loss of
reduction of the posterior ring, with
a resultant displacement of more
than 1 cm. Patients with displaced
pelvic fractures had been managed
by 12 orthopedic surgeons over 4
years by a variety of treatment
methods, including pelvic sling,
skeletal traction, external fixation
and open reduction with internal
fixation.
Fifteen (88%) of 17 patients with
less than 1 cm of residual displace
ment had no pain (Table III); 14
(82%) had no functional restrictions
in their daily, recreational or workrelated activities. Of 26 patients
who had more than 1 cm of residual
displacement, only 8 (30%) had no
pain, and only 8 (30%) had no
functional disability. Both pain and
function were significantly worse in
the group with more than 1 cm of
displacement (p < 0.01, Student’s
t-test).
Thirteen patients had sustained
bladder or urethral injuries at the
time of pelvic fracture (Table II).

Feature
Age (range), yr
Sex, M:F
Fracture pattern
Anteroposterior compression
Lateral compression
Vertical shear

< 1 cm (n = 17)

> 1 cm (n = 26)

26 (18-44)
12:5

34 (21-50)
16:10

8
6
3

6
15
5

Table II. Associated Injuries and Conditions, Local and Remote (n = 35)
Site or type of injury/condition

_____________ _______ Ncr
9
4
2
2
2
7
6
2
3
11
18
5
3
2
1

Bladder
Urethra
Rectum
Bowel
Kidney
Spleen or liver
Head
Cervical spine
Lumbar spine
Upper extremity
Lower extremity
Acquired respiratory distress syndrome
Pulmonary embolism
Pneumonia
Fat embolism syndrome

Table III. Occurrence of Pain and Disability
Displacement of posterior ring
Findings
Pain
None
With activity, no analgesia
Continued analgesia needed
Function
No restriction
Modified physical activities or job
Modified daily activities or inability to
work
Neurologic symptoms
Paresthesia
Weakness
Paresthesia and weakness
Urologic problems’
Structural injury to bladder or urethra
Residual incontinence

< 1 cm (n = 17)

> 1 cm (n = 26)

15
2
0

8
12
6

14
2

8
13

1

5

2
0
0

5
10
2

5
0

8
3

’ Thirteen patients had had bladder or urethral injuries at the time of pelvic fracture, 5 i
with < 1 cm of displacement and 8 among those with > 1 cm of displacement.
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ual deformity had neurologic prob
lems (p < 0.01); there was pares
thesia in 5 and muscle weakness in
10 (Table III).
Leg-length discrepancies of more
than 1.5 cm had occurred in six
patients with residual deformity;
three of them had serious back
pain. The importance of this trend
could not be determined because of
other factors such as lumbar spine
injuries and degenerative disc dis
ease.

Discussion
The results of this study support
aggressive treatment of pelvic frac
tures to prevent malunion of the
pelvic ring. Significant residual de
formity of the posterior portion of
the pelvic ring is associated with
increased long-term pain and dis
ability. These conclusions are con
sistent with those in the report by
Henderson, Nepola and Claverie7
and do not support the conclusion
of Monohan and Taylor8 that there
is minimal late morbidity associated
with malunion of the pelvic ring.
The stability of pelvic fractures is
determined by more than the pat
tern of bony injury and the associ
ated soft-tissue injury. Fractures as
sociated with extensive soft-tissue
disruption are more unstable and
have a greater risk of malunion if
left unstabilized. The importance of
this factor is difficult to assess on
late follow-up. The displacement
that occurs during the injury is

often far greater than might be
expected from the initial x-ray
films, and the final, healed position
does not reliably indicate the severi
ty of the soft-tissue injury, al
though one would expect a greater
degree of initial soft-tissue disrup
tion when there is substantial resid
ual deformity. Visceral injuries are
most likely related to the degree of
initial displacement. The residual
deformity at healing cannot be con
sidered a reliable indicator for the
recovery of bladder and bowel func
tion either.
Trauma-management protocols
generally include stabilization of
pelvic fractures in the acute phase,
usually by immediate anterior exter
nal fixation.3-4 This is our current
practice. Displaced posterior frac
tures require subsequent reduction
and stabilization. In the meantime,
the pelvis is generally stable enough
with the anterior fixator to allow
for nursing care. The fixator pro
vides sufficient pelvic stability for
transportation to a trauma unit if
the expertise for posterior stabiliza
tion is not locally available.
It has been our experience that
reduction becomes increasingly dif
ficult as time passes. There can be
delays of up to 3 or 4 weeks before
reduction can be carried out in
multiply injured patients, so while
the patients are awaiting definitive
stabilization we maintain them in
skeletal traction to prevent migra
tion of the hemipelvis. This traction
can be removed and reapplied as
required for nursing care. Prefera

bly, these patients are returned to
the operating room 3 to 5 days
after injury for reduction and stabi
lization.
Patients in this follow-up study
had all abandoned seeking further
orthopedic attention, even though
they had significant pain and dis
ability; they had been discharged
without further treatment being of
fered. The fact that patients do not
return with long-term disability
should therefore be attributed to
their having ceased looking for
help, rather than to an actual lack
of long-term morbidity.
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Laser-Assisted Balloon Angioplasty:
Initial 18 Months’ Experience
D.L. Doyle, MD, FRCSC; P.D. Fry, MD, FRCSC
The authors describe their initial 18-month experience with laser-assisted balloon
angioplasty (LABA) of femoral arteries in 44 patients. Primary patency was achieved
in 28 patients, but within 30 days the artery became occluded in 9 of them.
Perforation occurred much more frequently early in the study. Complications
associated with antegrade femoral artery puncture have led to more liberal use of
LABA through an operative approach in the femoral artery. Attention to technical
detail is critical. When LABA fails it does not appear to worsen the patient’s
condition clinically or radiologically. Endovascular procedures are undergoing
continued, rapid change, so ongoing development and assessment of results are
necessary for those who perform LABA.

Les auteurs font part de leur experience initiale de 18 mois en angioplastie par
ballonet aidee de laser (ABAL) des arteres femorales de 44 patients. Une
permeabilite primaire a ete obtenue chez 28 patients, mais en dedans de 30 jours
l’artere s’est obstruee chez 9 d’entre eux. Une perforation s’est produite beaucoup
plus souvent au debut de l’etude. Les complications associees a la ponction
antegrade de l’artere femorale ont mene a une utilisation de ABAL beaucoup liberate
par approche chirurgicale de l’artere femorale. Une attention toute particuliere doit
etre vouee aux details techniques. En cas de faillite du ABAL, il ne semble pas que
la condition du patient en soit affectee cliniquement ou radiologiquement. Les
interventions endovasculaires subissent des changements continuels et rapides; la
poursuite des ameliorations et l’etude des resultats sont necessaires a ceux qui
utilisent le ABAL.

he ability to re-establish arteri
al flow through previously oc
cluded blood vessels using percuta
neous transluminal techniques has
great appeal. The ideal technique
has not yet been developed but
would be applicable to long- as well
as short-segment occlusions of
large- and small-calibre arteries. Re
canalization would be possible in
the presence of soft and calcified
plaque, and the technique would

T

have a high initial and long-term
success rate and employ relatively
inexpensive technology.
Since the early reports of suc
cessful laser vaporization of athero
sclerotic plaque in cadaveric ves
sels1 and, later, in animals, laser
angioplasty has been greatly modi
fied. Laser-assisted balloon angio
plasty (LABA) is widely used.2-6 In
this paper we report our early expe
rience with laser angioplasty.

From the Division o f Vascular Surgery, Department o f Surgery, University Hospital, University
o f British Columbia, Vancouver, BC
Accepted fo r publication Dec. 10, 1989
Reprint requests to: Dr. D.L. Doyle, Department o f Surgery, University Hospital, UBC Site, 2211
Wesbrook Mall, Vancouver, BC V6T 1 W5

Patients and Methods
The first LABA performed in
western Canada was at University
Hospital, UBC Site, in Vancouver in
June 1987. The series included 44
patients (30 men, 14 women) who
had claudication and threatened
limb loss. They had a relatively
short segment (less than 12 cm) of
superficial femoral or popliteal ar
tery occlusion that could not be
crossed with a guide wire. Patients
were admitted to hospital the day
before the procedure and started on
acetylsalicylic acid, 325 mg twice
daily. After an overnight fast, pa
tients were taken to the operating
room. In patients who had no dis
ease of the common femoral artery,
the Seldinger technique with ante
grade common femoral artery punc
ture and local anesthesia was used
to place a no. 8 French sheath in
the common femoral artery with its
tip in the superficial femoral artery.
In patients requiring a common
femoral thromboendarterectomy, a
femoral arteriotomy was performed
under local, regional or, occasional
ly, general anesthesia. The choice
of anesthetic was directed by pa
tient factors and anesthetist prefer
ence. After thromboendarterectomy,
with or without a patch, the arteri
otomy was nearly closed and a no. 8
French sheath placed directly into
the common and superficial femoral
arteries. Patients were systemically
heparinized, and a slow, steady in
fusion of dilute heparin in normal
saline was begun through the side
port of the sheath.
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A Trimedyne Laserprobe (Trimedyne, Santa Ana, Calif.) was cou
pled to a continuous-wave 12-W
Trimedyne argon laser, set between
8 and 10 W. Lasing and dilatation
were conducted under fluoroscopic
control. All fluoroscopic images
were recorded on 1.9-cm videotape.
This allows for immediate image
review and long-term data storage.
After the Laserprobe had been
passed to the level of the occlusion
the laser was activated and the
probe was slowly passed through
the occlusion. Continuous fluoro
scopic guidance with a slow, steady
injection of nonionic contrast mate
rial was maintained throughout
laser recanalization. In long-seg
ment occlusions, the recanalization
proceeded in stages. The Laser
probe was withdrawn and accumu
lated charring cleaned from the tip.
In all cases, once laser recanaliza
tion was complete, balloon angio
plasty was performed to dilate resid
ual stenosis.
Perforation of the artery was not
necessarily a signal to abandon the
procedure, unless the perforation
was large or associated with an
arteriovenous fistula or loss of con
tinuity of the distal vessel. Pressure
was briefly maintained on the site of
arterial perforation and reconstruc
tive bypass surgery performed at
the surgeon’s discretion.
After successful laser angioplasty
by cutdown, sheaths were removed
and arteriotomies and wounds
closed. For percutaneous proce
dures, sheaths were removed and
pressure was maintained on the
puncture site until hemostasis oc
curred; later in the study, sheaths
were left in place for 12 to 24 hours
and intra-arterial infusion of hepa
rin was continued. Angiography
was done, and if all appeared well
the sheaths were removed. All pa
tients were heparinized for 24
hours after the procedure. Acetylsalicylic acid administration was re
496

sumed and patients were discharged
home 24 to 48 hours after the
procedure.
As a result of some initial prob
lems with vasospasm during and
after the procedure, we chose to
start all patients who were not
normally taking calcium channel
blockers on nifedipine, 10 mg oral
ly, three times a day. The nifedipine
was begun the evening before the
procedure and continued for 48 to
72 hours after.
Ankle-brachial pressure indices
were measured before and after
LABA.
Laser angioplasty was considered
successful if the completion angio
gram demonstrated free flow of
contrast material from the proximal
vessel through the previously oc
cluded segment. Ongoing patency
was assessed by clinical and labora
tory means, including the disap
pearance or marked reduction of
symptoms, improvement in anklebrachial pressure indices, the pres
ence of previously absent pedal
pulses and the successful healing of
ischemic ulcers or digital amputa
tion wounds. Repeat angiography
was performed when symptoms oc
curred, when ankle-brachial pres
sure indices fell or when segmental
Doppler flow velocities rose.

Results
The mean age of the 44 patients
was 69 years for men and 67 years
for women. Fourteen were diabet
ics. Twenty-one procedures were
done percutaneously and 23 were
open procedures; femoral cutdown
was necessary in three patients be
cause of a failed percutaneous ap
proach. In 20 patients disease of
the common femoral or deep femo
ral artery necessitated thromboendarterectomy. Four procedures
were performed under general anes
thesia; in one of them it was used
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because a spinal anesthetic failed.
The other three general anesthetics
were used early in our laser angio
plasty experience. In 18 sheath in
sertions, laser angioplasty was per
formed with lidocaine infiltration of
the inguinal area. Regional (spinal
or epidural) anesthesia was per
formed in 22 patients. Thirty-six
LABAs were performed for claudi
cation with a walking distance of
between one-half and three blocks;
8 were performed for limb salvage.
Three of the 44 procedures were
performed by a visiting authority.
The mean ankle-brachial pressure
index for each symptom category is
listed in Table I.
Twenty-nine occlusions were of
the distal superficial femoral artery.
There were 11 combined occlusions
of the distal superficial femoral ar
tery and the proximal popliteal ar
tery. Laser angioplasty was at
tempted in two patients who had
isolated popliteal artery occlusions,
in one who had occlusion of the
popliteal artery and tibioperoneal
trunk and in one who had an
isolated occlusion of the common
iliac artery.
Primary patency was obtained in
28 patients. There were 13 perfora
tions. Three perforations occurred
because of disconnection of the
fibre tip, which allows the laser
energy to spray indiscriminately
within the vessel. One perforation
was caused by a guide wire after a
successful laser recanalization.
Table I. Symptoms and Average
Ankle-Brachial Pressure Index

Symptoms
Gangrene
Rest pain
Claudication
< 1/2 block
1/2 to 2
blocks
> 2 blocks

Mean
No. of ankle-brachial
patients pressure index
6
2*

0.33
0.59

4

0.57

29
3

0.60
0.72

'Both patients were diabetic.

LASER-ASSISTED ANGIOPLASTY

There was one vessel dissection; the
true lumen could be entered with a
guide wire but could not be entered
with the Laserprobe, so that reca
nalization could not be completed.
In one case the guide wire would
not cross a channel created and
subsequently widened by repeat
passage of the laser.
Of the 28 procedures in which
primary patency was obtained, 2
were “rescued perforations”. Both
vessels reoccluded within 1 month.
Seven other laser angioplasties also
failed within 1 month; one of the
failures occurred in a patient who
had both LABA of an occluded
segment and a balloon angioplasty
of a hemodynamically significant
nonocclusive lesion. Restenosis oc
curred at the nonlased balloon angi
oplasty site. The patient refused
repeat balloon angioplasty. In two
patients the vessel became occluded
within 3 months. In one patient the
vessel at the angioplasty site oc
cluded at 6 months. One man, a
diabetic, died of a sudden myocardi
al infarction 3 months after laser
angioplasty; the vessel at the angio
plasty site was still patent at the
time of his death. Another diabetic
man who underwent laser angio
plasty for frank gangrene died of
multiorgan failure associated with
chronic renal failure 6 weeks after
Table II. La te F a ilu re s o f L a s e r-A s s is te d
B a llo o n A n g io p la s ty

Time to occlusion, mo

No. of patients

< 0 .2 5

5

>1

4

3
6

2

1

Table III. L o n g -T e rm P a te n cy o f V e s s e ls
S u b je cte d to L a s e r-A s s is te d B allo o n
A n g io p la s ty

Time after
angioplasty, mo
0 .5
3
6
9
12

No. of vessels
1
4
2
2
5

successful laser angioplasty. The
vessel at the angioplasty site re
mained patent and the amputation
wounds of his gangrenous toes had
healed. The arteries at all other
laser angioplasty sites remained pa
tent. The average rise in the anklebrachial pressure index in patients
whose arteries at LABA sites re
mained patent at least 1 month was
0.4. An average rise of up to 0.1
was seen in patients with an angiographically patent LABA in whom
clinical or radiologic failure was
seen within 30 days of angioplasty.
The long-term results are shown
in Tables II and III.

Discussion
Like others357 we have demon
strated that laser angioplasty can
successfully recanalize arterial seg
ments that cannot be reopened by
balloon angioplasty alone. All pa
tients in our series had lesions that
could not be crossed by a guide
wire. Vessel wall perforation is an
ongoing problem, but it does not
seem to be a life- or limb-threaten
ing complication. Some perforations
can be “rescued” by a channel
created through the occlusion, and
subsequent balloon angioplasty can
achieve patency in those with small
perforations, without arteriovenous
fistulas in whom the distal vessel
can continue to be visualized. We
found that long-term patency could
not be maintained in these vessels.
All the recanalized segments in
those with so-called rescued perfo
rations occluded within 1 month.
Probably the added trauma leaves a
surface that is more thrombogenic
after angioplasty than usual. Per
haps the addition of a stent at these
sites will improve patency.
The effects of the learning curve
have once again been confirmed.
The likelihood of achieving primary
patency was much higher later in

our series. Attention to fine techni
cal details is critical. Like others357
we found that longer segments
were more difficult to recanalize
and were associated with a lower
long-term patency rate. Our num
bers are small and our follow-up is
relatively short, so that detailed
statistical analysis of patency is not
meaningful.
We encountered a higher fre
quency of problems with antegrade
femoral puncture than did other
investigators. These problems in
cluded failure to cannulate the ves
sel and hemodynamically important
bleeding at the puncture site. In
one case of short-segment occlu
sion, a hemodynamically important
lesion at the origin of the superfi
cial femoral artery was not detected
and therefore not dilated. This
proximal lesion caused occlusion 6
weeks after laser angioplasty and
led to secondary occlusion of the
artery at the lased site. We are now
much more liberal in our indica
tions for an open approach to laser
angioplasty than we were earlier in
our experience. Patients with ab
dominal “aprons” that drape over
the groin, those with a very short
common femoral artery and those
with any suggestion of disease in
the common, superficial or deep
femoral artery now undergo femoral
cutdown, thromboendarterectomy
and patch angioplasty. This proce
dure is routinely done under local
or regional anesthesia. Nearly 40%
of our procedures are now done
using an open femoral approach.
The incidence of groin complica
tions has fallen markedly.
We prefer to use a regional anes
thetic. An epidural or spinal anes
thetic is well tolerated in this age
group, and the frequency of head
ache is low. The sympathetic block
ade associated with regional anes
thesia decreases the likelihood of
vasospasm during or after the pro
cedure, and this may improve pat-
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er, are not at the laser angioplasty
site. Our experience suggests that if
the vessel at the angioplasty site
can be kept patent for 1 month
after the procedure intermediateterm patency is likely. The early
failures seem to be related to tech
nical problems with perforation and
the creation of a thrombogenic sur
face and possibly large flaps.
Laser balloon angioplasty seems
to have application in a fairly small
percentage of patients with athero
sclerotic occlusive disease. For
those in whom it is successful,
revascularization is achieved with
low risk, decreased cost and a
shortened hospital stay when com
pared with femoropopliteal bypass.
For those in whom it fails, it does
not appear to worsen the patient’s
status clinically or radiologically.
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ency. We have found that patients
in whom LABA is performed under
local anesthesia experience mild dis
comfort during lasing. Not infre
quently, the patients move their
legs as an involuntary response to
this sensation. Regional anesthesia
provides excellent sensory and
motor blockade.
Guidance and steerability remain
major problems with this technique.
We do laser angioplasty under fluo
roscopic guidance. The vessel is
visualized with a slow, steady injec
tion of nonionic contrast material.
Transcutaneous duplex scanning
has proved cumbersome in our ex
perience. It can be difficult to com
bine with fluoroscopy, as the ultrasonographer’s hand may be ex
posed to radiation. An exciting new
development is endovascular ul
trasonography. The laser probe and
its relation to the luminal surface
are seen more clearly with this
technique than with transcutaneous
imaging. The margin between suc
cess and perforation is greater. The
problem of steerability continues to
be addressed. Cables that deflect
the tip have been added to allow for
one degree of freedom. “Over-thewire” probes are now available for
peripheral and coronary lesions that
can be crossed with a guide wire.
Eccentric metal probes have been
developed; they allow control of
ablation in eccentric atherosclerotic
plaque.
Our long-term follow-up is too
short and our numbers are too
small to compare the patency
achieved by LABA with that
achieved by femoropopliteal bypass.
Others have reported an incidence
of failure between 6 months and 1
year of up to 30% for those with
occlusions of the superficial femoral
artery who underwent LABA.8 This
failure is believed due to neointimal
hyperplasia. We have seen some
failures at this stage. The majority
of our intermediate failures, howev
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SESAP VI Critique
A

Item 125
Life-threatening hemorrhage is an all-too-common complication of
pelvic fractures. Mortality up to 40% has been reported. The control of
bleeding has been problematic. External pelvic fixation devices to
stabilize the fracture have greatly reduced morbidity and the require
ment for transfusion. The external fixation device should be applied as
soon as the unstable fracture is recognized. If external fixation fails to
control the bleeding, arteriography with embolization, or open reduc
tion and internal fixation with control of hemorrhage, may subsequently
be required.
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M alignant Transformation Occurring
in Mature Cystic Teratomas of the Ovary
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Two cases in which tumours of contrasting malignant potential arose in mature
cystic teratomas (dermoid cysts) of the ovary are presented: one patient had a
spindle-cell sarcoma and the other a trabecular carcinoid. The first patient’s clinical
course was characterized by rapid recurrence of the tumour and death 3 months
after surgery. The second patient is alive and well with no evidence of residual
carcinoid, although the follow-up time is short. Since the surgical procedure of
choice differs substantially if malignant transformation occurs in an ovarian dermoid
cyst, the pathologist should be consulted intraoperatively in selected cases.

On presente deux cas ou des tumeurs ayant une potentialite cancerigene tres
differente se sont developpees a partir de teratomes kystiques ovariens murs (kystes
dermoides): il s’agissait d’un sarcome a cellules fusiformes dans un cas et d’un
carcinoi'de trabeculaire dans l’autre. devolution clinique de la premiere patiente fut
caracterisee par une recidive rapide de la tumeur et son deces 3 mois apres
l’operation. La seconde patiente est saine et sauve, sans signes de carcinoi'de
residuel, bien que la periode de post-cure soit courte. Comme le choix de
l’intervention chirurgicale differe sensiblement quand il y a transformation maligne
d’un kyste dermoide ovarien, un pathologiste devrait etre consulte durant l’opera
tion dans les cas choisis.

M

alignant transformation is an
uncommon complication in a
mature cystic teratoma (dermoid
cyst) of the ovary, usually being
reported in about 2% of cases,1-2
although one series reported a fre
quency of 4%.3 Sarcomatous trans
formation is even rarer, occurring
in only 7% of malignant tumours
that develop from dermoid cysts.2
In a comprehensive review, up to
1957, of malignant tumours devel

oping from dermoid cysts, Peter
son1 noted that the first dermoid
cyst of the ovary was reported by
Johannes Schultetus in 1659 and
was accompanied by “excellent il
lustrations” . Peterson credited
Pesch, in 1857, with the first de
tailed discussion of a malignant
tumour complicating a dermoid cyst
and Pommier in 1864 with the first
case of sarcomatous degeneration.
Since Peterson’s review only a few
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isolated reports of sarcomatous
transformation occurring in a der
moid cyst have appeared in the
English literature.4^6 This report
was prompted by our recent experi
ence with two unusual examples of
malignant tumours occurring in
ovarian dermoid cysts. One tumour
was of high-grade and the other of
low-grade malignancy.

Case Reports
Case 1
An 83-year-old woman, gravida
3, para 3, complained of progres
sive abdominal distension for 2
months, bloating after eating and
early satiety for 2 weeks and uri
nary retention for 3 days. The abdo
men was distended, with tenderness
to deep palpation in both lower
quadrants. Pelvic examination re
vealed a smooth-edged mass filling
the pelvis and displacing the uterus
anteriorly. A computed tomography
scan confirmed the presence of a
large mass located centrally within
the pelvis, with associated marked
compression and displacement of
the posterior aspect of the urinary
bladder and bilateral hydronephro
sis.
At operation, the mass posterior
to the uterus was found to extend
deeply into the cul-de-sac and onto
the pelvic side wall. Further dissec
tion revealed that most of the mass
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consisted of blood clot and edema
tous connective tissue encasing the
left ovary, which had undergone
torsion on its pedicle several times.
A left salpingo-oophorectomy was
performed, and examination of a
frozen section revealed a malignant
tumour arising in a dermoid cyst.

The tumour was considered most
likely to be an undifferentiated car
cinoma. The right ovary was also
enlarged, and frozen-section exami
nation showed that it too contained
a dermoid cyst but without any
apparent malignant transformation.
A total hysterectomy was per

FIG. 1. Case 1. Undifferentiated spindle-cell sarcoma; many mitotic figures are
present (original magnification X 200).

FIG. 2. Case 1. Section stained to show vimentin (immunoperoxidase stain, original
magnification X 200).
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formed, and at the end of the
operation no residual tumour was
visible in the abdomen. The patient
had a smooth recovery and was
transferred to the referring institu
tion for follow-up care.
She did not receive adjuvant che
motherapy because of its potentially
limited benefits and her advanced
age.
Three weeks later vaginal bleed
ing developed and re-exploration
was necessary. Tissue fragments
were found floating in the pelvis
and were sent for pathological ex
amination. The pelvis was packed in
an attempt to achieve hemostasis.
However, vaginal bleeding contin
ued, and the patient required up to
four units of blood daily. Despite
another laparotomy, the vaginal
bleeding continued, so the patient
was again transferred to the Foot
hills Hospital. Angiography re
vealed a tumour blush in the pelvis,
which was thought to represent
recurrent tumour. The bleeding was
unresponsive to radiotherapy and to
internal iliac artery embolization,
necessitating a further laparotomy,
at which time the hypogastric arter
ies were ligated. Tissue from the
pelvic tumour was again obtained
for pathological examination. The
patient recovered but had internal
bleeding 1 week later. She died of
complications from her tumour 3
months after her original surgery.
No autopsy was performed.
Pathological findings. The left
ovary measured 9 X 8 X 5 cm. On
sectioning, it was was found to be
unicystic and filled with sebaceous
material and hairs. At one pole the
wall was irregularly thickened and
firm. Paraffin-embedded sections
showed areas of respiratory and
squamous epithelium as well as
mature adipose, skeletal and cartilagenous tissues. Arising within the
dermoid cyst was an undifferentiat
ed spindle-cell sarcoma (Fig. 1),
which extended to the capsule of

-V
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the ovary. The malignant compo
nent was composed of solid and
myxoid areas without neoplastic os
teoid or cartilage components. The
mitotic rate was high, with more
than 10 mitoses per single highpower field. Immunoperoxidase

stains for epithelial differentiation,
including AE1,3 (a mixture of anti
bodies to different molecular weight
cytokeratins), CTK (a mixture of
antibodies to other different mole
cular weight cytokeratins) and EMA
(epithelial membrane antigen), all

gave negative results. Markers for
mesenchymal differentiation includ
ing vimentin (Fig. 2) and actin were
detected; myoglobin showed only
rare focal positivity. Desmin and
S-100 (a protein with a molecular
weight of 21 000) gave negative
results. Tumour obtained in the
peripheral hospital during the sec
ond operation had an identical ap
pearance and similar immunoperox
idase staining characteristics.
Tumour obtained from the last
operation was submitted for elec
tron microscopy and showed an
undifferentiated sarcoma with focal
rhabdomyosarcomatous differentia
tion (Fig. 3). Flow cytometry of a
tumour specimen revealed an aneuploid cell population, with 36% of
the cells being in the S phase of the
cell cycle.
Case 2

F1G. 3. Case 1. Electron photomicrograph of undifferentiated sarcoma. Note highly
convoluted and irregular nucleus, paucity of cytoplasmic organelles, many interme
diate filaments, absence of basement membrane and lack of intercellular junctions
(original magnification X 5000).

FIG. 4. Case 2. Carcinoid tumour composed of anastomosing trabeculae of columnar
cells (hematoxylin and eosin, original magnification X 40).

In 1985, at the age of 41 years, a
woman underwent laparotomy for
an intussusception of the terminal
ileum, which was involved by a
low-grade malignant lymphoma. A
left ovarian mass was noted during
surgery, but it was not removed.
She received a course of chemother
apy and remained in good health. In
1989 she requested tubal ligation
and removal of the ovarian mass,
which had not changed in size,
according to ultrasonographic ex
amination. A left ovarian cystecto
my was performed in addition to the
tubal ligation. The patient recov
ered smoothly and was well 3
months later.
Pathological findings. The cyst
measured 6.5 X 4.5 X 3 cm and
contained sebaceous material and
hair. Paraffin-embedded sections of
the cyst revealed a predominantly
squamous lining and skin adnexal
structures. Other cell types identi
fied included a minor enteric epithe
lial component, mature fat, glia and
smooth muscle. No immature ele-
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When dermoid cysts of the ovary
were recognized over 300 years ago
they were thought to represent a
baby, and a major concern at the
time was whether or not the “baby”
should be baptized.1 We now know

tumours, which contain similar
high-grade malignant elements.1041
The survival of patients with
high-grade malignant tumours aris
ing in a dermoid cyst is extremely
poor; the majority die within 12
months of diagnosis.8 There have
been no long-term survivors when
the malignant element has been a
sarcoma.1 In view of the advanced
age of many of these patients and
their concomitant medical prob
lems, clinical judgement should be
exercised before prescribing treat
ments that have unproven or limit
ed value and will increase morbidi
tyBy contrast, trabecular carcinoids
developing in ovarian dermoid cysts
are regarded as tumours of low
malignant potential.12 In only one
case has recurrence been reported;
it resulted in death 5V& years after
diagnosis.13 If a patient wishes to
preserve her fertility and if the
trabecular carcinoid component is
recognized at surgery, a unilateral
salpingo-oophorectomy is the pro
cedure of choice. However, if the
patient is postmenopausal and if the
trabecular carcinoid component is
recognized at surgery, the proce
dure of choice is total hysterectomy

t

Discussion

that dermoid cysts do not represent
the products of conception but re
sult from the parthenogenic devel
opment of a single germ cell.7
The primary management of pa
tients with a high-grade malignant
tumour arising from a dermoid cyst
remains surgical excision, although
the extent has varied from cystecto
my to total abdominal hysterectomy
and bilateral salpingo-oophorectomy. However, if the malignant na
ture of the tumour is recognized at
laparotomy, the surgical procedure
of choice is complete removal of the
pelvic genital organs. Such exten
sive surgery may lead to improved
survival.8
The role of chemotherapy or ra
diotherapy postoperatively is un
clear. Radiotherapy alone appears
not to be efficacious.9 The role of
adjuvant chemotherapy is difficult
to assess, since there are only anec
dotal reports of a variety of largely
ineffective combinations.8 Since
high-grade malignant tumours aris
ing from ovarian dermoid cysts are
so uncommon, it is unlikely that
meaningful conclusions regarding
treatment will be reached without
extrapolation from results of treat
ment for malignant mixed mullerian

*">

ments were identified. In the cyst
wall a firm nodule measuring up to
1.5 cm in diameter was noted.
In the thickened part of the cyst
wall a secondary cyst, up to 6 mm
in its greatest dimension, was iden
tified. Arising on a stalk and largely
filling this smaller cyst was a tra
becular carcinoid composed of intri
cately anastomosing trabeculae or
cords of columnar cells (Fig. 4).
Some of these cells had eosinophilic
subnuclear vacuoles.
The Grimelius stain was strongly
positive in many cells (Fig. 5). Immunoenzyme staining by the perox
idase-antiperoxidase technique was
strongly positive in some cells for
chromogranin and diffusely but
weakly positive for neuron-specific
enolase. The carcinoid was entirely
confined to the smaller, secondary
cyst.

'>
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FIG. 5. Case 2. (Left) Diffuse intracytoplasmic staining and concentrated (black) subnuclear staining in some cells (Grimelius
stain, original magnification X 400). (Right) Black reaction for chromogranin concentrated in subnuclear location
(immunoperoxidase stain, original magnification X 400).
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and bilateral salpingo-oophorecto-

References

my.
As our first case emphasizes,
intraoperative frozen-section exami
nation should be considered for
ovarian dermoids in selected pa
tients. In addition to the younger
woman whose dermoid is suspected
to be part of a mixed malignant
germ-cell tumour, those with der
moids that become manifest in the
peri- or postmenopausal years,
those that are symptomatic at the
time of presentation and those with
cysts that feel solid are more likely
to harbour an occult, malignantly
transformed element.
The discovery of this unsuspect
ed malignant tumour should modify
the extent of surgery, depending on
the histologic type of malignant
transformation. It may also obviate
the need for a second, more exten
sive surgical procedure shortly
thereafter.
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Abstract Submissions for the
1991 Royal College Annual Meeting
September 20-23, 1991, Quebec, Quebec

Presentation des resumes pour
I’assemblee annuelle de 1991 du College royal
20-23 septembre 1991, Quebec, Quebec

In December 1990, the Annual Meeting Committee
will invite all Fellows of the College and members of
the Canadian Society for Clinical Investigation to
submit abstracts of scientific papers for consideration
by the specialty review panels for the 1991 scientific
program.

En decembre 1990, le Comite de I’assemblee
annuelle invitera les Associes du College et les
membres de la Societe canadienne de recherches
cliniques a soumettre des resumes d’articles scientifiques dans le cadre du programme scientifique de
1991 pour etre evalues par les comites de revision
des specialties.

The abstract submission forms will be distributed
to Fellows as an insert to the December 1990 Annals,
RCPSC and to members of CSCI in the December
issue of Clinical and Investigative Medicine. Watch for
your copy.
Members of participating societies who are neither
Fellows of the College nor members of CSCI will
receive abstract forms from their specialty society.
Please note that the deadline for receipt of the
abstracts with the processing fees will be Feb. 27,
1991.

Les formules pour presentation de resumes seront
distributes aux Associes en encart aux Annates du
CRMCC de decembre 1990 et aux membres de la
SCRC en encart au numero de decembre de Medecine clinique et experimental. Assurez-vous d’avoir
votre exemplaire.
Les membres des societes participantes qui ne
sont ni Associes du College ni membre de la SCRC
recevront les formules pour resumes de leur associa
tion ou societe de specialistes.
La date limite pour faire parvenir les resumes et les
frais pour manutention a ete fixee au 27 fevrier 1991.
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Drs. C.B. Mueller and N. Watters Receive Honorary
Fellowship in the Canadian Association of General Surgeons

On Friday, Sept. 14, 1990 at the
14th annual business meeting of
the Canadian Association of Gen
eral Surgeons Drs. C. Barber
Mueller and Neil A. Watters re
ceived honorary fellowships in
the association. This award is
presented annually to Canadian
general surgeons who have con
tributed to the advancement of
surgical education, administra
tion and research.
In introducing Dr. Mueller to
the association’s members, Dr.
Homer Beattie, past chairman of
the Department of Surgery at
McMaster University, highlighted
Dr. Mueller’s career: Dr. Mueller
graduated from Washington Uni
versity in St. Louis, Mo. During
World War II he served in the
US Navy Marine Corps. After the
war he was involved in the inves
tigation of renal function at Har
vard University. Subsequently he
was accepted at Barnes Hospital,
St. Louis, for general surgical
training and was accepted into
the teaching faculty. From 1956
to 1967 he served as chairman
of the Department of Surgery,
Upstate Medical Center of the
State University of New York, at
Syracuse, NY. He then was ap
pointed as professor and chair
man of the Department of Sur
gery at McMaster University in
Hamilton, Ont.
Dr. Mueller’s career has been
highlighted by national and in
ternational awards, which are

credits to his service to the sur
gical community at large. He has
been recognized as an outstand
ing educator and throughout his
career has been at the leading
edge of the development of new
teaching methods. It is to his
credit that surgical investigation
and enquiry into biostatistics and
epidemiology have been recog
nized as mandatory for surgical
postgraduate training.
In 1984, the American Col
lege of Surgeons recognized Dr.
Mueller through their highest
honour — the Distinguished Ser
vice Award.
The fellowship award was pre
sented by Dr. Jean Couture,
president of the Canadian Asso
ciation of General Surgeons. In
accepting the award, Dr. Mueller
acknowledged his appreciation of
the recognition given to him by
the association and the enrich
ment of his life through associa
tion with Canadian surgical col
leagues and friends.
Dr. Neil A. Watters was intro
duced by Dr. John Provan, asso
ciate dean of postgraduate edu
cation at the University of To
ronto. Dr. Watters trained in
general surgery at the University
of Toronto and served during
World War II in the Royal Cana
dian Army Medical Corps. After
the war he completed his post
graduate training in the Gallie
Course at the University of To
ronto. He practised general sur

gery in Guelph, Ont. Subse
quently he returned to academic
surgery in Toronto and in 1967
was appointed surgeon in chief
at the Wellesley Hospital in To
ronto. Dr. Watters has had an
impressive career as a surgeon,
surgical educator and adminis
trator. He was instrumental, as
director of undergraduate educa
tion for the Department of Sur
gery at the University of Toron
to, setting up the clinical clerk
ship at that school. He was also
chairman of the Interhospital Co
ordinating Committee in General
Surgery. He served as chairman
of the Examining Board in Gen
eral Surgery for the Royal Col
lege of Physicians and Surgeons
of Canada and was chairman of
the Royal College Specialty Com
mittee in General Surgery. He
has also served as a governor of
the American College of Sur
geons. Dr. Watters was one of
the founding members of the
Canadian Association of General
Surgeons and served as president
of the association. His most re
cent, continuing contribution to
the association has been as presi
dent of the Canadian Surgical
Research Fund.
In receiving his award, Dr.
Watters thanked his friends
and associates in the association
and acknowledged his heartfelt
appreciation for the honour be
stowed on him by the award
of honorary fellowship.
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BOOKS RECEIVED
continued from page 491

Complication Rates in Medical Prac
tice. Edited by Wolfgang Mattig. 671
pp. Denis J. Paradis Editions Inc., Mon
treal. 1989. Price not stated. ISBN 0920211-02-X
Follies & Fallacies in Medicine. Petr
Skrabanek and James McCormick. 146
pp. Prometheus Books, Buffalo, NY.
1990. $19.95 (US). ISBN 0-87975630-6
In the Country of Hearts: Journeys in
the Art of Medicine. John Stone. 211
pp. Delacorte Press, New York. 1990.
$17.95. ISBN 0-385-30169-3

Laparoscopy for Surgeons. Barry A.
Salky. 157 pp. Must. Igaku-Shoin Med
ical Publishers, Inc., New York; W.B.
Saunders Company, London/Harcourt
Brace Jovanovich, Inc., Philadelphia;
HBJ-Holt-Saunders Distribution Ser
vices, Toronto. 1990. Price not stated.
ISBN 0-89640-166-9

Malignant Cerebral Glioma. American
Association of Neurological Surgeons
Publications Committee, Michael L.J.
Apuzzo. Neurosurgical Topics series.
231 pp. Must. American Association of
Neurological Surgeons, PO Box
94078, Chicago, 111. 1990. AANS mem
bers, $70, nonmembers, $80, residents,
$60. (Add $10 outside US). ISBN 0 9624246-3-3
Metabolic Bone Disease and Clinically
Related Disorders. 2nd ed. Edited by
Louis V. Avioli and Stephen M. Krane.
912 pp. Must. W.B. Saunders Company/Harcourt Brace Jovanovich, Inc.,
Philadelphia. 1990. Price not stated.
ISBN 0-7216-2766-8

Neuroscience Critical Care: Patho
physiology and Patient Management.
Sharon Bowers Marshall, Lawrence F.
Marshall, Helen R. Vos et al. 459 pp.
Must. W.B. Saunders Company, Lon
don/Harcourt Brace Jovanovich, Inc.,
Philadelphia; HBJ-Holt-Saunders Dis
tribution Services, Toronto. 1990. Price
not stated. ISBN 0-7216-2790-0
Pediatric Urology. Keith W. Ashcraft.
540 pp. Must. W.B. Saunders Compa
ny, London/Harcourt Brace Jovano
vich, Inc., Philadelphia; HBJ-HoltSaunders Distribution Services, Toron
to. 1990. Price not stated. ISBN 0 7216-2746-3
Sports Injuries: Diagnosis and Man
agement. James G. Garrick and David
R. Webb. 347 pp. Must. W.B. Saunders
Company, London/Harcourt Brace Jo
vanovich, Inc., Philadelphia; HBJHolt-Saunders Distribution Services,
Toronto. 1990. Price not stated. ISBN
0-7216-2127-9

Mirror of Medicine: a History of the
British Medical Journal. Peter W.J.
Bartrip. 338 pp. Clarendon Press, Oxford/Oxford University Press, New
York/British Medical Journal, London.
1990. $69 (US). ISBN 0-19-261844-X

Savoir preparer une recherche: la definir, la structurer, la financer. AndrePierre Contandriopoulos, Francois
Champagne, Louise Potvin et al. 197
pp. Must. Les presses de l’Universite de
Montreal, Montreal. 1990. $19. ISBN
2-7606-1535-9
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The Lactation Consultant’s Topical
Review and Bibliography of the Litera
ture on Breastfeeding. Edited by MaryMargaret Coates. 188 pp. La Leche
League International, Franklin Park, 111.
1990. $25.95 (US). ISBN 0-91250039-5

Lasers in Otolaryngology: Head and
Neck Surgery. Edited by R. Kim Davis.
208 pp. Must. W.B. Saunders Compa
ny, London; HBJ-Holt-Saunders Distri
bution Services, Toronto. 1990. Price
not stated. ISBN 0-7216-3124-X
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GENERAL SURGEON: BC - In beautiful agri
cultural valley at south end of Kootenay Lake,
southeastern B.C. Referral population 15 000
with broad-based economy and mild climate.
Many recreational and cultural opportunities.
This 44-acute-bed-hospital staffed by six
GPs, three GP/anesthetists and one GP/OB/Gyn. Involved in UBC Family Practice Resi
dency program. Equipped with colonoscope,
gastroscope, and tw o operating rooms. Po
tential gross at least $250 OOO. Contact: Dr.
John Kennedy, Chief of Staff, Creston Val
ley Hospital. Bag 3 0 0 0 , Creston, BC VOB
1 GO. Tel: (604) 4 2 8 -9 3 7 1 ; or (604)
4 2 8 -3 5 6 2 , evenings.
-S 90-40
GENERAL SURGERY LOCUM WANTED:
BC - Appropriately qualified general surgeon

required for 6 months to 1 year to fill in for
surgeon going on sabbatical. Interest in
teaching preferred. Expertise in trauma,
breast disease, and G.l. endoscopy an asset.
One-in-six-call at Lion's Gate Hospital in North
Vancouver, B.C. Recreational paradise. Please
call: Dr. Bob Fris, tel: (604) 9 8 0 -5 1 4 1 .
-S90-38

GENERAL/GI SURGEON: US - BC/BE gen
eral surgeon with Gl training and interest in
endoscopy/laparoscopy/lazer therapy to join
busy general surgery practice. Practice seek
ing to enhance current Gl services in midwest
market of 90 OOO adjacent to metropolitan
area and medical schools. Excellent benefits

and competitive salary leading to partnership
opportunity. Send CV to: Box 0 6 6 , CJS.
-S 9 0-3 6

GENERAL/ONCOLOGICAL SURGEON: US
- BC/BE with training/fellowship in oncology
to join busy general surgery practice. |n addi
tion to general surgery, will be responsible for
the enhancement of current oncologic ser
vices. Situation will provide opportunity for
clinical research. Attractive, family-oriented
midwestern community with service area of
90 OOO close to metropolitan area. Competi
tive compensation package with excellent
benefits and growth opportunities. Early part
nership available. Send CV to: Box 0 6 5 , CJS.
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urwersily
of Alberta
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hospitals

%/

University
of
Alberta

A S S O C IA T E D IR E C T O R
Critical Care/Traum a Unit
The University of Alberta Hospitals is accepting applica
tions for the position of Associate Director, Critical
Care/Trauma Unit. This multidisciplinary adult ICU
serves as a regional unit for Central and Northern
Alberta, Northeastern British Columbia and the Northwest
Territories.
The successful applicant must have fulfilled the fellowship
qualifications of the Royal College of Physicians and
Surgeons of Canada in one of Surgery, Medicine or
Anaesthesia. Fellowship training or attending staff expe
rience in Critical Care is required. Primary appointment
will be to the base specialty with cross appointment to the
Faculty Division of Critical Care.
The University of Alberta Hospitals is committed to pro
viding exemplary patient care and education in an atmo
sphere of compassion and scholarly inquiry while pre
serving the dignity and rights of patients and their fami
lies.
P lea se subm it e n q u irie s to : Dr. S.M . H am ilton ,
Director, Critical Care/Trauma Unit, 2D4.37 Mackenzie
Centre, 8440-112 Street, Edmonton, Alberta T6G 2B7
Telephone: (403) 492-6306 Fax: (403) 492-4923 - S 90-39
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! S C O T T & W H IT E

TEXAS A&M UNIVERSITY
College of Medicine
TEMPLE CAMPUS

The Department o f Neurologic Surgery o f the Scott
and White Institutions and Texas A&M University
College o f Medicine is seeking applications for
senior staff physician faculty in the Sections o f
Pain/Stereotaxic Surgery or Neurosurgical Oncology.
Residency or post residency experience and a
defined interest in either subspecialty area together
with a broad capability and interest in general
neurosurgical disorders is desired. Basic and clinical
research opportunities are available commensurate
with previous experience. Medical student and
resident teaching/daily responsibilities are required.
The main campus is located in central Texas, north
o f Austin in the approximate center o f the Dallas/ Ft.
Worth, San Antonio, Houston triangle and benefits
from easy access to other surrounding universities
(Southwestern University, Georgetown; University o f
Mary Ilardin-Baylor, Belton; Baylor University,
Waco.)
For further information, please send curriculum
vitae and references to:
Mitchell Smigicl, M.D.
Chairman, Neurologic Surgery
Scott and White, Texas A&M University
College o f Medicine
2401 South 31st Street
Temple, TX 76508
—S90-06
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THE SURGEON’S CHOICE
STERILE SINGLE USE SURGICAL BLADES & SCALPELS
SCALPELS WITH BLADES - SINGLE U SE

SURGICAL BLADES

/

Superb sharpness, foil wrapped individually in quick- | E a c h scalpel is packed in a polyester and aluminum foil to
dispenser boxes. Made from the highest quality materials, Iprotect blade edges. Unique dispenser box of 20 scalpels,
for assured uniformity.
BEach scalpel in individually inspected.
A va ila b le in all sizes:

I A va ila b le in all sizes:

#'s 10, II, 12, 14, 15A, 15, 20, 21, 22, 23, 24 and 25.
Any size, 100 per box.

1 10. 11. 12, 14, I5A, 15, 20, 21, 22, 23, 24 and 25.
|Any size, 20 per box.

V E R ^ S P E C IA ^ ^ 9^ 9^ ^ 3^ I3E G U L A ^ ^ ^ ^ 5^ ^ ^ ^ ^ ^ S U P E ^ ^ P E C IA L ^ $6 j 9 9 ^
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STAINLESS STEEL HANDLES
M ade from Rust-Free stainless steel. Arrow sh aped design for assured grip. Sim ply The Finest. G uaranteed

VERY SPECIAL:

$6.95

MICROBLADES AND M ICROKNIVES
These Microblades have been developed in conjunction with leading surgeons and have achieved the aim of
developing a well balanced instrument to ensure precision and consistency in microsurgeiy.
•
•
•

Sterile and disposable.
Microblade cutting edges are available in four standard angles.
Blade after blade, cutting edges are precision-ground for sharpness
and consistent cutting angles.

•

Microblades are color-coded to determine different blade angles.
For greater cutting ed ge protection, microblades are individually
encased in plastic and wrapped in a pre-sterilized p eel-off pouch.
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Microknives

M icroblades
SPECIAL 10/Box: $ 3 9 . 5 0 / b x

REGULAR $59.95

MICROBLADE HANDLE ONLY
MDICL INC.
175 TORYORK DRIVE, UNIT #6
WESTON, ONTARIO
M9L2Y7

KBSEI

VISA

SPECIAL ONLY:

$49.95 10/bx

REGULAR $69.95/ 10/bx

SPECIAL: $ 19.95 each

All our products carry a one-year limited warranty
Please call from anywhere in Canada

Toll F ree - 1-800-387-7477

CALL 24 HRS A DAY
TEL: (416) 747-1125
FAX: (416) 783-5795
VISA & MASTERCARD

Ereamisol' + 5-FU.
The first adjuvant therapy proven to
reduce recurrence by 41%.
t

LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF
RESECTED COLON CARCINOMA
Abstract Twelve hundred ninety-six patients with resected
colon cancer that either was locally invasive [Stage BJ or
had regional nodal involvement [Stage C] were randomly
assigned to observation or to treatment for one year with
levamisole combined with fluorouracil. Patients with Stage
C disease could also be randomly assigned to treatment
with levamisole alone. The median follow-up time at this
writing is 3 years [range, 2 to 5'/2).
Among the patients with Stage C disease, therapy with
levamisole plus fluorouracil reduced the risk of cancer
recurrence by 41 percent [P < 0.0001], The overall death
rate was reduced by 33 percent [P ~ 0.006], Treatment
with levamisole alone had no detectable effect. The results
in the patients with Stage B2 disease were equivocal and

too preliminary to allow firm conclusions. Toxic effects of
levamisole alone were infrequent, usually consisting of
mild nausea with occasional dermatitis or leukopenia,
and those of levamisole plus fluorouracil were essentially
the same as those of fluorouracil alone-i.e., nausea,
vomiting, stomatitis, diarrhea, dermatitis, and leukopenia.
These reactions were usually not severe and did not greatly
impede patients' compliance with their regimen.
We conclude that adjuvant therapy with levamisole and
fluorouracil should be standard treatment for Stage C
colon carcinoma. Since most patients in our study were
treated by community oncologists, this approach should
be readily adaptable to conventional medical practice
[N Engl J Med 1990; 322:352-8.]’
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THERAPY SHOULD BE INITIATED WITHIN 5 WEEKS OF SURGERY.
NEW

'E rgam isol
■

JANSSEN
P H A R M A C E U T IC A
M ississauga. O ntario

LEVAMISOLE HC1IB

A

in combination with 5-fluorouracil

Now a reason to refer patients
after surgery

i.

'Trademark
M EM BER

